360biolabs |
Contract service provider bringing together virology and immunology in a quality-assured environment |
3Derm Systems |
AI to automate Dermatological Care |
7D Surgical |
Image Guided Surgery System |
Abiomed |
Medical Devices |
Absolute Antibody |
Antibody expression and engineering services |
Abveris |
Custom Antibodies |
Acacia Pharma |
Small Molecules |
Acme Bioscience |
Medicinal chemistry, custom synthesis |
ACT Genomics |
Cancer Genomic Profiling |
Adesis |
Custom Organic Synthesis |
ADL Biopharma |
Biologics, Contract Work |
Admescope |
ADME-tox services |
Advanced Biomatrix |
3D Tissue Culture, Assays and Cell Proliferation |
Advanced Cell Diagnostics |
RNA Detection |
Aegea Biotechnologies |
Molecular Diagnostics, Next-Gen Sequencing |
Agena Bioscience |
High throughput targeted & multiplexed genetic analysis |
Agena Bioscience |
High throughput targeted & multiplexed genetic analysis |
Agrisera |
Antibodies |
Aimmune Therapeutics |
Food allergy therapies |
Ajinomoto Bio-Pharma Services |
Contract Manufacturing |
Ajinomoto Bio-Pharma Services |
Contract Manufacturing |
Ajinomoto Bio-Pharma Services |
Contract Manufacturing |
Ajinomoto Bio-Pharma Services |
Contract Manufacturing |
Akouos |
Gene Therapy for Hearing Disorders |
Aldevron |
High-quality plasmid DNA, proteins, enzymes, antibodies, and other biologicals |
Aldevron |
High-quality plasmid DNA, proteins, enzymes, antibodies, and other biologicals |
Alexion Pharmaceuticals |
Biologics |
Alexion Pharmaceuticals |
Biologics |
Alexion Pharmaceuticals |
Biologics |
Alexza Pharmaceuticals |
Drug Delivery, Small Molecule |
AllCells |
Cytokines, Stem Cells, Media, etc. |
Allied Medical |
Medical Devices |
AlterG |
Anti-gravity treadmill |
AMAL Therapeutics |
Therapeutic Vaccines |
Ambry Genetics |
Genetic Testing |
Amolyt Pharma |
Therapeutic Peptides |
Amoun |
Many branded generics |
Amplion |
Pharma Intelligence Platform powered by Machine Learning and Biomedical PhDs |
Amryt Pharma |
Orphan Specialty Drugs |
Apicore |
API Development & Manufacturing |
ApiFix |
Scoliosis Device |
Apollo Endosurgery |
Lab Band |
Applied BioMath |
Systems Pharmacology & Mechanistic Modeling for Drug R&D |
Applied BioMath |
Systems Pharmacology & Mechanistic Modeling for Drug R&D |
Aran Biomedical |
Custom Design, Development & Manufacturing of Medical Implants - Medical Fabrics, Coating and PTFE Encapsulation |
Artelon |
Biomaterial for soft tissue healing |
Arxspan |
ELN & Scientific Workflow Solutions |
Astex Pharmaceuticals |
Small Molecules |
Astex Pharmaceuticals |
Fragment-Based Drug Discovery |
Asuragen |
Diagnostics |
ATDBio |
Custom Oligo Synthesis |
Atos Medical |
Voicebox Implants |
Atos Medical |
Voicebox Implants |
Attune Medical |
Temperature Management Therapy |
Aurinia Pharmaceuticals |
Small Molecules, Diagnostics |
AusDiagnostics |
Multiplexed Diagnostics |
Avenu Medical |
Vascular Access System |
Avitide |
Custom affinity purification discovery service |
Bardy Diagnostics |
Cardiac Monitors |
Bespak |
CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products |
Bespak |
CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products |
Bespak |
CDMO focused on inhaled and nasal drug delivery devices and drug-device combination products |
BioCentriq |
Boutique cell therapy CDMO with a proven track record of successful clinical manufacturing. |
BioFire Diagnostics |
Diagnostics System |
BioLegend |
Cytokines, Reagents, etc. |
Biologos |
Standard and custom cell culture media and reagents |
BioMagnetic Solutions |
Magnetic Cell Separation |
Biomed Diagnostics |
In Vitro diagnostic devices and custom laboratory tools |
Bionova Scientific |
Full-service Biologics CDMO |
BioPharma Services |
Clinical Trial Services |
BioPharma Services |
Clinical Trial Services |
BioReference Laboratories |
Genetic, Diagnostic Testing |
Biosero |
Laboratory Automation, Liquid-handling |
Biostrand |
Omics Analysis |
Biotest Pharmaceuticals |
Biologics |
BioXyTran |
Modified hemoglobin therapy |
Blacktrace |
Acquired by Unchained Labs, Jul 2023 |
Blue Heron Biotech |
DNA Synthesis |
Blueprint Genetics |
Genetic tests |
Blueprint Genetics |
Genetic tests |
c-Lecta |
Enzymes, Microbial Strains, Contract Manufacturing |
Canopy Biosciences |
Gene Editing, Gene Expression, Bioprocessing |
Canyon Labs |
Pharma & Device Consulting |
Cavion |
Neurologic diseases and cancer |
Cellenion |
Single Cell Testing |
Cellesce |
Organoid biobank for R&D, contract bioprocessing |
Center for Breakthrough Medicines |
Cell Therapy Contract Research & Manufacturing |
Cepheid |
Molecular Diagnostics |
Cerevel Therapeutics |
Neuro |
Cerveau Technologies |
Tau Imaging |
Chembio Diagnostic Systems |
Rapid diagnostics |
Compass Therapeutics |
Antibody Therapies |
Conformis |
Knee replacement implants, customized orthopedics |
Corgenix |
Diagnostics |
Corium |
Transdermal Generics, Consumer Products |
Corium |
Transdermal Generics, Consumer Products |
Covaris |
DNA Sample Prep |
Crown Bioscience |
Drug Development |
Crown Bioscience |
Drug Development |
Crown Bioscience |
Drug Development |
Crown Bioscience |
Drug Development |
Crown Bioscience |
Drug Development |
Crown Bioscience |
Drug Development |
Crown Bioscience |
Drug Development |
CTI BioPharma |
Small Molecules, Biologics |
Cytognos |
Flow Cytometry Solutions |
DDL |
Device Testing |
DDL |
Device Testing |
DDL |
Device Testing |
deCode Genetics |
Biotech Services |
DermTech |
Molecular Testing |
Diagenode |
Lab Assays & Reagents |
Diagenode |
Lab Assays & Reagents |
Diagnostics Research Group |
Acquired by IMA Group, Oct 2021 |
DICE Therapeutics |
Small molecule compounds that act by unlocking protein-protein interfaces |
Digirad |
Mobile diagnostic services, imaging |
Dimerix |
Drug Discovery Platform |
Diurnal |
Small Molecules |
Diversigen |
Microbiome Analysis |
DJS Antibodies |
Therapeutic antibody discovery and design |
DPT Laboratories |
Semi-solid & Liquids - Contract Development, MFG |
DRG International |
In Vitro Diagnostics |
DSG |
Clinical Trial Software |
Easthorn |
Acquired by Novotech, Jan 2023 |
EirGen Pharma |
Contract Small Molecule Manufacturing & Development |
Eloxx Pharmaceuticals |
Rare Genetic Diseases |
Empire Genomics |
High throughput genome-wide analysis |
Endomag |
Biopsy Tracer |
Enzyvant Sciences |
Merging with Altavant Sciences, Dec 2022; Acquired by Sumitomo Dainippon Pharma with four other Roivant companies, Dec 2019, $3B; |
Escient Pharmaceuticals |
GPCR-targeted Drugs |
Essential Pharmaceuticals |
Organ Preservation |
Eton Bioscience |
Research Reagents, Kits, Peptides, Services, etc. |
Eton Bioscience |
Research Reagents, Kits, Peptides, Services, etc. |
Eton Bioscience |
Research Reagents, Kits, Peptides, Services, etc. |
Eton Bioscience |
Research Reagents, Sequencing, Kits, Peptides, Services, etc. |
Eurofins Advinus |
Drug Discovery |
EUROIMMUN |
Lab Assays |
Exelead |
Clinical Development, Commercial & Clinical Manufacturing |
Exemplify BioPharma |
CMC laboratory and consulting services for small molecule programs - Process, Analytical, Formulation Development, QA, and Reg Affairs |
Exosome Diagnostics |
Biofluid-based molecular diagnostic tests |
Exosome Diagnostics |
Biofluid-based molecular diagnostic tests |
EyeBio |
Ophthalmology Treatments |
F-star Therapeutics |
Antibody Engineering |
Farapulse |
Acquired by Boston Scientific, Jun 2021 |
Fiagon AG Medical Technologies |
Electromagnetic Navigation for Surgery |
Fluent BioSciences |
Single Cell Analysis Without Complex Instrumentation |
Fusion Pharmaceuticals Inc. |
Targeted Alpha Therapeutics for chemo-resistant Cancers |
GenDx |
HLA Typing via NGS |
Genewiz |
Sequencing, Biotech Services |
Genovac |
Antibody Discovery Tools |
Genpro Research |
Clinical Research Services |
Genuity Science |
Genomic Data Platform |
GenWay Biotech |
Reagents, Kits, Antibodies |
GigaGen |
Immune therapeutics |
Glen Research |
Oligos |
GRAIL |
Cancer diagnostics |
HansaBioMed |
Antibodies |
Haystack MRD |
Minimal residue disease testing for oncology |
Hemera Biosciences |
Gene Therapy |
High Purity New England |
Single use products, Additional distributed equipment |
Hikma |
Medication Delivery |
Hoth Therapeutics |
Small Molecules |
Iconic Therapeutics |
Biologics |
iHear medical |
Hearing aid |
Immunodiagnostic Systems |
Immunoassay System |
Immunodiagnostic Systems |
Immunoassay System |
Immunodiagnostic Systems |
Immunoassay System |
Immunodiagnostic Systems |
Immunoassay System |
Immunodiagnostic Systems |
Immunoassay System |
Immunodiagnostic Systems |
Immunoassay System |
Immutep |
Cell therapies & antibodies |
Impact Analytical |
Contract testing laboratory. comprehensive analytical services |
Impeto Medical |
Medical Devices |
Imris, Deerfield Imaging |
Image Guided Therapy Solutions |
Inform Diagnostics |
Anatomic Pathology Lab |
InfraReDx |
Medical Devices |
InnoN |
Biologics, Small Molecules |
Inscopix |
Miniature Microscope |
Insulet |
Insulin Pump |
IntegraGen |
Biomarker identification, diagnostics |
Integrated DNA Technologies |
Nucleic Acid Synthesis |
Intercept Pharmaceuticals |
Small Molecules |
Intercept Pharmaceuticals |
Small Molecules |
InterX |
Biomolecular Simulation for Drug Discovery |
Invicro |
Imaging services & software |
InVivo BioTech Services |
Contract Manufacturing Organization for antibodies, recombinant proteins and final immunoassay kits |
iota Biosciences |
Implantable Bioelectronic Devices |
iovera |
Cold-treatment for nerves |
Itamar Medical |
Sleep Apnea Diagnostic Device |
Ivenix |
Infusion pumps |
IZI Medical |
Bone Cement, Imaging Markers, Surgical Needles |
J-Star |
Contract Chemistry |
Kemp Proteins |
Mammalian & insect culture services |
Kerafast |
Reagents for the Greater Good |
Latham Biopharm Group |
Consulting |
Leaf Healthcare |
Wireless, wearable Patient Sensor |
Leica Biosystems |
Diagnostic Lab Products |
LifeSpan Biosciences |
Immuno histochemistry Products and Services |
LimFlow |
Critical Limb Ischemia Treatment |
LimFlow |
Critical Limb Ischemia Treatment |
Lino Biotech |
Focal Molography |
Lobsor Pharmaceuticals |
Formulation of Parkinson's Treatment |
Lotus Pharmaceuticals |
Generics |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lumenis |
Energy-based medical treatments |
Lunaphore Technologies |
Tissue Analytics for In Vitro Diagnostics |
Lung Therapeutics |
Respiratory Treatments |
Lynch Biologics |
Biologic for Hard & Soft Tissue Applications |
Marker Therapeutics |
Cell Therapy |
Mathys Medical |
Orthopedic Devices |
Meridian Bioscience |
Diagnostics |
Millipore |
Purification, Analytic Biologics, Discovery |
Millipore |
Purification, Analytic Biologics, Discovery |
Millipore |
Purification, Analytic Biologics, Discovery |
Millipore |
Purification, Analytic Biologics, Discovery |
Millipore |
Purification, Analytic Biologics, Discovery |
Mobidiag |
Molecular diagnostics |
Mobius Medical |
Clinical Research |
ModeX Therapeutics |
Biologics |
MyChem |
Nucleotides |
Myovant Sciences |
Fully acquired by Sumitomo, Oct 2022, $2.9B; Majority Acquired by Sumitomo Dainippon Pharma with four other Roivant companies, Dec 2019, $3B |
Namocell |
Single Cell Sorter |
Nanosyn |
Medicinal chemistry, drug screening |
Native Antigen Company |
Development and manufacture of native viral and bacterial antigens |
Natus Medical |
Medical Devices, software |
Nebula Genomics |
Consumer Sequencing, Blockchain, Selling Personal Data, George Church, etc |
Neogene Therapeutics |
T Cell Therapies for Cancer |
NeuroDerm |
Reformulations of established drugs |
New England Drug Discovery Partners |
Synthetic organic and medicinal chemistry |
Nexcelom Bioscience |
Cell counters |
NexusPharma |
Oncology CRO with over 150 proprietary extensively characterized PDX models of different tumor types available for efficacy studies in vivo. |
Novastep |
Foot & Ankle Implants |
Novitium Pharma |
Generics |
Novocol |
Sterile Manufacturing |
NuChem Sciences |
Medical chemistry contract research |
Nucro-Technics |
Contract Testing |
NuVasive |
Minimally Invasive Spinal Surgery Devices |
NxStage |
Medical Devices |
Olink Proteomics |
Protein & Nucleic Acid Analysis |
Olink Proteomics |
Protein & Nucleic Acid Analysis |
Olon Ricerca Bioscience |
Contract Research |
OmegaChem |
Organic Molecule Manufacturing |
Oncternal Therapeutics |
Oncology antibody treatments |
One Codex |
Microbiome Sequencing Platform |
Organix |
Contract Research & Development |
Owl Biomedical |
Microchip-based disposable cell sorting technology |
Oxford Immunotec |
Diagnostics |
Oxgene |
Biomanufacturing |
Panag Pharma |
OTC Cannabinoids |
Paramit |
Medical Device and Life Science Instrument Product Development and Manufacturing |
Paratek Pharmaceuticals |
Small Molecules |
Paratek Pharmaceuticals |
Small Molecules |
Parexel |
Clinical Research |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Patheon |
Contract Manufacturing and Development |
Pega Medical |
Pediatrics Orthopedics |
Personal Genome Diagnostics |
Tumor Genome Analysis |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmaLex |
Development Consulting, Regulatory Affairs Consulting, Quality Management and Compliance, Pharmacovigilance to the Biopharma, Pharma and Medical Device Industries. |
PharmOptima |
ADME, PK, DMPK, assay dev., pharmacology, protein cloning & expression, cell-based assays, biomarkers, and ocular drug discovery models |
PhenoPath |
Diagnostic and contract research services |
Pillar5 Pharma |
Contract Everything |
PPD |
Contract R & D, Consulting |
PPD |
Contract R & D, Consulting |
PPD |
Contract R & D, Consulting |
PrecisionMed |
Human Tissues |
preclinics |
Contract Research |
preclinics |
Contract Research |
preclinics |
Contract Research |
preclinics |
Contract Research |
Prevail Therapeutics |
AAV-based gene therapies |
Processa Pharmaceuticals |
Small Molecule |
ProciseDx |
Diagnostics |
Protomer Technologies |
Glucose-responsive Insulin |
Protypia |
|
PTS Diagnostics |
Diagnostic test systems |
Pulse Technologies |
Contract Medical Device Manufacturing |
Pulvinar Neuro |
Transcranial Direct Stimulation |
Quantigen Biosciences |
Contract diagnostic tests and medical devices |
Quintara Discovery |
In vitro ADME profiling, bioanalysis services, and dedicated assay development and compound screening |
Rebiotix |
Microbiota Restoration Therapy |
Relievant Medsystems |
Back Treatment |
ReShape Lifesciences |
Weight loss device |
Resolution Bioscience |
Next gen sequencing tech for cancer diagnostics |
RespirTech |
Airway Clearance Devices |
Reveal Biosciences |
Contract Tissue-Based Research |
Rewrite Therapeutics |
Acquired by Intellia Therapeutics, Feb 2022, $45M + $155M milestones |
Rosemont Pharmaceuticals |
Liquid Medicines |
Samsung Bioepis |
Biologics, Biosimilars |
Sciex |
Mass Spectrometers and Training |
SCILEX |
Transdermal Drug Delivery |
SDIX |
Diagnostics |
Searchlight Pharma |
Specialty Pharmaceuticals |
Second Source Medical |
Medical Device Contract Manufacturing |
Seqens CDMO North America |
Contract Manufacturing & Research |
Sequilite |
NGS platform |
Seracare Life Sciences |
Biologic Diagnostic Products |
Seracare Life Sciences |
Biologic products for research |
Silicon Biosystems |
Lab-on-a-Chip Cellular Separation |
Simbex |
Biomechanical devices |
SmartPharm Therapeutics |
Production of biologics within patients via gene therapy |
SomaLogic |
Blood Analysis |
Somatex |
Biopsy Marker, tumor localization |
Sonosite |
Portable Ultrasound |
Spark Therapeutics |
Singe Dose Gene Therapy |
Speclipse |
Laser-Based Medical Diagnostics |
Speclipse |
Laser-Based Medical Diagnostics |
Spinal Elements |
Spinal Implants |
Spirovant Sciences |
Gene Therapy - Lung Diseases |
Sprout Pharmaceuticals |
Treatment for Hypoactive Sexual Desire Disorder |
Spur Therapeutics |
Protein replacement via Gene Therapy |
STA Pharmaceutical |
API manufacturing |
STA Pharmaceutical |
API manufacturing |
STA Pharmaceutical |
API manufacturing |
STA Pharmaceutical |
API manufacturing |
Stallergenes Greer |
Allergen Desensitization |
Standard Bariatrics |
Bariatric Clamps |
STATKING Clinical Services |
Clinical Trial Consulting |
Stemline Therapeutics |
Cancer Stem Cells |
Sunovion |
Acquired by Sumitomo, Jul 2023; fka Sepracor |
SuperSonic Imagine |
Ultrasound Devices |
SynCardia Systems |
Artificial Hearts |
SynHelix |
DNA Synthesis Technology |
T3 Pharmaceuticals |
Bacterial Cancer Therapy |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Taconic Biosciences |
Genetically engineered rodent models and services. Specialists in Mouse Model Humanization and GEMs Management. |
Telomere Diagnostics |
Business filings late mid-2023, seems to have pivoted to consumer Covid testing?; Acquired by Orig3n, Late 2020 |
Tenex Health |
Minimally invasive technology for treatment of chronic tendon pain |
Tetra Therapeutics |
Neurological targets |
TGR BioSciences |
Cell assays |
Theramex |
Women's Health |
TIB Molbiol |
Reagents for research and medical diagnostics |
Transplant Genomics |
Monitoring to prevent transplant rejection |
Trigen Laboratories |
Generic Small Molecules |
TriLink Biotechnologies |
Custom Nucleotides |
Trukera Medical |
Dry eye diagnostic |
TUBE Pharmaceuticals |
Tubulysins for potential therapeutic applications |
Upsher-Smith |
Small Molecules, Generics |
Upsher-Smith |
Small Molecules, Generics |
Upsher-Smith |
Small Molecules, Generics |
Valence Labs |
AI-Enabled Drug Design |
Valence Labs |
AI-Enabled Drug Design |
Varian Medical Systems |
Medical Devices & Software |
Vector Laboratories |
Blotting Products, Antibodies |
Vectura |
Inhalers |
Veriton Pharma |
Small Molecules, Compounded Formulations |
Vernalis Research |
Contract drug discovery & development offering integrated solutions from Target ID through to Clinic |
Versanis Bio |
Acquired by Lilly, Aug 2023, $1.9B |
Veryan Medical |
Helical Stent |
Veryan Medical |
Helical Stent |
Vesper Medical |
Venous Stent |
Villaris Therapeutics |
Vitiligo Treatment |
Viridian Therapeutics |
MicroRNA |
Viridian Therapeutics |
MicroRNA |
Vividion Therapeutics |
Proprietary Screening |
Vyrsa Technologies |
Sacroliac Joint Pain Implant |
Xell |
Cell Culture Media |
Xenotech |
Contract Research & Consulting - Drug Metabolism |
Xinvento |
Congenital hyperinsulinism treatment |
Xyphos |
Cell-based cancer therapies |
Yurogen Biosystems |
Antibodies & Services |
Ziath |
Barcode Tube Management Scanners |
Zynerba Pharmaceuticals |
Transdermal synthetic cannabinoid treatments |
159 Solutions |
Acquired by IQVIA, May 2018 |
3-Dimensional Pharmaceuticals |
Acquired by J&J, Jan 2003, $88M |
3Clinical Research |
Acquired by Parexel, Mar 2004 |
3F Therapeutics |
Acquired by ATS Medical, Jan 2006 |
4-Antibody |
Bought by Agenus, Jan 2014, $10M |
454 Life Sciences |
Bought by Roche, Mar 2007, $454M |
4C Biotech |
Acquired by Henogen, Jul 2003 |
4SC-Discovery |
Sold to BioNTech Small Molecules, Apr 2016 |
510 Kardiac Devices |
Acquired by Keystone Heart, Jun 2020 |
A&E Medical |
Acquired by Zimmer Biomet, Dec 2020, $250M |
Aaren Scientific |
Bought by Zeiss, Jan 2014 |
AavantiBio |
Acquired by Solid Biosciences, Dec 2022 |
Ab Initio Biotherapeutics |
Acquired by Ligand Pharmaceuticals, Jul 2019, $12M |
Abaxis |
Bought by Zoetis, Jul 2018 |
Abceutics |
Acquired by Merck, Apr 2024, $208M |
Abcore |
Acquired by Fortis Life Sciences, Mar 2022 |
abCRO |
Acquired by PPD, Apr 2009 |
AbD Serotec |
Acquired from MorphoSys by Bio-Rad, Jan 2013, €53M |
Abeta |
Assets bought by The Genetics Company, Jun 2003 |
Abexxa Biologics |
Acquired by Boehringer-Ingelheim, Sep 2021 |
ABF Pharmaceutical Services |
Acquired by GBF Group Pharma, 2017 |
AbFero Pharmaceuticals |
Acquired by Pharmacosmos, Nov 2021, $225M |
ABgene |
Bought by Apogent, Dec 2001 |
Abgenix |
Bought by Amgen 2006 |
Abide Therapeutics |
Acquired by Lundbeck, May 2019, $250M |
Ability Biomedical |
Acquired by Medarex, $4.7M, Jul 2004 |
Ablation Frontiers |
Acquired by Medtronic, Jan 2009, $225M |
Ablynx |
Acquired by Sanofi, Jun 2018, $4.8B |
Abmaxis |
Acquired by Merck, May 2006, $80M |
Abound Bio |
Acquired by Galapagos Jun 2022, $14M |
Abraxis Bioscience |
Bought by Celgene, Jun 2010, $2.9B |
Abrika Pharmaceuticals |
Acquired by Actavis, Apr 2007 |
Absalus |
Acquired by EvoGenix, Apr 2005 |
Absorption Systems |
Acquired by Pharmaron, Oct 2020 |
Abt Bio-Pharma Solutions |
Acquired by United Biosource, May 2010 |
AbVitro |
Bought by Juno Therapeutics, Jan 2016, $125M |
Acacia Biosciences |
Acquired by Rosetta Inpharmatics, Feb 1999 |
Acambis |
Bought by Sanofi Pasteur, $276M, Sep 2008 |
Accel Biotech |
Acquired by Ximedica, Jul 2016 |
Acceleron Pharma |
Acquired by Merck, Nov 2021, $11.5B |
AccelLAB |
Acquired by Charles River, Apr 2019 |
Accelrys |
Bought by Dassault, 2014 |
Acceptys |
Assets acquired by Patrys, Oct 2008 |
ACCESS Oncology |
Acquired by Keryx Biopharmaceuticals, Jan 2004 |
Access Scientific |
Acquired by Smiths Medical, May 2020 |
AccessClosure |
Bought by Cardinal Health, May 2014 |
Acclarent |
Acquired by Integra LifeSciences, Mar 2024; Bought by J&J, Dec 2009, $785M |
Accovion |
Acquired by Clinipace, Apr 2015 |
Accriva Diagnostics |
Acquired by Werfen/Instrumentation Laboratory, Jan 2017; fka ITC |
Accugenix |
Bought by Charles River, Aug 2012 |
Accuimage Diagnostics |
Acquired by Merge eFilm, Jan 2005 |
Accuri Cytometers |
Acquired by BD, Mar 2011 |
Ace Biosciences |
Acquired by Zymenex, Nov 2009 |
ACEA Biosciences |
Acquired by Agilent, Nov 2018 |
ACell |
Acquired by Integra LifeSciences, Jan 2021, $300M |
Acer Therapeutics |
Acquired by Zevra Therapeutics, Nov 2023, $15M |
Acessa Health |
Acquired by Hologic, Aug 2020, $80M + Milestones |
Acetylon Pharmaceuticals |
Acquired by Celgene, Dec 2016 |
Achillion Pharmaceuticals |
Acquired by Alexion, Jan 2020, $930M |
ACI Clinical |
Acquired by WCG, Mar 2018 |
Aciex Therapeutics |
Acquired by Nicox, Oct 2014, $120M |
Aclara Biosciences |
Bought by ViroLogics, Dec 2004, $160M |
ACMI |
Acquired by Gyrus, 2005, $500M |
Acolyte Biomedica |
Acquired by 3M, Feb 2007 |
Acris Antibodies |
Acquired by OriGene Technologies, Sep 2015, became OriGene Europe |
AcroMetrix |
Acquired by Life Technologies Jan 2010 |
Acrymed |
Bought by Halyard (Halyard fka Kimberly-Clark Healthcare) |
AcSentient |
Main assets acquired by Ista Pharmaceuticals, May 2002 |
ACT Oncology |
Acquired by Precision for Medicine, Mar 2016, renamed Precision Oncology |
Acta Vascular |
Acquired by CardioVasc, Apr 2007 |
Actagene Oncology |
Acquired by Ignyta May 2013 |
Actavis |
Acquired Allergan, $70B, Took Allergan name |
Actelion Pharmaceuticals |
Acquired by J&J, Jun 2017, $30B |
Actient Pharmaceuticals |
Acquired by Auxilium Pharmaceuticals, Apr 2013 |
Actimis Pharmaceuticals |
Acquired by Boehringer Ingelheim 2008 |
Activaero |
Bought by Vectura, €130M, Mar 2014 |
ActivaTek |
Acquired by North Coast Medical |
ActiViews |
Acquired by Stryker, Oct 2013, $30M |
Activiomics |
Acquired by Retroscreen Virology Group, Mar 2014 |
Activus Pharma |
Acquired by Sosei Group, Jun 2010, $5.6M |
ActoGeniX |
Acquired by Intrexon, $60M, Feb 2015 |
Acton Pharmaceuticals |
Acquired by Meda, Aug 2013 |
AcuFocus |
Acquired by Bausch + Lomb, Jan 2023 |
Acuity Bio |
Acquired by Cook Biotech, May 2021 |
Acuson |
Acquired by Siemens, Sep 2000, $700M |
Acute Innovations |
Acquired by Acumed, Mar 2020 |
Adamas Pharmaceuticals |
Acquired by Supernus, Nov 2021 |
Adapt Pharma |
Bought by Emergent Biosolutions, Oct 2018, $635M + $100M milestones |
Adaptate Biotherapeutics |
Acquired by Takeda, Jan 2022; Spun out of Gammadelta Therapeutics, Oct 2019 |
Adaptive Phage Therapeutics |
Acquired by BiomX, Mar 2024 |
ADC Biotechnology |
Acquired by Sterling Pharma Solutions, Apr 2021; aka ADCBIO |
Additive Orthopaedics |
Acquired by Paragon 28, Jun 2021 |
Addrenex |
Bought by Shionogi subsidiary Sciele, Nov 2009, $29M |
Adello Biologics |
Acquired by Kashiv Pharma, Jan 2019 |
Adenosine Therapeutics |
Bought by Clinical Data, Aug 2008, $11M |
AdeptBio |
Bought by Asterand Bioscience, Aug 2015 |
Aderis Pharmaceuticals |
Acquired by Schwarz Pharma, Jul 2005 |
Adeza Biomedical |
Acquired by Cytyc, Apr 2007 |
Adheron Therapeutics |
Bought by Roche, Oct 2015, $105M + $475 Milestones |
Adhesys Medical |
Bought by Grunenthal, Apr 2017; fka Medical Adhesive Revolution |
Admune Therapeutics |
Acquired by Novartis, Oct 2015 |
Adnexus Therapeutics |
Bought by BMS, Sep 2007, $415M |
Adolor |
Acquired by Cubist, Oct 2011, $415M |
AdProtech |
Acquired by Inflazyme Pharmaceuticals, Apr 2004 |
Adrestia Therapeutics |
Acquired by Insmed, Jul 2023 |
ADSM-Synchro Medical |
Acquired by Tyber Medical, Feb 2023 |
Aduro Biotech |
Acquiring Chinook Therapeutics, Jun 2020, taking name |
Advalytix |
Acquired by Beckman Coulter, 2009 |
Advanced Analytical Technologies |
Acquired by Agilent, Mar 2018 |
Advanced Biohealing |
Bought by Shire 2011, Now Shire Regenerative Medicine |
Advanced Biotherapy |
Acquired for cash assets by energy company, Mar 2009 |
Advanced Circulatory |
Bought by Zoll Medical, Mar 2015 |
Advanced Circulatory Systems |
Acquired by Zoll, Dec 2014 |
Advanced Clinical Research |
Acquired by Velocity Clinical, Jun 2019 |
Advanced Influenza Technologies |
Acquired by CytoDyn, Jul 2006 |
Advanced Inhalation Research |
Acquired by Alkermes, Feb 1999 |
Advanced Memory Institute of NJ |
Acquired by Cenexel, Aug 2021 |
Advanced Ocular Systems |
Acquired by scaffolding company, Dec 2008 |
Advanced Stent Technologies |
Acquired by Boston Scientific Dec 2004 |
Advanced Technology and Regenerative Medicine |
Bought by DePuy |
AdvancedCath |
Acquired by TE Connectivity, Feb 2015, $190M |
AdvanDx |
Acquired by OpGen, Jul 2015 |
Advangen |
Acquired by Cellmid, May 2013 |
Advantar Laboratories |
Acquired by Eurofins, Mar 2016 |
Advion Bioanalytical |
Bought by Quintiles, Nov 2011 |
ADViSYS |
Acquired by VGX Pharmaceuticals, 2007 |
AEGEA Medical |
Acquired by CooperSurgical, Feb 2021 |
Aegera Therapeutics |
Acquired by PharmaScience, May 2011 |
Aegis Therapeutics |
Acquired by Neurelis, Dec 2018 |
Aelian Biotechnology |
Renamed Myllia, Apr 2022 |
Aequus Biopharma |
Owned by CTI Biopharma, no news since 2012, no employees on LinkedIn |
Aerie Pharmaceuticals |
Acquired by Alcon, Nov 2022, $770M |
Aero Pharmaceuticals |
Acquired by Cocrystal Pharma, May 2011 |
Aerocrine |
Bought by Circassia Pharmaceuticals, May 2015, $219M |
AES Chemunex |
Bought by bioMerieux, May 2011 |
Aesgen |
Acquired by MGI Pharma, Sep 2004 |
Aesica Pharmaceuticals |
Bought by Consort Medical for $374M, Sep 2014 |
AesRx |
Bought by Baxter, Jul 2014 |
Aesthera |
Acquired by Solta Medical, Feb 2010 |
Aevi Genomic Medicine |
Acquired by Cerecor, Feb 2020, $15.6M + $6.5M Milestones |
AexeRNA |
Acquired by BioNTech, Nov 2023 |
Afexa Life Sciences |
Acquired by Valeant Oct 2011 |
Affera |
Acquired by Medtronic, Sep 2022, $1B |
Afferent Pharmaceuticals |
Bought by Merck, Jul 2016, $1.25B |
Affinity BioReagents |
Acquired by Thermo Fisher, Jul 2008 |
Affinium Pharmaceuticals |
Assets acquired by Debiopharm, Feb 2014 |
Affinivax |
Acquired by GSK, Aug 2022 |
Affomix |
Acquired by Illumina, Jul 2010 |
Affymetrix |
Acquired by Thermo Fisher, Apr 2016, $1.3B |
Afmedica |
Acquired by Angiotech, Sep 2005 |
AGA Medical |
Acquired by St. Jude Medical, Oct 2010, $1.3B |
Agalimmune |
Acquired by BioLineRx, Mar 2017, $6M |
Agenovir |
Acquired by Vir Biotechnology, May 2018 |
Agensys |
Acquired by Astellas Pharma, Nov 2007, $387M + $150M milestones |
Agere Pharmaceuticals |
Acquired by Patheon, Mar 2015 |
AGI Dermatics |
Acquired by Estee Lauder, Sep 2008 |
AGI Therapeutics |
Bought by Videra |
Agilis Biotherapeutics |
Bought by PTC Therapeutics, Aug 2018, $50M cash + $150M stock |
Agility Clinical |
Acquired by Precision for Medicine, Sep 2017 |
Agilix |
Acquired by Perkin-Elmer, Feb 2006 |
Agilux Laboratories |
Acquired by Charles River, Oct 2016, $64M |
Agouron Pharmaceuticals |
Acquired by Warner-Lambert, Jan 1999, $2.1B stock |
AGTC |
Acquired by Syncona, Dec 2022, $23.5M + $50M milestones |
Ahura Scientific |
Acquired by Thermo Fisher |
AI Biomed |
Acquired by Medtronic, Oct 2020 |
Aiolos Bio |
Acquired by GSK, Feb 2024, $1B + $400M milestones |
Aires Pharmaceuticals |
Acquired by Mast Therapeutics, Apr 2014 |
AIT Bioscience |
Acquired by Nexelis, Jul 2020 |
Akarna Therapeutics |
Acquired by Allergan, Sep 2016, $50M + milestones |
AkaRx |
Acquired by Eisai, Dec 2009 |
Akcea Therapeutics |
Spun out of Ionis Pharmaceuticals, fully reacquired Aug 2020 |
Akers Biosciences |
Acquired by MyMD Pharmaceuticals via Reverse Merger, Nov 2020 |
AKESOgen |
Acquired by Tempus, Dec 2019 |
AKRN Scientific Consulting |
Acquired by NAMSA, Mar 2022 |
Alanex |
Acquired by Agouron, Apr 1997 |
Alantos Pharmaceuticals |
Bought by Amgen 2007 |
Alaris Medical |
Acquired by Cardinal Health, May 2004 |
Alaven Pharmaceutical |
Bought by Meda, $350M, Oct 2010 |
Albireo Pharma |
Acquired by Ipsen, Mar 2023; Merged with Biodel Nov 2016; Spun out of AstraZeneca in 2008 |
Albumedix |
Acquired by Sartorius, Sep 2022, £415M |
Alcobra Pharma |
Acquired by Arcturus, Sep 2017 via reverse merger |
Aldagen |
Bought by Cytomedix Feb 2012 |
Alder BioPharmaceuticals |
Acquired by Lundbeck, Oct 2019, $1.95B |
Alere |
Acquired by Abbott, Oct 2017, $4.6B |
Alfigen |
Acquired by Genzyme, Feb 2004 |
Algeta |
Acquired by Bayer, Mar 2014 |
AlgoNomics |
Acquired by Lonza, Nov 2009 |
Algorx Pharmaceuticals |
Acquired by Corgentech in reverse merger, Dec 2005 |
Algynomics |
Acquired by Proove Biosciences, May 2016 |
Align Pharmaceuticals |
Acquired by Cyclacel, Oct 2007 |
Alimetrix |
Acquired by Spectrum Solutions, Mar 2023 |
Alios Biopharma |
Acquired by J&J Nov 2014, $1.75B |
Alivio Therapeutics |
Fully absorbed into PureTech, Jun 2021 |
Alize Pharma |
Acquired by Millendo Therapeutics, Dec 2017 |
Alize Pharma II |
Acquired by Jazz Pharmaceuticals, Jun 2016, €8M + €10M milestones |
Alkan Pharma |
Acquired by Hikma, Apr 2011, $60.5M |
Allcyte |
Acquired by Exscientia, Jun 2021 |
Allegro Diagnostics |
Acquired by Veracyte, late 2014 |
Allendale Pharmaceuticals |
Acquired by Synova Healthcare, Feb 2007, $16M stock |
Allenex |
Bought by CareDx, Apri 2016 |
Allergan |
Acquired by AbbVie, May 2020, $63M |
Allergy Immuno Technologies |
Acquired by rubber company, 2003 |
Allergy Laboratories |
Likely acquired by ALK-Abello, Dec 2016 |
Alliance Biosciences |
Acquired by WIRB-Copernicus Group, Jul 2014 |
Alliance Contract Pharma |
Acquired by Altasciences, Feb 2020 |
Alliance Medical Products |
Acquired by Siegfried, May 2012 |
Alliance Protein Laboratories |
Acquired by KBI Biopharma, Jun 2017 |
Alliant Pharmaceuticals |
Acquired by Sciele Pharma, Jun 2007 |
AlliedPath |
Acquired by IRIS International, Aug 2010 |
Allomek Therapeutics |
Acquired by Pasithea Therapeutics, Oct 2022 |
Allon Therapeutics |
Assets acquired by Paladin Labs, Jun 2013 |
Allos Therapeutics |
Acquired by Spectrum Pharmaceuticals Sep 2012 |
Alltracel Pharmaceuticals |
Bought by HemCon, 2008 |
Allylix |
Acquired by Evolva, Nov 2014, $59M stock |
AlmataBio |
Acquired by Avalo Therapeutics, Mar 2024, $22M |
Almedica |
Acquired by Aptuit, Sep 2005 |
Alnara Pharmaceuticals |
Bought by Eli Lilly, Jul 2010, $380M |
Aloka |
Acquired by Hitachi Medical, Jun 2011 |
Alpha Innotech |
Acquired by Cell Biosciences, Sep 2009 |
Alpha-5 integrin |
Acquired by Pasithea Therapeutics, Jun 2022 |
AlphaCore Pharma |
Bought by MedImmune, Apr 2013 |
AlphaPharm |
Acquired by Mylan, 2007 |
Alpharma |
Bought by King Pharmaceuticals, now part of Zoetis |
Alphora Research |
Acquired by eurofins, Jun 2017 |
Alpine Biomed |
Acquired by Natus, Sep 2009 |
Alpine Biosciences |
Acquired by Oncothyreon Aug 2014, $27M in stock |
Alsius |
Assets purchased by Zoll Medical, May 2009, $12M |
Altair Clinical |
Bought by Accelovance, Feb 2015 |
Alteris Therapeutics |
Bought by Celldex Oct 2005, $1.5M plus stock/milestones |
Althea Technologies |
Acquired by Ajinomoto, Mar 2013 |
AltheaDx |
Acquired by Castle Biosciences, Apr 2022 |
Altiva |
Acquired by Exactech, Jan 2008 |
Altor Bioscience |
Bought by NantCell, Aug 2017, $360M |
Altura Medical |
Bought by Lombard Medical Aug 2015, though it was closed Aug 2013 according to Crunchbase |
ALung Technologies |
Acquired by LivaNova, Jul 2022 |
Alveolus |
Assets acquired by Merit Medical, Mar 2009 |
Alverix |
Acquired by BD, Jan 2014 |
Alvine Pharmaceuticals |
Assets acquired by ImmunogenX, Mar 2016 |
Alvos Therapeutics |
Bought by Arrowhead Research, Apr 2012, $23.5M stock |
Alydia Health |
Acquired by Organon Jun 2021; fka InPress Technologies |
ALZA |
Bought by J&J, Jun 2001, $11.8B stock |
AMAG Pharmaceuticals |
Acquired by Covis Pharma, Nov 2020 |
Amalyte Pharmaceuticals |
Acquired by Kemin Jun 2009 |
Amaryllis Nucleics |
Acquired by Active Motif, Jan 2022 |
amaxa |
Acquired by Lonza, Jul 2008 |
Ambest Pharmaceuticals |
Bought by Sihuan Pharmaceutical, Mar 2017, $160M |
AMBI Pharmaceuticals |
Acquired by Neuro-Hitech, Nov 2008 |
Ambion |
Bought by Applied Biosystems 2006 |
Ambit Biosciences |
Bought by Daiichi Sankyo, Nov 2014 |
Amblyotech |
Acquired by Novartis, Apr 2020 |
Ambys Medicines |
Acquired by Cytotheryx, Feb 2023 |
AmCell |
Seems to have been subsumed into Miltenyi |
AmCyte |
Acquired by ReNeuron, Aug 2007, $4M |
Amdipharm |
Acquired by Concordia Healthcare, Sep 2015 |
Amedis Pharmaceuticals |
Acquired by Takeda, Jan 2005 |
Amedra Pharmaceuticals |
Acquired by Impax Laboratories, Mar 2015 |
American Bionostica |
Acquired by Ott Scientific, May 2021 |
American Peptide Company |
Acquired by Bachem, Feb 2015 |
AMF Medical |
Acquired by Tandem Diabetes, Jan 2023 |
Amide Pharmaceutical |
Acquired by Actavis, Jul 2005 |
Amira Medical |
Acquired by Roche, Nov 2001 |
Amira Pharmaceuticals |
Acquired by BMS, Jul 2011, $325M |
Amnestix |
Acquired by SYGNIS, Jun 2008, $6M |
Amnis |
Acquired by EMD Millipore, Aug 2011 |
Amomed Pharma |
Acquired by AOP, Jan 2022 |
Amorcyte |
Acquired by Neostem, Oct 2011 |
Amorsa Therapeutics |
Acquired, 2022 |
Amplimmune |
Bought by MedImmune Oct 2013, $225M |
Amplyx Pharmaceuticals |
Acquired by Pfizer Apr 2021 |
AmpTec |
Acquired by Merck KGaA, Jan 2021 |
Amresco |
Acquired by VWR, Feb 2011 |
Amring Pharmaceuticals |
Acquired by Nordic Pharma, Mar 2024 |
Amsterdam Molecular Therapeutics |
Acquired by UniQure |
Amunix Pharmaceuticals |
Acquired by Sanofi, Feb 2022, $1B + $225 milestones |
AMUR Pharmaceuticals |
Bought by SuperGen |
Amylin Pharmaceuticals |
Bought by BMS Aug 2012 |
ANA Therapeutics |
Acquired by NeuroBo Pharmaceuticals, Dec 2020 |
Anacor Pharmaceuticals |
Bought by Pfizer, Jun 2016, $5.2B |
Anadys Pharmaceuticals |
Acquired by Roche 2011 |
Anagnostics |
Assets acquired by CubeDx, Jul 2015 |
Anakuria Therapeutics |
Acquired by Janssen, Feb 2022 |
Analgesic Solutions |
Acquired by WCG, Apr 2019 |
Analytical Bio-Chemistry Laboratories |
Acquired by EAG, Jul 2015 |
Analytical Lab Group |
Acquired by Element, now Element Life Sciences |
Anayaderm |
Acquired by Alexar Therapeutics, 2014 |
Anchen |
Bought by Par Pharmaceutical |
Anchen Pharmaceuticals |
Acquired by Par Pharmaceutical, Aug 2011 |
Ancile Pharmaceuticals |
Acquired by Mera Pharmaceuticals, Jan 2003 |
Ancora Pharmaceuticals |
Assets Acquired by Corden Pharm, Oct 2013 |
Andara Life Science |
Acquired by CyberKinetics, Feb 2006 |
Andromeda Biotech |
Acquired by Hyperion, Jun 2014 |
Andrx Pharmaceuticals |
Acquired by Watson Pharmaceuticals, Nov 2006, $1.9B |
Anelixis Therapeutics |
Acquired by Novus Therapeutics, Sep 2020; fka Anelixis Pharmaceuticals |
Angioblast Systems |
Acquired by Mesoblast, May 2010 |
Angiolink |
Acquired by Medtronic, Nov 2004 |
Angion Biomedica |
Acquired by Elicio Therapeutics, Jun 2023 |
AngioScore |
Acquired by Spectranetics, May 2014, $230M+ |
AngioSense |
Acquired by MicroHeart, Sep 2001 |
Angiosyn |
Acquired by Pfizer 2005 |
Angstrom Medica |
Acquired by Pioneer Surgical, Oct 2007 |
Annovation Biopharma |
Acquired by The Medicines Company, Feb 2015 |
Annovis |
Acquired by Transgenomic, May 2001 |
AnorMED |
Acquired by Genzyme, Oct 2006 |
Anosys |
Acquired by Chromos Molecular Systems, Dec 2001 |
Ansan Pharmaceuticals |
Acquired by Discovery Labs, Jul 1997 |
Antares Pharma |
Acquired by Halozyme, May 2022, $960M |
Anteco Pharma |
Acquired by Attwill Vascular, Nov 2017 |
Anterios Therapeutics |
Acquired by Allergan, Jan 2016, $90M |
Antex Biologics |
Bought by BioPort, Jun 2003 |
Anthrogenesis |
Acquired by Celegene, Jan 2003, $45M |
Anvil Biosciences |
Assets acquired 2017-2018 |
Anza Therapeutics |
Closed Feb 2009, assets bought by Aduro Biotech |
AorTech |
Acquired RUA Medical, Mar 2020,, took name |
Aortica |
Acquired by Terumo, Nov 2019 |
AorTx |
Acquired by Hansen Medical, Nov 2007, $4.5M |
Apama Medical |
Acquired by Boston Scientific, Oct 2017, $175M + $125 Milestones |
ApaTech |
Acquired by Baxter, Mar 2010, $330M |
apceth |
Acquired by Hitachi Chemical, Apr 2019 |
ApcinteX |
Centessa Company |
Apex Bioscience |
Acquired by CuraCyte, fka Strohtech |
Apexigen |
Acquired by Pyxis Oncology, Aug 2023, $16M |
Apica Cardiovascular |
Acquired by Thoratec, Jul 2014 |
Apitope |
Acquired by Worg Pharmaceuticals, Aug 2021 |
ApoCell |
Acquired by Precision for Medicine, Jul 2019 |
Apogent |
Acquired by Fisher, Aug 2004 |
Apollo Biopharmaceutics |
Acquired by MitoKor, May 2001 |
Apollo Cytokine Research |
Acquired by Symansis, Jun 2008 |
Apoptos |
Acquired by Receptos |
APP Pharma |
Bought by Fresenius Kabi, Jul 2008, $4.6B |
Applied Biology |
All assets purchased by Jupiter Wellness, Jun 2022 |
Applied Biosystems |
Bought by Thermo Fisher, Jun 2008, $6.7B |
Applied Immune Technologies |
Bought by Adicet Bio, Jan 2016 |
Applied Immunology |
Acquired by Precision for Medicine, May 2016 |
Applied Molecular Evolution |
Bought by Eli Lilly, Feb 2004 |
Applied Proteomics |
Assets bought by DiscernDx, Feb 2018, $1.85M |
Applikon Biotechnology |
Acquired by Getinge, Jan 2020 |
Aptalis |
Acquired by Forest Labs, Jan 2014, $2.9B |
Aptiv Solutions |
Bought by ICON plc, May 2014 |
Apton Biosystems |
Acquired by Pacific Biosciences, Sep 2023, $85M + $25M milestones |
Aptuit |
Bought by Evotec, Aug 2017, $300M |
Aptus Endosystems |
Acquired by Medtronic, Jul 2015, $110M |
Aqua Pharmaceuticals |
Acquired by Almirall, up to $400M |
Aquapharm Biodiscovery |
Acquired by Lallemand Dec 2013 |
Aquarius Biotechnologies |
Acquired by Matinas Biopharma, Jan 2015 |
Aquatrove BioSciences |
Bought by SASMAR, Aug 2016 |
AqueSys |
Acquired by Allergan, Oct 2015, $300M |
Aquila Biopharmaceuticals |
Acquired by Antigenics, Aug 2000, $40M |
Aquinox Pharmaceuticals |
Acquired via Reverse Merger by Neoleukin Therapeutics Aug 2019; Stopped all RD Jul 2018 |
Aragon Pharmaceuticals |
Bought by J&J, Jun 2013, $1B |
Aratinga Bio |
Acquired by Ixaka, Jan 2021, $54M |
Arbor Pharmaceuticals |
Acquired by Azurity, Sep 2021 |
ARC Medical Design |
Acquired by Olympus, Aug 2020 |
ArcherDx |
Acquired by Invitae, Oct 2020, $1.4B; Spun out of Enzymatics after Qiagen acquired |
Archimedes Pharma |
Acquired by ProStakan, Jul 2014, $394M |
Arcinova |
Acquired by Quotient Sciences, Feb 2021 |
Ardea Biosciences |
Bought by AstraZeneca, Jun 2012, $1.26B; Closed 2018 |
Ardian |
Acquired by Medtronic, Nov 2010, $800M |
Arena Pharmaceuticals |
Acquired by Pfizer, Dec 2021, $6.7B |
Argene |
Acquired by bioMérieux, Jul 2011, $60M |
Argenta Discovery |
Bought by Charles River Labs, Mar 2014 |
Ariad Pharmaceuticals |
Acquired by Takeda, Feb 2017, $5.2B |
Aribex |
Acquired by Danaher, Nov 2012 |
Ariosa Diagnostics |
Bought by Roche, Dec 2014, $400M+$225M contingent |
Aristos Pharmaceuticals |
Owned by Cornerstone Therapeutics |
Arius Pharmaceuticals |
Acquired by BioDelivery Sciences, Aug 2004 |
Arixa Pharmaceuticals |
Acquired by Pfizer, Oct 2020 |
Arkis Biosciences |
Acquired by Integra LifeSciences, Jul 2019 |
ArmaGen |
Acquired by JCR Pharmaceuticals, Apr 2020 |
ARMO BioSciences |
Acquired by Lilly, Jul 2018, $1.6B |
Armune Bioscience |
Acquired by Exact Sciences, Dec 2017 |
Aronex Pharmaceuticals |
Acquired by Antigenics, Apr 2001 |
Aros Applied Biotechnology |
Acquired by eurofins |
Arpida |
Acquired by Evolva, Sep 2009 |
ArQule |
Bought by Merck, Jan 2020, $2.7B |
Arranta Bio |
Acquired by Recipharm, Apr 2022 |
Array Biopharma |
Bought by Pfizer, Jul 2019, $11.4B |
Arrayon Biotechnology |
Acquired by Endetec@Veolia, 2011 |
Arresto Biosciences |
Bought by Gilead, Jan 2011, $225M |
Arrevus |
Acquired by Aceragen, Nov 2021 |
Arrow Therapeutics |
Bought by AstraZeneca, Feb 2007 |
Arsanis Biosciences |
Acquired by X4 Pharmaceuticals via reverse merger, Mar 2019 |
Arsia Therapeutics |
Bought by Eagle Pharmaceuticals, Nov 2016, $30M + $48M milestones |
Artegraft |
Acquired by Lemaitre Vascular, Jun 2020, $72.5M |
Arterys |
Acquired by Tempus, Feb 2023, became Tempus Radiology |
Arthrocare |
Acquired by Smith & Nephew, May 2014 |
Arthrosurface |
Acquired by Anika Therapeutics, Feb 2020, $100M |
Artisan Pharma |
Acquired by Asahi Kasei Pharma, Nov 2011 |
Artu Biologicals |
Sold by Fornix Biosciences to ALK-Abello |
Arvelle Therapeutics |
Acquired by Angelini Pharma, Jan 2021 |
Asante Solutions |
Assets acquired by Bigfoot Biomedical, May 2015 |
Ascendance Biotechnology |
Acquired by BioIVT, Mar 2018 |
Ascyrus Medical |
Bought by CryoLife Medical, Sep 2020 |
Asentral IRB |
Acquired by Brany, Dec 2019 |
Ash Stevens |
Acquired by Piramal, Aug 2016, $53M |
Aspreva |
Acquired by Vifor Pharma |
Assurex Health |
Acquired by Myriad Genetics, Sep 2016, $200M, renamed GeneSight |
Asterand |
Bought by Stemgent, Aug 2012, Some assets sold on to ReproCELL, then company renamed Asterand Bioscience |
Asterand Bioscience |
Bought by BioreclamationIVT, Aug 2017; Bought by Stemgent, Aug 2012 |
Asterias Biotherapeutics |
Fully absorbed into BioTime Mar 2019; Technology acquired from Geron |
Astero Bio |
Acquired by BioLife Solutions, Apr 2019, $8M; Bought all assets of MedCision, May 2018 |
Asthmatx |
Bought by Boston Scientific, Sep 2010, $194M + milestones |
Astion Pharma |
Products acquired by Cipher Pharmaceuticals, Feb 2015 |
ASTrego Diagnostics |
Acquired by Sysmex, May 2022 |
Astute Medical |
Acquired by bioMérieux, Apr 2018, $90M |
Asymptote |
Acquired by GE Healthcare, Apr 2017 |
Ataxion Therapeutics |
Bought by Clal Biotech, Mar 2017, became Luc Therapeutics |
Athena Diagnostics |
Acquired by Fisher Diagnostics, Mar 2006 |
Athena Neurosciences |
Acquired by Elan, 1996 |
Atheromed |
Acquired by Volcano, May 2014, $115M |
Atlab Pharma |
Bought by Telix Pharmaceuticals, Jan 2017 |
Atlanta Biologicals |
Acquired by Bio-Techne, 2018 |
Atlantic Therapeutics |
Acquired by Caldera Medical, Sep 2023 |
Atlas Chemical Industries |
Acquired by ICI, 1972 |
ATMI - Life Sciences |
Life Science business acquired by Pall, Feb 2014 |
Atoll |
Acquired by Repligen, Apr 2016, $9.1M cash + stock |
Atopix Therapeutics |
Bought by Chiesi, 2016 |
Atreus Pharmaceuticals |
Acquired by Advanced Accelerator Applications, Jan 2015 |
Atrin Pharmaceuticals |
Acquired by Aprea Therapeutics, May 2022 |
Atritech |
Bought by Boston Scientific, Mar 2011, $100M + $275 milestones |
ATS Medical |
Bought by Medtronic, Apr 2010, $370M |
Attenua |
Acquired by CODA Biotherapeutics, Feb 2020 |
Atugen |
Acquired by SR Pharma 2005 |
ATXCo |
Acquired by Blade Therapeutics, Sep 2019 |
Audentes Therapeutics |
Acquired by Astellas, Jan 2020, $3B |
Augmenix |
Acquired by Boston Scientific, Oct 2018, $500M + $100M milestones |
Aurelia Bioscience |
Acquired by Chernwood Molecular, Jun 2021 |
Aurex Laboratories |
Acquired by APNAR Pharma, Jul 2022 |
Auris Health |
Acquired by J&J, Apr 2019, $3.4B; fka Auris Surgical Robots |
AurKa Pharma |
Acquired by Lilly, May 2018 |
Aurora Biosciences |
Acquired by Vertex Pharmaceuticals, 2001 |
Aushon Biosystems |
Acquired by Quanterix, Jan 2018 |
Auspex Pharmaceuticals |
Bought by Teva Mar 2015, $3.2B |
Auxilium Pharmaceuticals |
Acquired by Endo Oct 2014, $2.6B |
Avalon |
Acquired by Nordson Medical, Aug 2014 |
Avalon Pharmaceuticals |
Bought by Clinical Data |
Avanir Pharmaceuticals |
Website down Jan 2023 - Mar 2023; Bought by Otsuka, Jan 2015, $3.5B |
Avant Diagnostics |
Assets acquired by OncBioMune, Jun 2020 |
Avecia |
Bought by Nitto Denko |
Avedro |
Acquired by Glaukos, Nov 2019 |
Avema Pharma |
Bought by PL Developments |
Averitas Pharma |
Acquired by Grunenthal Nov 2018 |
Aves Labs |
Now part of Antibodies Inc |
Aveva Drug Delivery Systems |
Acquired by DifGen Pharmaceuticals, Apr 2023; Acquired by Apotex, Mar 2012 |
AveXis |
Acquired by Novartis, Apr 2018, $8.7B |
Avia Biosystems |
Acquired by Unchained Labs, Jun 2015 |
Avid Radiopharmaceuticals |
Bought by Lilly, Nov 2010, $800M |
Avida Biomed |
Acquired by Agilent, Jan 2023 |
Avidea Technologies |
Acquired by Vaccitech, Dec 2021 |
Avidex |
Bought by MediGene, Aug 2006, $62.4M |
Avidia |
Bought by Amgen 2006, Sep 2006, $380M |
Avigen |
Bought by Medicinova, Dec 2009, $37M |
Avila Therapeutics |
Bought by Celgene, Jan 2012, $350M |
Aviragen Therapeutics |
Acquired by reverse merger by Vaxart, Jan 2018; fka Biota Pharmaceuticals |
Aviron |
Acquired by Medimmune, Dec 2001, $1.5B |
Avista Pharma Solutions |
Bought by Cambrex, Jan 2019, $252M; Formed from the CMC business of Array BioPharma and contract services business of Scynexis |
Avizorex Pharma |
Acquired by Aerie Pharmaceuticals, Nov 2019; aka AVX Pharma |
Avolynt |
Acquired by AstraZeneca, Mar 2024, $1.05B; fka BHV Pharma |
Avomeen |
Acquired by Element, Mar 2021 |
Avrio Biopharma |
Company was consolidated into Irvine Pharmaceutical Services |
Axela |
Acquired by Angle plc, Oct 2017, $6M |
Axenis |
Acquired by genOway, Sep 2018 |
Axio Research |
Acquired by Cytel, Jun 2019 |
AxioMx |
Acquired by Abcam, Nov 2015, $20M + $25 milestones |
Axis-Shield |
Acquired by Alere, Aug 2011 |
Axsun |
Acquired by Excelitas Technologies Jan 2019; Spun back out by Philips, Oct 2015; Acquired by Volcano Jan 2009 |
Axys Pharmaceuticals |
Acquired by Celera, Nov 2001, $174M |
Azanta |
Acquired by Norgine, Mar 2020 |
Azur Pharma |
Acquired by Jazz Pharmaceuticals, Sep 2011 |
Bacchus Vascular |
Bought by Covidien, Jun 2009, undisclosed terms |
Baergic Bio |
Acquired by Avenue Therapeutics, Nov 2022 |
Baliopharm AG |
Acquired by Promethera Biosciences, Apr 2018 |
Baliopharm GmbH |
Bought by Alvotech, May 2016 |
Bamboo Therapeutics |
Bought by Pfizer, Jul 2016, $150M + milestones |
Banner Pharmacaps |
Acquired by Patheon, Dec 2012, Renamed Banner Life Sciences |
Barofold |
Assets Acquired by Pressure Biosciences, Dec 2017 |
Barr Pharmaceuticals |
Acquired by Teva, Jul 2008, $7.46B |
Barrier Therapeutics |
Bought by Stiefel |
Barrx Medical |
Acquired by Covidien, Nov 2011, $325M |
Base Genomics |
Acquired by Exact Sciences, Oct 2020 |
BaseHealth |
Acquired by Genalyte, Apr 2020 |
Bausch & Lomb |
Acquired by Valeant, rebranded as Bausch Health |
Baxa |
Acquired by Baxter, Nov 2011, $380M |
Baxalta |
Bought by Shire, $32B, Jun 2016 |
Bay Bioanalytical |
Acquired by Pacific BioLabs |
Bayhill Therapeutics |
Wound Down and Assets acquired by new-incarnation of Tolerion |
Baylis Medical |
Acquired by Boston Scientific, Feb 2022, $1.75B |
Baylis Medical |
Acquired by Boston Scientific, Feb 2022, $1.75B |
Bayon Therapeutics |
Acquired by EyeGate Pharmaceuticals, Oct 2021 |
Bazell Pharma |
Acquired by Amzell, Mar 2021 |
Beacon Discovery Inc |
Acquired by Eurofins Scientfiic, Feb 2021; Spun out of Arena Pharmaceuticals, Sep 2016 |
Beardsworth |
Bought by TFS International 2013 |
Beckley Canopy Therapeutics |
Acquired by Canopy Growth, Oct 2019 |
Beckman Coulter Genomics |
Bought by Genewiz, Dec 2015 |
Belkin Vision |
Acquired by Alcon, Jul 2024, $81M |
Bellus Health |
Acquired by GSK, Jun 2023, $2B |
Bellwether Bio |
Acquired by Guardant Health, Apr 2019, $10M + $20M milestones |
Benchmark Biolabs |
Parent acquired by Huvepharma, Jan 2018 |
Bend Research |
Acquired by Capsugel, Sep 2013 |
BeneChill |
Assets purchase by BrainCool, Oct 2016 |
BeneVir Biopharm |
Acquired by J&J, May 2018, $140M + $900M milestones |
Benten BioServices |
Acquired by Deltagen, Dec 2009 |
Bentley Pharmaceuticals |
Bought by Teva, Mar 2008, $360M |
Benvenue Medical |
Assets acquired by Spinal Elements, Dec 2020 |
Beogenomics |
Acquired by APIS Assay Technologies, Sep 2020 |
Berg |
Acquired, Jan 2023 |
Bertek |
Acquired by Mylan, Apr 1993, $39M |
Beryllium |
Acquired by UCB Pharma, Jun 2017 |
BetaLogics |
Absorbed by ViaCyte, Feb 2016 |
Bethyl Laboratories |
Acquired by Fortis Life Sciences, Mar 2021 |
Bexel Pharmaceuticals |
Bought by Orchid Pharma, Aug 2006, $3M |
BHV Pharma |
Acquired by Avolynt, Mar 2016 |
Biacore |
Acquired by GE, Jun 2006, $390M |
Bigfoot Biomedical |
Acquired by Abbott, Sep 2023 |
Bikam |
Acquired by Shire, Aug 2015, $92M |
Bina Technologies |
Acquired by Roche, Dec 2014 |
Binax |
Acquired by Alere, Feb 2005, $9M |
Bio Processing |
Bought by Bio-rad |
Bio-Concept Laboratories |
Acquired by Pace Analytical, Dec 2020 |
BioAnalytix |
Acquired by Protagen Protein Services, Apr 2019 |
BioArra |
Bought by VWR Nov 2016 |
BioAxoneTherapeutic |
Founded 2000, all assets acquired by BioAxone Biosciences |
Biobase |
Bought by Qiagen, May 2014 |
BioBehavioral Diagnostics Company |
Assets acquired by Pearson, Aug 2013 |
Bioceros |
Bought by Epirus Biopharmaceuticals, Sep 2015, $14M |
Biochrom GmbH |
Bought by Millipore, Nov 2012 |
BioCision |
Acquired by Brooks, Nov 2016 |
BioDelivery Sciences International |
Acquired by Collegium Pharmaceuticals, Mar 2022, $604M |
Biodiscovery |
Acquired by Bionano Genomics, Oct 2021 |
Bioelectron |
Assets bought by PTC Therapeutics; fka Edison Pharmaceuticals |
BioElectron Technology |
Assets Acquired by PTC Therapeutics, Oct 2019 |
Bioenvision |
Acquired by Genzyme, Oct 2007, $345M |
Biofocus |
Bought by Charles River Labs, Mar 2014, $179M |
Biogazelle |
Acquired by CellCarta, Dec 2021 |
BioHelix |
Acquired by Quidel, $10+milestones, May 2013 |
Bioinduction |
Acquired by Amber Tx, Sep 2023 |
Bioject |
Assets acquired by Inovio, Mar 2016, $5.5M |
Biolipox |
Bought by Orexo, €94M, Oct 2007 |
Biological Industries |
Acquired by Sartorius, Dec 2019, $50M |
Biologics Process Development |
Acquired by ViroPro, 2010 |
BioLogo |
Acquired by Nordic MUbio, Mar 2018 |
Biomage |
Acquired by Parse Biosciences, Jan 2024 |
Biomatrica |
Acquired by Exact Sciences, Oct 2018 |
BioMedical Enterprises |
Bought by DePuy Synthes, May 2016 |
Biomedical Systems |
Acquired by ERT, Sep 2017 |
Biomet |
Bought by Zimmer, Apr 2014, $13.4B - combined company renamed Zimmer Biomet |
Biomeva Manufacturing |
Acquired by Asahi Glass, Nov 2016; Now part of AGC Biologics |
BioMimetic |
Acquired by Wright Medical, Mar 2013, $190M cash + $190M milestones |
Biomimetic Therapeutics |
Acquired by Wright Medical group Apr 2013 |
Bion Enterprises |
Acquired by MBL International, 2008 |
Bioness |
Acquired by Bioventus, Mar 2021, $45M + $65M milestones |
Bioniche Pharma |
Acquired by Mylan, Sep 2010, $550M |
Bionix Implants |
Bought by CONMED, Mar 2003 |
Bioniz Therapeutics |
Acquired by Equillium, Feb 2022, $329M |
Bionostics |
Bought by Techne, Jun 2013 $104M |
BioNovion |
Bought by Aduro Biotech, Sep 2015, $32.5M |
BionX Medical |
Acquired by Ottobock |
Bioo Scientific |
Acquired by Perkin Elmer, Aug 2016 |
BioPharma Global |
Acquired by Pace Life Sciences, Sep 2022 |
BioPharmX |
Acquired via Reverse Merger by Timber Pharmaceuticals, May 2020 |
BioProcess Technology Consultants |
Acquired by BDO USA, Apr 2019 |
Bioprocessing Inc. |
Bought by Bio-Rad |
Biopta |
Acquired by ReproCELL, combined with Reinnervate to become ReproCELL Europe, Jul 2016 |
Biopure |
Assets bought by OPK Biotech, Aug 2009 |
BioReliance |
Bought by Sigma-Aldrich, Jan 2012, $350M |
BioRelix |
Acquired by Pfizer, Sep 2005 |
BioRexis |
Acquired by Pfizer, Feb 2007 |
Biorez |
Acquired by CONMED, Aug 2022; fka Soft Tissue Regeneration |
BioScreen Testing Services |
Acquired by ALS Group USA, Feb 2019 |
Bioseek |
Bought by Asterand Nov 2009, Sold to DiscoveRx Nov 2012 |
Bioserve |
Acquired by ReproCell, 2014 |
BioSolutia |
Acquired by CareMetx, Oct 2018 |
BioStable |
Acquired by Corcym, Apr 2023 |
BioStorage Technologies |
Acquired by Brooks Life Sciences, Nov 2015 |
BioSyntech |
Bought by Piramal |
Biotectix |
Acquired by Heraeus Medical Components, Aug 2017 |
Biotek |
Acquired by Agilent, Aug 2019 |
Biotel |
Acquired by CardioNet, 2010 |
BioTelemetry |
Acquired by Philips, Feb 2021; fka CardioNet |
Biotest Labs |
Acquired by/Merged with Steris |
Biotez |
Acquired by BBI Solutions, Jan 2022 |
Biothera Pharmaceuticals |
Acquired by Hibercell, Jul 2020 |
bioTheranostics |
Acquired by Hologic, Feb 2021, $230M; bought by bioMérieux 2008, spun out again Jan 2016 |
Biotie Therapies |
Bought by Acorda Therapeutics, Jan 2016, $363M |
Biotrace Medical |
Acquired by Merit Medical, Oct 2022 |
Biotronic |
Bought by NuVasive, Jul 2016, $98M |
BioTrove |
Acquired by Life Technologies, Dec 2009 |
Bioverativ |
Acquired by Sanofi, Jan 2018, $11.6B; Biogen's spinout hemophilia group |
Biovertis |
Acquired by Deinove, May 2018 |
BioVex |
Bought by Amgen, Jan 2011, $425M + $575M milestones |
BioVision |
Acquired by Abcam, Oct 2021, $340M |
Bioxalis |
Bought by Procyon Biopharma, Jun 2005, $3.5M |
BioXell |
Acquired by Cosmo Pharmaceuticals, Nov 2009 |
Bipar Sciences |
Bought by Sanofi-Aventis, Apr 2009, $500M |
Bird Rock Bio |
Acquired by Skye Bioscience, Aug 2023 |
BISC Global |
Acquired by Excelra, Apr 2023 |
Biscayne Neurotherapeutics |
Acquired by Supernus, Oct 2018, $15M + $168M milestones |
Bitome |
Acquired by Ginkgo Bioworks, Jun 2022 |
BlackThorn Therapeutics |
Acquired by Neumora, Oct 2021 |
BLIRT |
Acquired by Qiagen, May 2022 |
Blockade Medical |
Acquired by BALT, Sep 2016 |
Blu Pharmaceuticals |
Acquired by PuraCap, Mar 2016 |
Blue Sky Bioservices |
Acquired by LakePharm Mar 2016 |
Blue Stream Laboratories |
Acquired by Charles River, Jun 2016 |
Blue Stream Labs |
Acquired by Charles River Labs, Jun 2016 |
BlueReg |
Acquired by Pharmalex, Nov 2022 |
Blueshift Biotechnologies |
Acquired by MDS Analytical, Jun 2008, $13M |
BN-ImmunoTherapeutics |
Absorbed into Bavarian Nordic, 2010? |
Boca Pharmacal |
Bought by Qualitest |
Boehringer Ingelheim Vetmedica |
Acquired by Elanco, Oct 2016, $885M |
Boehringer Mannheim |
Bought by Roche, May 1997, $11B |
Bolder Surgical |
Acquired by Hologic, Nov 2021, $160M |
Bonti |
Bought by Allergan, Sep 2018, $195M |
Boston Biochem |
Acquired by Techne, Apr 2011 |
Boston Biomedical |
Renamed Sumitomo Dainippon Pharma Oncology, Jun 2020; Bought by Dainippon Sumitomo Pharma, Feb 2012, $200M plus milestones up to $2.4B |
Boston Genetics |
Acquired by Genomenon, Jun 2023 |
Boulder Diagnostics |
Assets purchased by Oxford Immunotec, Aug 2014 |
Brabant Pharma |
Acquired by Zogenix, Oct 2014, $20M cash, $15M stock |
Brainbits |
Acquired by Transnetyx, Feb 2021 |
Brains On-Line |
Acquired by Charles River, Aug 2017 |
Braintree Labs |
Bought by Sebela Pharmaceuticals, May 2018 |
Brainvectis |
Acquired by AskBio, Apr 2020 |
Brammer Bio |
Bought by Thermo Fisher, May 2019, $1.7B |
Brandwood Biomedical |
Acquired by PharmaLex |
Breath Therapeutics |
Bought by Zambon, Jul 2019, $160M + $405 Milestones |
Breathe Technologies |
Acquired by Hillrom, Aug 2019, $130M |
Brecon Pharmaceutical |
Acquired by AmerisourceBergen Mar 2006 $28M, Merged with Anderson Packaging Jun 2012, Acquired by Frazier Apr 2013 and merged with Packaging Coordinators Inc. (Frazier) |
Breethe |
Acquired by Abiomed, Apr 2020 |
BRI Biopharmaceutical Research |
Acquired by Frontage, Dec 2019 |
Bridge Design |
Acquired by Ximedica, Aug 2015 |
Bridgehead International |
Bought by Gfk, Mar 2012 |
BrightWater Medical |
Acquired by Merit Medical, Sep 2019, $50M |
Brivant Medical Engineering |
Bought by Lake Region Medical, Aug 2009 |
Brogan Pharma |
Acquired by IMS Health, 2010 |
BSN Medical |
Acquired by Essity, Apr 2017 |
BTG plc |
Acquired by Boston Scientific, Aug 2019, $4.3B |
BTG Specialty Pharmaceuticals |
Acquired by SERB, Mar 2021 |
C.R. Bard |
Acquired by BD, Dec 2017, $24B |
C1 Consulting |
Acquired by Charles River, Jan 2017 |
C2 Therapeutics |
Acquired by Pentax Medical, Jan 2017 |
C2i Genomics |
Acquired by Veracyte, Feb 2024, $70M +$25M milestones |
C3 Research Associates |
Acquired by Avance Clinical, Sep 2022 |
Cabrellis Pharmaceuticals |
Acquired by Pharmion, Nov 2006 |
Cadence Pharmaceuticals |
Acquired by Mallinckrodt, Mar 2014, $1.4B |
Cadent Therapeutics |
Acquired by Novartis, Dec 2020, $210M + $560M milestones; fka Luc Therapeutics |
Caelum Biosciences |
Acquired by AstraZeneca, Sep 2021, $150M + $350M milestones |
Calibra Medical |
Acquired by JNJ 2012 |
California Peptide Research |
Acquired by Echelon Biosciences, Apr 2014 |
California Stem Cell |
Bought by NeoStem, renamed NeoStem Oncology May 2014 |
CALiMMUNE |
Acquired by CSL Behring, Aug 2017 |
Caliper Life Sciences |
Bought by Perkin Elmer, Sep 2011, $600M |
Calistoga Pharmaceuticals |
Bought by Gilead, Feb 2011, $375M + $125Milestones |
Calixa Therapeutics |
Acquired by Cubist, Dec 2009, $92.5M + $310 milestones |
CallistoGen |
Assets acquired by The Genetics Company, Mar 2003 |
Calporta Therapeutics |
Acquired by Merck, Nov 2019, $576M |
Calvert Laboratories |
Acquired by Altasciences, May 2021 |
Calydon |
Acquired by Cell Genesys Aug 2001, $17.4M stock |
Calypso Biotech |
Acquired by Novartis, Jan 2024, $250M; Spun out of Merck-Serono |
Calypso Medical Technologies |
Acquired by Varian Medical Systems, Sep 2011, $10M |
Camargo Pharmaceutical Services |
Acquired by Premier Research, May 2021 |
Cambridge Biomedical |
Acquired by Bioagilytix, Nov 2019 |
Cambridge Biotechnology |
Acquired by Biovitrum, Mar 2005 |
Cambridge Cancer Genomics |
Acquired by Dante Labs, Oct 2021 |
Cambridge Research Biochemicals |
Acquired by Biosynth, May 2023 |
Cancer Prevention Pharmaceuticals |
Acquired by Panbela Therapeutics, Jun 2022 |
Cancervax |
Acquired by Micromet, May 2006 |
Cangene |
Acquired by Emergent Biosolutions, Dec 2013, $222M |
CAPP Medical |
Acquired by Roche, Apr 2015 |
caprotec bioanalytics |
Company or Technology Acquired by Charles River |
Capsugel |
Bought by Lonza, Dec 2016, $5.5B |
Captozyme |
Acquired by Arrant Bio, Nov 2019 |
Capua BioServices |
Acquired by Olon, Jan 2019 |
Caraco Pharmaceutical Labs |
Bought by Sun Pharma |
Caraway Therapeutics |
Acquired by Merck, Nov 2023, $610M; fka Rheostat Therapeutics |
Cardea Bio |
Acquired by Paragraf, May 2023; fka Nanomedical Diagnostics |
Cardiac Science |
Acquired by Zoll, Aug 2019 |
CardiAQ Valve Technologies |
Acquired by Edwards Life Sciences, Jul 2015, $350M + $50M milestones |
Cardiogen Sciences |
Acquired by Audentes Therapeutics, Sep 2015 |
Cardioinsight Technologies |
Acquired by Medtronic, Jul 2015 |
Cardiokine |
Acquired by Cornerstone Therapeutics 2011 |
CardioLabs |
Acquired by AliveCor, Jun 2021 |
CardioMEMS |
Acquired by St. Jude Medical, Jun 2015, $455M |
CardioPep Pharma |
Acquired by and converted to Cardiorentis |
CardioProlific |
Bought by Philips, Jun 2017 |
Cardiovalve |
Acquired by Venus Medtech, Dec 2021 |
Cardioxyl Therapeutics |
Bought by BMS, Nov 2015, $300M |
Cardiva Medical |
Acquired by Haemonetics, Jan 2021, $510M |
Carefusion |
Bought by BD, Mar 2015, $12.2B; Spun out of Cardinal Health Sep 2009 |
Carmel Biosciences |
Acquired by Nutriband, Sep 2018, $2.7M |
Carmenta Bio |
Acquired by Progenity, Apr 2015 |
Cartana |
Bought by 10X Genomics, Oct 2020 |
Cartiva |
Acquired by Stryker as part of Wirght Medical, Nov 2019 |
Cascade Chemistry |
Acquired by Aceto, Jun 2021 |
Cascadian Therapeutics |
Bought by Seattle Genetics, Feb 2018, $614m stock |
Catalytica Pharmaceuticals |
Acquired by DSM |
Catherex |
Spun out of Medigene, sold to Amgen, Dec 2015, $10.5M |
CATLab - Accredited Calibration Laboratories |
Acquired by Trescal, Jan 2022 |
cCAM Biotherapeutics |
Acquired by Merck, Aug 2015, $605M |
CDD |
Acquired by Biofocus, Jun 2001 |
Cedarburg Hauser Pharmaceuticals |
Acquired by AMRI, Mar 2014 |
Cedilla Therapeutics |
Shut down May 2023 |
CeeTox |
Acquired by Cyprotex, Jan 2014 |
Ceiba Solutions |
Bought by Perkin-Elmer, Mar 2015 |
Celares |
Acquired by Biosynth, Jul 2023 |
Celator Pharmaceuticals |
Bought by Jazz Pharmaceuticals, Jul 2016, $1.5B |
Celenex |
Bought by Amicus Therapeutics, Sep 2018, $100M |
Celera |
Acquired by Quest Diagnostics, Mar 2011, $671M |
Celgene |
Bought by BMS, Nov 2019, $74B |
Celixir |
Shell acquired Dec 2023 |
Cell Culture Service |
Acquired by Evotec, Jan 2013 |
Cell Design Labs |
Acquired by Gilead, Dec 2017, up to $567M |
Cell IDx |
Acquired by Leica Biosystems, Nov 2022 |
Cell Matrix |
Acquired by Cancervax |
Cell Pathways |
Acquired by OSI Pharmaceuticals, Feb 2003, $32M |
Cell Targeting Inc |
Bought by Biotime |
CellAct Pharma |
Tech acquired by Mundipharma, 2017 |
Cellartis |
Acquired by Takara Bio Jul 2014 |
CellASIC |
Bought by Millipore, May 2012 |
Cellective Therapeutics |
Acquired by MedImmune 2005, Up to $175M |
Celleration |
Acquired by Alliqua Biomedical, Jun 2015, $30.4M |
Cellerix |
Acquired by TiGenix Mar 2011 |
Cellero |
Acquired by Charles River, Aug 2020, $38M; fka Astarte Biologics; Merged with Key Biologics, Aug 2018 |
Cellestis |
Acquired by Qiagen Aug 2011 |
CellforCure |
Acquired by Novartis, Feb 2019 |
Cellgate |
Acquired by ProGen, Feb 2008, $2.5M |
CellPoint |
Acquired by Galapagos, Jun 2022, €125M + €100M milestones |
CellRight Technologies |
Acquired by Tissue Regnix, Aug 2017 |
Celltech |
Acquired by UCB, May 2004, $2.7B |
Cellular Research |
Acquired by BD, Aug 2015 |
CellzDirect |
Acquired by Life Technologies, Jan 2008 |
Cellzome |
Acquired by GSK Mar 2012 |
Celmed BioSciences |
Acquired by Kiadis Pharma, Dec 2006 |
Celsee Diagnostics |
Acquired by Bio-Rad, Apr 2020 |
Celsius Therapeutics |
Acquired by AbbVie, Jun 2024, $250M; fka Cellular Ecosystems Therapeutics |
Celtrix Pharmaceuticals |
Acquired by Insmed in reverse merger, May 2000 |
Celula |
Acquired by NeoSeq |
Cenetron Diagnostics |
Acquired by Versiti Blood Center, Jul 2019 |
Censa Pharmaceuticals |
Acquired by PTC Therapeutics, Jun 2020 |
CenterVue |
Merged into iCare, Apr 2020 |
Cephalogics |
Assets acquired by Invisio Medical, Feb 2018 |
Cephalon |
Acquired by Teva, Oct 2011, $6.8B |
Cephea Valve Technologies |
Acquired by Abbott, Jan 2019 |
Ceptaris Therapeutics |
Bought by Actelion, Sep 2013, $250M |
Ception |
Bought by Cephalon, Jan 2009, $250M |
Ception Therapeutics |
Acquired by Cephalon, 2010 |
Cerebrus CNS Drug Discovery |
Acquired by Vernalis |
Ceregene |
Acquired by Sangamo, Aug 2013 |
Cereius |
Acquired by Solve Therapeutics, Jun 2023 |
Cerep |
Acquired by eurofins, Dec 2012 |
Cerexa |
Acquired by Forest Labs Dec 2006 |
Cergentis |
Acquired by Solvias, Jul 2022 |
Cernostics |
Acquired by Castle Bioscience, Dec 2021, up to $30M + $50M Milestones |
Ceros Pharmaceuticals |
Acquired by Auxeris Therapeutics, Jan 2004 |
CerSci Therapeutics |
Acquired by Acadia Pharmaceutical, Aug 2020, $52.5M stock |
Cerulean Pharma |
Bought by Dare Bioscience, Mar 2017 |
Cerus Endovascular |
Acquired by Stryker, May 2023 |
Cerus Endovascular |
Acquired by Stryker, May 2023 |
Ceterix Orthopaedics |
Acquired by Smith & Nephew, Jan 2019, $50M + $55M Milestones |
CEVEC Pharmaceuticals |
Acquired by Cytiva, Oct 2022 |
CGI Pharmaceuticals |
Bought by Gilead 2010 |
Chamow & Associates |
Acquired by Alira Health, Jan 2021 |
ChanTest |
Acquired by Charles River, Oct 2014, $52M + $2M milestones |
Chase Pharmaceuticals |
Acquired by Allergan, Nov 2016, $125M |
Chatham Therapeutics |
Acquired by Baxter, Apr 2014, $70M+ |
Chattem |
Bought by Sanofi, Dec 2009, $1.9B |
Checkmate Pharmaceuticals |
Acquired by Regeneron, May 2022, $250M |
Cheetah Medical |
Bought by Baxter, Oct 2019, $190M + $40 Milestones |
Chelsea Therapeutics |
Acquired by Lundbeck, Jun 2014, up to $658M |
Chem-Tech |
Bought by Neogen, Jan 2014 |
ChemGen |
Bought by Elanco (Lilly) Jan 2012 |
ChemGenex |
Bought by Cephalon Mar 2011 |
Chemgenics Pharmaceuticals |
Acquired by Millennium Pharmaceuticals, Feb 1997, $89M |
Chemic Laboratories |
Acquired by Solvias, Jun 2021 |
Chemir Analytical Services |
Acquired by EAG, 2011 |
ChemoCentryx |
Acquired by Amgen, $3.7B, Oct 2022 |
Cherokee Pharmaceuticals |
Bought by Merck Aug 2010? |
Chester Valley Pharmaceuticals |
Bought by Graceway |
Chiasma Pharma |
Acquired by Amryt Pharma, Aug 2021 |
Chikujee Therapeutics |
Acquired by Investors, Website Gone, CEO gone Aug 2016 |
Chiltern |
Acquired by LabCorp, $1.2B, Jul 2017 |
Chinook Therapeutics |
Acquired by Novartis, Aug 2023, $3.2B; Acquired Aduro Biotech, Oct 2020, for ticker |
Chinook Therapeutics |
Acquired by Novartis, Aug 2023, $3.2B; Acquired Aduro Biotech, Oct 2020, for ticker |
Chiron |
Bought by Novartis |
Chiron Behring Vaccines |
Bought by Bharat Biotech, Feb 2019 |
Chord Therapeutics |
Acquired by Merck KgAA, Dec 2021 |
ChromoTek |
Acquired by Proteintech, Oct 2020 |
Chronos Therapeutics |
Acquired by Evgen, Mar 2024 |
Cianna Medical |
Acquired by Merit Medical, Nov 2018, $200M |
Ciba Vision |
Bought by Alcon, bought by Novartis |
Ciclofilin Pharmaceuticals |
Acquired by ContraVir, Jun 2016, $17M + stock |
Ciel Medical |
Acquired by Vyaire Medical, Apr 2017 |
CIMA Labs |
Acquired by Teva, May 2011 |
CIMEX Pharma |
Acquired by Acino, 2004 |
CinCor Pharma |
Acquired by AstraZeneca, Feb 2023 |
Cinfa Biotech |
Acquired by Mundipharma, Oct 2018 |
Circe Biomedical |
Acquired by ICN Pharmaceuticals, Oct 2002 |
Circularis |
Acquired by Ginkgo Bioworks, Oct 2022 |
CircuLite |
Bought by HeartWare, Dec 2013, $30M+$320Milestones |
Circulomics |
Acquired by Pacific Biosciences, Aug 2021 |
Cirrus Bio |
Acquired by Maverix Medical, Mar 2024 |
Cirrus Pharmaceuticals |
Acquired by Kemwell, Jul 2013 |
Cisbio |
Acquired by PerkinElmer, Apr 2019 |
Cistron Biotechnology |
Acquired by Celltech Group, Nov 2000 |
CiToxLAB |
Acquired by Charles River, Apr 2019, €448M |
CITrials |
Acquired by Cenexel Clinical Research, Mar 2021 |
Citron Pharma |
Assets acquired by Rising Pharmaceuticals, Dec 2016 |
CiVentiChem |
Acquired by Sterling Pharma |
Civitas Therapeutics |
Acquired by Acorda, Sep 2014, $525M. Formerly an Alkermes spinout. |
Clade Therapeutics |
Acquired by Century Therapeutics, Apr 2024 |
Claret Medical |
Acquired by Boston Scientific, Jul 2018, $220M + milestone |
Clarient |
Acquired from GE Healthcare by NeoGenomics, Oct 2015, $265M |
Claris Lifesciences |
Bought by Baxter, Jul 2017 |
Claritas Pharmaceuticals |
Website down Jul 2022 - Mar 2023; fka Kalytera; Acquiring Salzman Group Feb 2021 |
Claros Diagnostics |
Acquired by Opko Health, Oct 2011 |
CLCbio |
Acquired by Qiagen, 2013 |
Clear Genetics |
Being Acquired by Invitae, Nov 2019, $50M |
Clementia Pharmaceuticals |
Bought by Ipsen, Apr 2019, $1.31B |
Cleveland Biolabs |
Acquired by Cytocom via Reverse Merger, Oct 2020 |
ClinArt MENA |
Acquired by CTI Facts, Sep 2020 |
Clinical Data |
Bought by Forest Labs Feb 2011 |
Clinical Network Services (Cns) |
Acquired by Novotech |
Clinical Research Advantage |
Bought by Radiant Research, Nov 2012 |
Clinical Research Laboratories |
Acquired by eurofins, Sep 2018 |
Clinical Trial Center North (CTC North & KG) |
Acquired by Agenus, Feb 2022 |
ClinicalRM |
Acquired by Icon plc, Sep 2016; aka Clinical Resource Management |
Clinlogix |
Bought by NAMSA, Aug 2021 |
Clintec |
Acquired by IQVIA, Dec 2018 |
Clintrax Global |
Acquired by WCG, Mar 2016 |
Co-Formulate |
Acquired by Quotient Clinical, Feb 2017 |
Coastal Genomics |
Acquired by Yourgene, Aug 2020, up to $5.5M + $8M milestones |
Cobra Biologics |
Bought by Cognate BioServices, Nov 2019 |
Codman Neurosurgery |
Bought by Integra Life Sciences, Oct 2017, $1.045B |
Cody Laboratories |
Bought by Lannett, 2007 |
Cogentix Medical |
Acquired by Laborie, Apr 2018 |
Cognate Bioservices |
Acquired by Charles River, Mar 2021; $875M |
Cognis Corp |
Acquired by BASF 2010 |
Coldstream Laboratories |
Bought by Piramal |
Coley Pharma |
Acquired by Pfizer |
CollaGenex |
Acquired by Galderma, Feb 2008, $420M |
Collateral Therapeutics |
Acquired by Schering, Mar 2002, $140M stock |
CoLucid Pharmaceuticals |
Acquired by Lilly, Jan 2017, $960M |
Combangio |
Acquired by Kala Pharmaceuticals, Nov 2021 |
CombiMatrix |
Acquired by Invitae, Nov 2017 |
Combinati |
Acquired by Thermo Fisher, Oct 2021 |
Comet Therapeutics |
Acquired by VectIvBio, Aug 2021 |
Companion Medical |
Acquired by Medtronic, Aug 2020 |
Compendia Bioscience |
Acquired by Life Technologies, Oct 2012 |
Complement Pharma |
Acquired by Graviton Bioscience, Dec 2022 |
Comprehend Systems |
Acquired by Saama Technologies, Aug 2019 |
Conatus Pharmaceuticals |
Acquired by Histogen via Reverse Merger, Jun 2020 |
Concentric Medical |
Acquired by Stryker, Oct 2011 |
Concept Inc |
Bought by BMS, 1990; sold to CONMED Dec 1997 |
Conceptus |
Bought by Bayer Apr 2013 |
Concert Pharmaceuticals |
Acquired by Sun Pharma, Mar 2023 |
Concord Biosciences |
Acquired by Frontage Labs, Apr 2018 |
Concortis Biosystems |
Acquired by Sorrento Therapeutics, Dec 2013 |
Conexio Genomics |
Acquired by Illumina, Jan 2016 |
Confab Laboratories |
Bought by Mylan, Jun 2016 |
Confluence Life Sciences |
Acquired by Aclaris Therapeutics, Aug 2017, $10M cash + $10M shares |
Conforma Therapeutics |
Acquired by Biogen Idec, May 2006, $150M stock + $00M Milestones |
Conor Medsystems |
Acquired by Johnson & Johnson, Nov 2006, $1.4B |
Consort Medical |
Acquired by Recipharm, Apr 2020 |
Constellation Pharmaceuticals |
Acquired by MorphpSys, Jul 2021 |
Contura |
Acquired by Axonics, Feb 2021, $200M |
Conventus Orthopaedics |
Acquired Flower Orthopedics, May 2020, took name |
Convergence Pharmaceuticals |
Bought by Biogen Idec, Jan 2015, $200M +$475 Milestones |
Cook Biotech |
Acquired by RTI Medical, Feb 2024 |
Cook Pharmica |
Bought by Catalent, Oct 2017 |
CoreLab Partners |
Bought by JLL then merged with Bioclinica, 2013 |
CorePharma (1) |
Acquired by Impax Laboratories, Mar 2015 |
Corevalve |
Acquired by Medtronic, Feb 2009, $700M + milestones |
Corindus Vascular Robotics |
Acquired by Siemens Healthineers, Oct 2019 |
Corinthian Ophthalmic |
Assets bought by Eyenovia, Oct 2014 |
Corixa |
Bought by GSK, 2005; closed 2006 |
Corlieve Therapeutics |
Acquired by uniQure, Jun 2021, $55M + $240M milestones |
CorMatrix Cardiovascular |
Bought by Aziyo Biologics, May 2017 |
Cormorant Pharmaceuticals |
Acquired by BMS, Jul 2016, $95M + $425M milestones |
Cornerstone Therapeutics |
Acquired by Chiesi Farmaceutici, Feb 2014 |
CORPAK MedSystems |
Acquired by Avanos Medical, Apr 2016, $174M |
Correlogic |
Assets bought by Vermillion 2011 |
Correvio |
Acquired by Advanz Pharma, May 2020, $76M |
Correvio (1) |
Acquired by Cardiome, Nov 2013, name resurrected and taken by Cardiome, May 2018 |
Corthera |
Acquired by Novartis 2010, $120M + $500M milestones |
Corticrine |
Bought by Actinogen, Aug 2014, $5.75M |
Corus Pharma |
Bought by Gilead, Aug 2006 |
Corvas International |
Acquired by Dendreon Pharmaceuticals, Nov 2003 |
Corvidia Therapeutics |
Acquired by Novo Nordisk, Aug 2020, $725M |
Cosman Medical |
Bought by Boston Scientific, Jul 2016 |
CoStim Pharmaceuticals |
Acquired by Novartis, Feb 2014 |
Coté Orphan |
Acquired by Quintiles, Jun 2017 |
Cougar Biotechnology |
Bought by J&J |
Coulter Pharmaceutical |
Bought by Corixa, Oct 2000 |
Counsyl |
Acquired by Myriad Genetics, Aug 2018 |
County Line Pharmaceuticals |
Acquired by Alvogen, Mar 2016, $300M |
Courier Therapeutics |
Acquired by Valo Health, Jul 2021 |
Covagen |
Acquired by Janssen Pharmaceutical, Aug 2014 |
Covance |
Acquired by LabCorp, Feb 2015, $5.7B |
Covidien |
Bought by Medtronic, Jan 2015, $42.9B |
CovX Research |
Bought by Pfizer |
CPEX Pharmaceuticals |
Bought by FCB I Holdings, Apr 2011. Not sure what they did with the company/assets. Originally was a spinout from Bentley Pharmaceuticals when it was acquired by Teva in 2008 |
Creabilis |
Acquired by Sienna Biopharmaceuticals, Dec 2016, up to $150M |
Crealta Pharmaceuticals |
Acquired by Horizon Pharma, Dec 2015, $510M |
Creganna Medical |
Acquired by TE Connectivity, Apr 2016, $895M |
Creoptix |
Acquired by Malvern Panalytical, Jan 2022 |
Crescendo Bioscience |
Bought by Myriad Genetics, Mar 2014 |
CRISI Medical Systems |
Acquired by BD, Mar 2015 |
CrossRoads Extremity Systems |
Acquired by DePuy, Feb 2022 |
Crucell |
Acquired by J&J, Mar 2011, $2.3B |
Crux Biomedical |
Acquired by Volcano, Dec 2012, $36M |
CryoLife |
Renamed Artivion, Jan 2022 |
CryoVascular |
Bought by Boston Scientific, 2005 |
Crystal Bioscience |
Acquired by Ligand Pharmaceuticals, Oct 2017, $25M |
Crystal Laboratory |
Acquired by ALK-Abello, Dec 2016 |
Crystax Pharmaceuticals |
Acquired by Oryzon Genomics, Mar 2009 |
Cryterion Medical |
Boston Scientific acquired remaining 65% stake, Jul 2018, $202M |
Cubist Pharmaceuticals |
Bought by Merck Jan 2015 |
Curacyte Discovery |
Acquired by The Medicines Company, Aug 2008 |
CuraGen |
Bought by Celldex 2009, $94.5M |
Curative Medical |
Acquired by ResMed, Oct 2015 |
CureDM |
Acquired by Boston Scientific, Feb 2018 |
Curiosity Diagnostics |
Acquired by Bio-Rad, Aug 2022, $100M + $70M Milestones |
CURNA |
Acquired by Opko Health, Feb 2011 |
Curoverse |
Bought by Veritas Genetics, Aug 2017 |
CustomArray |
Acquired by GenScript, Dec 2017 |
Custopharm |
Acquired by Hikma, Apr 2022, $375M + $50M milestones |
Cutanea Life Sciences |
Acquired by Biofrontera, Mar 2019 |
CV Therapeutics |
Acquired by Gilead Apr 2009, $1.4B |
CXR Biosciences |
Acquired by Concept Life Sciences, Aug 2015 |
CyberHeart |
Acquired by Varian, May 2019 |
Cyclica |
Acquired by Recursion, May 2023, $40M |
CyDex Pharmaceuticals |
Acquired by Ligand Jan 2011 |
Cylex |
Bought by Viracor-IBT Feb 2013 |
CymaBay Therapeutics |
Acquired by Gilead, Mar 2024, $4.3B |
CymoGen Dx |
Acquired by Biocare Medical, Mar 2015 |
CynapseDx |
Acquired by Pharmakure, Apr 2021 |
Cynapsus Therapeutics |
Acquired by Sunovion, Oct 2016, $635M |
Cypher Genomics |
Acquired by Human Longevity, Dec 2015 |
Cypress Bioscience |
Acquired by Royalty Pharma |
Cypress Pharmaceuticals |
Acquired by Pernix |
Cyprotex |
Acquired by Evotec, Dec 2016, £ 55.7M |
Cytapex Bioinformatics |
Acquired by Insightful Science, May 2020 |
Cytes Biotechnologies |
Renamed BeCytes Biotechnologies, Jul 2023 |
CytoBioscience |
Acquired in Reverse Merger, entity renamed Inventa Biotech |
Cytocell |
Acquired by Oxford Gene Technology, Mar 2014 |
Cytochroma |
Acquired by Opko Health |
Cytogenesis |
Acquired by BresaGen, Nov 2000 |
Cytomed |
Operations acquired by UCB Pharma, Feb 1999 |
Cytomyx |
Acquired by Origene, fka Cambridge Bioscience |
Cytonet |
Key Assets acquired by Prometera Biosciences, Apr 2016 |
Cytopeia |
Acquired by BD, May 2008 |
Cytopia |
Acquired by YM Biosciences, Oct 2009, $14M |
CytoSen Therapeutics |
Acquired by Kiadis Pharma, Jun 2019 |
CytoTherapeutics |
Acquired and took on StemCells Inc name |
Cytune Pharma |
Bought by SOTIO, Aug 2018 |
Cytyc |
Acquired by Hologic, May 2007, $6.2B |
CyVek |
Acquired by Bio-Techne, 2014 |
Dako |
Bought by Agilent, May 2012, $2.2B |
Darwin Molecular |
Acquired by Chiroscience, Nov 1996, $120M stock |
Dascena |
Acquired by CirrusDx, Aug 2022 |
Dasgip |
Acquired by Eppendorf, Jan 2012 |
Davol |
Acquired by Bard, 1980 |
DCPrime |
Acquired by Immunicum, Dec 2020 |
Decibel Therapeutics |
Acquired by Regeneron, Sep 2023, $109M + $104M milestones |
deepCDR Biologics |
Acquired by Alloy Therapeutics, Dec 2021 |
Definiens |
Acquired by MedImmune, Nov 2014 |
Degge Group |
Acquired by PharmaLex, Apr 2014 |
Delenex Therapeutics |
Bought by Cell Medica, Jul 2016 |
Delinia |
Bought by Celgene, Jan 2017, $300M + $475 milestones |
Delivra |
Bought by Harvest One Cannabis, Mar 2019 |
Delphi Genetics |
Acquired by Catalent, Feb 2021 |
Dendritic Nanotechnologies |
Acquired by starpharma, Oct 2006 |
Denovium |
Acquired by AbSci, Jan 2021 |
Derma Sciences |
Acquired by Integra, Feb 2017, $240M |
Dermik Laboratories |
Owned by Sanofi, Acquired by Valeant Jul 2011 |
Dermira |
Bought by Eli Lilly, Feb 2020, $1.1B |
Devgen |
Bought by Syngenta, Sep 2012 |
Devoro Medical |
Acquired by Boston Scientific, Sep 2021, $320M + $80M Milestones |
Dey LP |
Bought by Mylan 2007 |
Dezima Pharma |
Acquired by Amgen Sep 2015, $300M+$1.2B milestones |
Dfine |
Acquired by Merit Medical, Jul 2016, $98M |
DFS Pharma |
Acquired by Medrio, Apr 2021?; fka DataFlex Solutions |
Dharmacon |
Bought by Horizon Discovery, Jul7 2017, $85M |
Diagnoplex |
Assets acquired by Novigenix, Feb 2015 |
Diagnostic Hybrids |
Acquired by Quidel, Nov 2013, $130M |
DiaKine Therapeutics |
Acquired by Islet Sciences Mar 2012 |
Diamed |
Bought by Bio-rad |
Diartis Pharmaceuticals |
Bought out by investors, Mar 2013. Not sure what will happen |
Diatherix Laboratories |
Acquired by eurofins, $50M |
Dicerna Pharmaceuticals |
Acquired by Novo Nordisk, Dec 2021, $3.3B |
Diffinity Genomics |
Acquired by Chiral Technologies, Aug 2015 |
Dilyx Biotechnologies |
Acquired by Soluble Therapeutics, Oct 2014 |
Dimension Therapeutics |
Bought by Ultragenyx, Nov 2017 |
Dionex |
Bought by Thermo Fisher, Dec 2010, $2.1B |
Diopsys |
Acquired by LumiThera, Mar 2022 |
Diosynth |
Bought by Organon, Jan 2005 |
Disarm Therapeutics |
Acquired by Eli Lilly, Oct 2020, $135M + $1.225B milestones |
Discovery Genomics |
Acquired by Immusoft, Mar 2016 |
DiscoveryBioMed |
Acquired by eurofins, Jul 2022 |
Discuva |
Acquired by Summit Therapeutics, Dec 2017, £10M |
Distributed Bio |
Acquired by Charles River, Jan 2021, $83M + $21M milestones |
Diteba Research Laboratories |
Acquired by Nutrasource Diagnostics |
Divergence |
Bought by Monsanto |
DNA Therapeutics |
Acquired by Onxeo, Mar 2016, €1.7M |
DNAprint Genomics |
Acquired by Nanobac Pharmaceuticals, Feb 2008 |
DNAx |
Acquired by Schering-Plough, Apr 1982 |
Dogma Therapeutics |
Product acquired by AstraZeneca, Sep 2020; Residential address |
Dokumeds |
Acquired by Rho, Dec 2021 |
Dolomite Bio |
Acquired by Unchained Labs, Jul 2023 |
DOV Pharmaceuticals |
Acquired by Euthymics |
Dova Pharmaceuticals |
Acquired by Swedish Orphan Biovitrum, Nov 2019, up to $915M |
Dow Pharmaceutical Sciences |
Bought by Valeant Dec 2008, Wound down late 2013 |
Draxis Pharma |
Bought by Jubilant 2008 |
Dream Pharma |
Acquired by Alvogen $186M, Jun 2014 |
Dropprint Genomics |
Acquired by Immunai, Mar 2021 |
Dropworks |
Acquired by Bio-rad, 2021 |
Drug Development Solutions |
Acquired by Alliance Pharma, Jul 2022 |
DTx Pharma |
Acquired by Novartis, Jul 2023, $500M + $500M milestones |
Dualogics |
Platform acquired by AbCellera, Aug 2020 |
Ducentis BioTherapeutics |
Acquired by Arcutis Biotherapeutics, Sep 2022, $30M + $370M milestones |
Dune Medical Devices |
Acquired by Dilon Technologies, Apr 2020 |
DuPont Pharmaceuticals |
Bought by BMS, Oct 2001, $7.8B |
Duramed |
Acquired by Barr Labs 2001 |
Durata Therapeutics |
Acquired by Actavis, Nov 2014, $675M |
DUSA Pharmaceuticals |
Part of Sun Pharmaceuticals |
DVS Sciences |
Acquired by Fluidigm, Jan 2014, $207M |
Dyax |
Bought by Shire, Jan 2016, $5.9B |
Dynacare |
Bought by LabCorp 2002 |
EastCoast Bio |
Acquired by Medic Biochemica, Jun 2020 |
EastHORN Clinical Services |
Acquired by Novotech, Jan 2023 |
eBioscience |
Acquired by Affymetrix, Nov 2011, $330M |
Eclipse Therapeutics |
Bought by Bionomics, Sep 2012, $10M |
Eden Biodesign |
Bought by Watson |
Eden Biologics |
Acquired by Bora Pharmaceuticals, May 2022; fka JHL Biotech |
Edge Therapeutics |
Acquired by PDS biotechnology, reverse merger, Mar 2019 |
Edico Genome |
Acquired by Illumina, May 2018 |
EEL transcriptomics |
Assets acquired by Rebus Biosystems, Dec 2021 |
EganLee - Trial Focus |
Acquired by Precision for Medicine |
EGEN |
Acquired by Celsion, Jun 2014 |
Egenix |
Assets acquired by Bantam Pharmaceutical, Aug 2015 |
EKG Labs |
Acquired by Infinity Life Sciences, Jun 2022 |
EKR Therapeutics |
Bought by Cornerstone Therapeutics 2012 |
Elan |
Bought by Perrigo, Dec 2013 |
Elastagen |
Acquired by Allergan, Feb 2018, $95M |
Element Genomics |
Acquired by UCB, Apr 2018, up to $30M |
Eleusis |
Acquired by Beckley PsyTech, Oct 2022 |
Elevation Pharmaceuticals |
Bought by Sunovion, $430M, Aug 2012 |
Elion Labs |
Acquired by KBI Biopharma, Jan 2018 |
Ellex |
Acquired by Lumibird, Jun 2020 |
Ellipse Technologies |
Bought by NuVasive, Jan 2016, $380M |
Elto Pharma |
Bought by Coeptis Pharmaceuticals, Nov 2018 |
Elucigene Diagnostics |
Bought by Yourgene Health, Apr 2019 |
Elusys Therapeutics |
Acquired by Heat Biologics, Apr 2022 |
Emas Pharma |
Acquired by Bionical, Nov 2016 |
Embark Biotech |
Acquired by Novo Nordisk, Aug 2023, €15M |
Embla Systems |
Acquired by Natus Medical, Sep 2011 |
Emerald Biostructures |
Acquired and renamed Beryllium |
Emergence Therapeutics |
Acquired by Eli Lilly, Aug 2023, $470M + $335M milestones |
Emisphere |
Acquired by Novo Nordisk, Dec 2020, $1.8B |
Emphasys Medical |
Assets acquired by Pulmonx, May 2009 |
Empirica Therapeutics |
Acquired by Century Therapeutics, Jun 2020 |
Empirical Bioscience |
Acquired by Fortis Life Sciences, Oct 2021; fka Syzygy Biotech |
Enantigen Therapeutics |
Acquired by OnCore Biopharma Oct 2014 |
EnBiotix |
Acquired by Polyphor, Oct 2021 |
Encore Vision |
Bought by Novartis, Dec 2016 |
Encycle Therapeutics |
Acquired by Zealand Pharma, Oct 2019, up to $80M |
Encysive Pharmaceuticals |
Bought by Pfizer 2008; fka Texas Biotechnology Corp |
EndoChoice |
Acquired by Boston Scientific, Nov 2016, $210M |
Endoclear |
Acquired by Avanos, Nov 2019 |
Endocyte |
Bought by Novartis, Dec 2018, $2.1B |
enEvolv |
Acquired by Zymergen, Mar 2020 |
Engage Surgical |
Acquired by Smith + Nephew, Jan 2022, $135M |
Engage Therapeutics |
Acquired by UCB, Jun 2020, $125M |
EngMab |
Bought by Celgene, Sep 2016, $625M + $2.4B milestones |
Enigma Therapeutics |
Acquired by NeuroDiscovery, Feb 2013 |
enobia pharma |
Acquired by Alexion Feb 2012 |
Enochian Biopharma |
Acquired by DanDrit Biotechnology, Feb 2018 |
Ensure Medical |
Acquired by Cordis, Jul 2006, up to $90M |
Entasis Therapeutics |
Acquired by InnoViva, Jul 2022, $113M; AstraZeneca spinout |
Entellus Medical |
Acquired by Stryker, Feb 2018, $662M |
Enteric Medical |
Bought by Boston Scientific, Jun 2002, $300M |
Entrepix |
Acquired by Amtech Systems, 2023 |
Envigo |
Acquired by Inotiv, Nov 2021; Swapped assets with Covance to exit preclinical CRO business |
Envision Medical |
Bought by BMS, Aug 1996 |
Envoy Therapeutics |
Acquired by Takeda, Nov 2012 |
Enzymatics |
Bought by Qiagen, Jan 2015, Colorado facility spun off as ArcherDx |
Epic Therapeutics |
Acquired by Baxter, Nov 2002, $50M+ |
Epicentre |
Acquired by Illumina, Jan 2011 |
Epicyte Pharmaceutical |
Acquired by Biolex May 2004 |
Epinomics |
Acquired by 10X Genomics, Aug 2018 |
EpiTherapeutics |
Bought by Gilead, May 2015, $65M |
Epitome Biosystems |
Assets acquired by Millipore, 2009 |
Epitomics |
Bought by Abcam, Mar 2012, $155M |
EPIX Therapeutics |
Bought by Medtronic, Jan 2019, $316M |
Epixis |
Acquired by VBI Vaccines |
Epocal |
Acquired by Alere, Feb 2013 |
Epoch Biosciences |
Acquired by Nanogen, Sep 2004 |
EpsilenBio |
Acquired by Chroma Medicine, Nov 2021 |
EQRx |
Acquired by Revolution Medicines, Nov 2023 for slightly over EQRx cash on hand |
Eragen Biosciences |
Bought by Luminex 2011 |
Erbi Biosystems |
Acquired by MilliporeSigma, Dec 2022; fka Pharyx |
Ercole Biotech |
Acquired by AVI Biopharma 2008 |
EryDel |
Acquired by Quince Therapeutics, Oct 2023 |
EsbaTech |
Bought by Alcan |
Esoterix |
Bought by LabCorp, May 2005 |
Esperance Pharmaceuticals |
Shut down late 2023; Technology sold to A28 Therapeutics, 2022 |
Esperion Therapeutics (1) |
Acquired by Pfizer early 2004 $1.3B |
Essen BioScience |
Bought by Sartorius, Apr 2017, $320M; fka Essen Instruments |
Estudysite |
Acquired by Velocity Clinical, Dec 2020 |
ETHICAL ONCOLOGY SCIENCE |
Acquired by Clovis Oncology, Nov 2013 |
Euprotein |
Acquired by Meridian Bioscience, Apr 2022 |
Eureka Genomics |
Acquired by Affymetrix, May 2015, $14M |
Eurofins DiscoverX |
Acquired by Eurofins, Jul 2017; fka Discoverx |
EUSA Pharma |
Acquired by Recordati, Dec 2021, $850M; Spun out of Jazz, Mar 2015; Acquired by Jazz Pharmaceuticals, Apr 2012, $700M |
Euthymics Biosciences |
Assets acquired by Ethismos Research, Nov 2017 |
Euticals |
Bought by AMRI, May 2016, $358M |
ev3 |
Acquired by Covidien, Jul 2010, $2.6B |
Evalve |
Owned by Abbot Vascular |
Evergreen Medical Technologies |
Acquired by Haraeus |
Exalenz Bioscience |
Acquired by Meridian Bioscience, Apr 2020 |
Exalpha Biologicals |
Acquired by LifeSpan Biosciences, Jul 2019 |
Excaliard |
Bought by Pfizer 2011 |
Excelsior Medical |
Acquired by ICU Medical, Oct 2015 |
Excelsyn |
Bought by AMRI |
Eximias Pharmaceutical |
Acquired by YM BioSciences, May 2006 |
Eximo Medical |
Acquired by AngioDynamics, Oct 2019, $46M + $20M milestones |
Exiqon |
Acquired by Qiagen, Oct 2017 |
Exocell |
Acquired by Ethos Biosciences, Nov 2018 |
Exonics Therapeutics |
Acquired by Vertex, Jun 2019, $245M |
Expedeon |
Acquired by Abcam, Jan 2020; Acquired by SYGNIS, Jun 2017, €11.5M |
Explora Biolabs |
Acquired by Charles River, Apr 2022, $295M |
ExplORer Surgical |
Acquired by GHX, Oct 2021 |
Expression Analysis |
Acquired by Quintiles, Aug 2012 |
EXPUTEC |
Acquired by Korber Group, Jun 2020 |
Exquiron |
Acquired by Aptuit, Apr 2016 |
ExsoMed |
Acquired by Acumed, Jul 2022 |
Eyevance Pharmaceuticals |
Acquired by Santen, Sep 2020 |
Fabrus |
Acquired by Sevion Therapeutics, May 2014 |
Facet Biotech |
Bought by Abbott 2010 |
Fairhaven Pharmaceuticals |
Acquired by Liminal BioSciences, Jul 2020 |
Falcon Pharmaceuticals |
Bought by Sandoz from Alcon Oct 2011 |
Famy Life Sciences |
Acquired by Viatris, Nov 2022 |
Fathom Pharma |
Acquired by Consegna Pharma, Apr 2022 |
Faulk Pharmaceuticals |
Bought by Panther Biotechnology, Jul 2015, stock plus royalty |
Faxitron Bioptics |
Acquired by Hologic, Jul 2018, $85M |
FazaClo |
Acquired by Azur Pharma 2007 |
Fermentas |
Acquired by Thermo Fisher, May 2010, $260M |
Ferrokin Biosciences |
Bought by Sandoz Jul 2012, $1.525B |
Fibrocell Science |
Acquired by Castle Creek Pharmaceuticals, Dec 2019; fka Isolagen |
Fidelta |
sold by Galapagos to Selvita, Nov 2020, $37M |
Finox Biotech |
Acquired by Gedeon Richter, Jun 2016 |
Firefly BioWorks |
Acquired by abcam, Jan 2015, $28M |
FirstString Research |
Renamed Xequal May 2022; Acquired by Relief Therapeutics, Jul 2016 |
Fitzgerald Industries International |
Acquired by Biosynth, Aug 2023, $30M; Acquired by Trinity Biotech, 2004 |
Five Prime Therapeutics |
Acquired by Amgen, Apr 2021, $1.9B |
Flame Biosciences |
Acquired by Leap Therapeutics, Jan 2023 |
Flaskworks |
Acquired by Northwest Biotherapeutics, Sep 2020 |
Flexion Therapeutics |
Acquired by Pacira BioSciences, Nov 2021 |
Flexus Biosciences |
Bought by BMS, Feb 2015, $800M + $450M milestones |
FloDesign Sonics |
Acquired by MilliporeSigma, Oct 2019 |
Florida Biotechnologies |
Acquired by NAYA Biosciences, Jan 2024, $20M |
Flow Forward Medical |
Acquired by Artio Medical, Jul 2020 |
FlowMetric |
Acquired by Kcas Bio, Feb 2022 |
FluoFarma |
Acquired by Porsolt, Dec 2015 |
Fluxion Biosciences |
Acquired by Cell Microsystems, Aug 2023 |
Focal Therapeutics |
Acquired by Hologic, $125M, Oct 2018 |
Focus-X Therapeutics |
Acquired by Full Life Technologies, Nov 2022, up to $245M |
Foguera |
Bought by Sandoz Jul 2012, $1.525B |
Foldrx Pharmaceuticals |
Bought by Pfizer, Sep 2010 |
Forbius |
Acquired by BMS, Aug 2020; fka Armada Pharmaceuticals, fka Formation Biologics |
Forendo Pharma |
Acquired by Organon, Dec 2021, $954M |
Foresight Biotherapeutics |
Bought by Shire, Aug 2015, $300M |
Forest Laboratories |
Bought by Actavis, Jul 2014, $25B |
FORMA Therapeutics |
Acquired by Novo Nordisk, Oct 2022, $1.1B |
Fornix Biosciences |
Acquired by skiing company in reverse merger, Dec 2013 |
ForSight VISION4 |
Acquired by Roche, Jan 2017 |
ForSight VISION5 |
Acquired by Allergan, Aug 2016, $95M |
Forte Bio |
Folded into Sartorious after purchasing from Danaher, Oct 2019 |
Forty Seven |
Acquired by Gilead, Apr 2020, $4.9B |
Forward Clinical Trials |
Acquired by Cenexel, Aug 2021 |
Fournier Pharma |
Acquired by Solvay, 2006 |
Fovea Pharmaceuticals |
Acquired by Sanofi Oct 2009 |
Frame Cancer Therapeutics |
Acquired by CureVac, Jun 2022 |
Freedom Meditech |
Acquired by Trividia Health, Jan 2017 |
Frontida BioPharm |
Acquired by Adare Pharma Solutions, Dec 2021 |
Frontier Global Sciences |
Acquired by eurofins, Sep 2012 |
Frugi Biotechnology |
Acquired by BigHat Biosciences, Mar 2022 |
FSC Pediatrics |
Acquired by Flamel, merged into Avadel Pharmaceuticals Jan 2017 |
Funxional Therapeutics |
Bought by Boehringer Ingelheim, Jul 2012 |
Furiex Pharmaceuticals |
Acquired by Forest Labs, Apr 2014 |
G7 Therapeutics |
Acquired by Heptares, Nov 2016, $12M |
Gadea Pharmaceutical |
Acquired by AMRI, 2015, $174M |
Gadeta |
Closed Feb 2024; Acquired by Clade Therapeutics, Oct 2023 |
Gala Biotech |
Acquired by Catalent Pharma Solutions, ~Jul 2007 |
Galena Biopharma |
Acquired via Reverse Merge by Sellas Life Sciences, Aug 2017 |
Galil Medical |
Acquired by BTG plc, May 2016 |
Gallus |
Bought by Patheon, Aug 2014 |
Gallus Immunotech |
Acquired by Exalpha Biologicals, Jun 2018 |
Gambro |
Acquired by Baxter, Sep 2013 |
GammaDelta Therapeutics |
Acquired by Takeda, Oct 2021 |
GAMUT Therapeutics |
Acquired by SparingVision, Apr 2021 |
GandTex |
Assets Acquired by SmooFi, Oct 2016 |
Ganymed Pharmaceuticals |
Bought by Astellas, Dec 2016, $1.4B |
GATC Biotech |
Acquired by eurofins, Jun 2017 |
Gauss Surgical |
Acquired by Stryker, Sep 2021 |
GAVIS PHARMACEUTICALS |
Acquired by Lupin |
GD Searle |
Acquired by Monsanto 1985, Merged into Pharmacia, name retired in 2003 after Pfizer acquisition |
GE Healthcare |
Acquired by Danaher, Apr 2020, $21.4B, rebranded as Cytiva |
Geltex Pharmaceuticals |
Bought by Genzyme |
Gema Biotech |
Acquired by AMEGA biotech, early 1990s |
Gemin X |
Acquired by Cephalon Mar 2011 |
Gemini Laboratories |
Acquired by Amneal, May 2018 |
GEMoaB Monoclonals |
Being acquired/relocated by consortium, Jun 2021, now part of Avancell |
Gemphire Therapeutics |
Acquired via Reverse Merger by NeuroBio, Dec 2019 |
Gen-probe |
Acquired by Hologic 2012 |
Gen9 Bio |
Bought by Ginkgo Bioworks, Jan 2017 |
Genable Technologies |
Bought by Spark Therapeutics, Mar 2016, $15M |
Genaco Biomedical |
Acquired by Qiagen 2006 |
Genae Associates |
Acquired by IQVIA |
Genaissance Pharmaceuticals |
Acquired by Clinical Data, Jun 2005 |
GenCell Biosystems |
Acquired by BD, Oct 2014 |
Gene Labs |
Bought by GSk 2008 |
GeneDx (old) |
Acquired by Sema4, Jan 2022, $623M |
Genelabs Technologies |
Acquired by GSK, Oct 2008, $57M |
Genelex |
Acquired by Invitae, Mar 2020 |
GeneLogic |
Bought by Ocimum, Oct 2007, $10M; bankrupt Dec 2011 |
Genencor |
Bought by DuPont |
GenePOC Diagnostics |
Acquired by Meridian Bioscience, Apr 2019, $50M + $70M milestones |
GeneSeek |
Bought by Neogen |
Genesoft Pharmaceuticals |
Acquired by Genome Therapeutics, Nov 2003 |
Genetic Systems |
Bought by Bristol-Myers, 1986 |
Genetic Therapy |
Bought by Sandoz, Jul 1995, #295M |
Genetics Institute |
Bought by Wyeth, Sep 1996 |
GeneTx Biotherapeutics |
Acquired by Ultragenyx, Jul 2022, $75M |
GeneWEAVE Biosciences |
Bought by Roche, Aug 2015, $190M |
Genexx |
Acquired by Opko Health , Oct 2009 |
Genhelix |
Acquired by mAbxience, Jun 2014 |
Genia Technologies |
Acquired by Roche, Jun 2014 |
Genibet Biopharmaceuticals |
Acquired by Recipharm, Feb 2022 |
Genkyotex |
Acquired by Calliditas, Nov 2020 |
Genlantis |
Acquired by AMSBIO |
GenMark Diagnostics |
Acquired by Roche, May 2021, $1.85B |
GenoLogics |
Acquired by Illumina, Sep 2015 |
GenoMatix |
Acquired by Intrexon |
Genome Explorations |
Acquired by Tesis Biosciences, Feb 2022 |
Genomic Health |
Acquired by Exact Sciences, Nov 2019, $2.8B |
Genomic Solutions |
Acquired by Digilab |
Genomics Collaborative |
Acquired by BioServe, 2007 |
Genopis |
Acquired by Wacker Feb 2021 |
Genoptix |
Bought by Novartis Jan 2011, sold off Jan 2017, bought by Neogenomics, Dec 2018, $125M + 1 million shares |
Genos |
Acquired by NantOmics, Apr 2017 |
Genosity |
Bought by Invitae, Apr 2021, $200M |
Genpathway |
Acquired by Active Motif, Nov 2010 |
Gentium |
Bought by Jazz Pharmaceuticals, Jan 2014, $1B |
Gentris |
Bought by Cancer Genetics Jun 2014 ($6.5M) |
GenturaDx |
Bought by Luminex 2012 |
GenVec |
Bought by Intrexon, Jun 2017, $16M in stock |
Genzyme |
Acquired by Sanofi, 2011, $20.1B |
Genzyme Genetics |
Bought by LabCorp, Dec 2010 |
Geospiza |
Acquired by Perkin Elmer, May 2011, $?? |
Gideon Pharmaceuticals |
Acquired by Elorac Pharmaceuticals, Apr 2016 |
Glamorous AI |
Acquired by X-Chem, Oct 2021 |
Global Blood Therapeutics |
Acquired by Pfizer, Oct 2022, $5.4B |
GlobalCare Clinical Trials |
Acquired by Covance, Jul 2020 |
Gloucester Pharma |
Bought by Celgene 2009 |
Gloucester Pharmaceuticals |
Acquired by Celgene, Dec 2009, $340M + $300M milestones |
GlyCart Biotechnology |
Acquired by Roche, Jul 2005 |
GlycoFi |
Bought by Merck, $400M, 2006 |
GlycoVaxyn |
Acquired by GSK, Feb 2015, $190M |
GLyPharma Therapeutic |
Acquired by Theracon, Oct 2018 |
GN Otometrics |
Acquired by Natus, Jan 2017 |
GnuBIO |
Bought by Bio-rad |
goBalto |
Acquired by Oracle, Oct 2018 |
Good Start Genetics |
Acquired by Invitae, Aug 2017 |
Good Therapeutics |
Acquired by Roche, $250M, renamed Bonum Therapeutics |
GoodStart Genetics |
Acquired by Invitae, Aug 2017 |
Gotham Therapeutics |
Acquired by 858 Therapeutics, Sep 2021 |
GPC Biotech |
Acquired by Agennix, Nov 2009 |
Grace Therapeutics |
Acquired by Acasti, Aug 2021 |
Gracell Biotechnologies |
Acquired by AstraZeneca, Feb 2024, $1.2B |
Graceway Pharmaceuticals |
Bought by Medicis out of Bankruptcy |
Greenleaf Health |
Acquired by Validant, Apr 2021, now part of Eliquent Life Sciences |
Greenwich Biosciences |
Acquired by Jazz Pharmaceuticals, May 2021 |
Griffin Laboratories |
Acquired by Atos Medical |
Grupo Biotoscana |
Acquired by Knight Therapeutics, Nov 2019 |
GSL Biotech |
Acquired by Dotmatics |
GTx |
Acquired by Oncternal via reverse merger ticker, Jun 2019 |
Guide Therapeutics |
Website down Oct 2021 - Dec 2021; Acquired by BEAM Therapeutics, Feb 2021, $120M + $320M Milestones |
Guilford Pharmaceuticals |
Bought by MGI Pharma, Jul 2005 |
Gyroscope Therapeutics |
Acquired by Novartis, Dec 2021, $1.5B |
Gyrus |
Acquired by Olympus, 2008, $2B |
H-Immune Therapeutics |
Acquired by HiFiBiO, Oct 2018 |
Haemostatix |
Acquired by Ergomed, May 2016 |
Hain Lifescience |
Acquired by Bruker, Oct 2018 (80% stake) |
Haina Pharmaceutical |
Acquired by China Sky One, $428k, Apr 2008 |
HalioDx |
Acquired by Veracyte, Aug 2021 |
Halo Genomics |
Bought by Agilent |
Halo Pharma |
Acquired by Noramco, Nov 2023; Acquired by Cambrex, Sep 2018, $425M |
Hamamatsu Pharma Research |
Acquired by CMIC, Oct 2023 |
Handl Therapeutics |
Acquired by UCB, Nov 2020 |
Hansen Medical |
Bought by Auris Surgical, Apr 2016, $40M |
Harbor Therapeutics |
Acquired by Crede Capital Group, Jan 2015. Website gone. |
Harbour Antibodies |
Acquired by Harbour Biomed, Dec 2016 |
Harpoon Therapeutics |
Acquired by Merck, Mar 2024, $680M |
Harrisvaccines |
Bought by Merck Animal Health, Nov 2015 |
Hauser Pharmaceutical Services |
Acquired by Cedarburg |
Hawthorn Pharmaceuticals |
Acquired by Pernix Jan 2012 |
Haystack Sciences |
Acquired by insitro, Oct 2020 |
HD Biosciences |
Acquired by WuXi Apptec, Jan 2016 |
Healeon Medical |
Acquired by Bimini HealthTech, Jun 2020 |
Health Advances |
Bought by Parexel, Jan 2016 |
Health Decisions |
Acquired by Premier Research, Jul 2021 |
Health-Chem Diagnostics |
Acquired by PL Developments, Jul 2017 |
HealthPoint Bio |
Bought by Smith & Nephew |
Healthpoint Biotherapeutics |
Acquired by Smith & Nephew, Sep 2013, $782M |
HeartWare |
Bought by Medtronic, Aug 2016, $1.1B |
Helio Vision |
Bought by Aldeyra Therapeutics, Jan 2019, $10M |
Helix Diagnostics |
Acquired by Bio-rad, Jul 2001 |
Hemacare |
Acquired by Charles River Labs, Jan 2020, $380M |
Hematech |
Acquired by Sanford Health, Jan, 2013, became Sanford Applied Biosciences |
Hemmo Pharmaceuticals |
Acquired by Piramal, Apr 2021, $106M + Milestones |
Henogen |
Acquired by Novasep, Jul 2009 |
Heptares Therapeutics |
Acquired by Sosei Group, Feb 2015 |
Hercon Pharmaceuticals |
Acquired by Zydus Cadila, 2019 |
Hexal |
Acquired by Sandoz, Jun 2005 |
Hi-Tech Pharmacal |
Acquired by Akorn, Apr 2014 |
Hibiskus Biopharma |
Acquired by Lodo Therapeutics, Sep 2020 |
Highline Sciences |
Acquired by Tempus, Feb 2022 |
HighPoint Solutions |
Acquired by IQVIA, Oct 2017 |
Hillrom |
Acquired by Baxter, Dec 2021, $12.5B |
HistoRx |
Acquired by Genoptix Sep 2012 |
HistoTox Labs |
Acquired by Inotiv, Apr 2021, $22M |
Horizon Discovery |
Acquired by Perkin Elmer, Oct 2020, $383M |
Horizon Therapeutics |
Acquired by Amgen, Oct 2023; fka Horizon Pharmaceuticals |
Horizon Therapeutics |
Acquired by Amgen, Oct 2023; fka Horizon Pharmaceuticals |
Hospira |
Acquired by Pfizer, Sep 2015 |
Hotspur Technologies |
Acquired by Teleflex, Jul 2012 |
HRA Pharma |
Acquired by Perrigo, May 2022, $2.1B |
Humabs BioMed |
Bought by Vir Biotechnology, Aug 2017 |
Human Genome Sciences |
Bought by GSK |
HumanZyme |
Acquired by Proteintech, Apr 2018 |
Hybritech |
Bought by Lilly, 1986, $400M+ |
Hygia Health Services |
Acquired by Stryker, May 2018 |
Hyperion Therapeutics |
Bought by Horizon Pharma Mar 2015 $1.1B |
Hypnion |
Acquired by Eli Lilly, Mar 2007 |
Hyseg Pharmaceuticals |
Acquired by ARCA Biopharma, Jan 2009 |
Ibex Technologies |
Acquired by BBI Solutions, Apr 2024 |
Ibis Biosciences |
Acquired by Abbott Jan 2009 |
Icagen (1) |
Acquired by Pfizer Oct 2011, Renamed Neusentis Mar 2012, Icagen name and assets acquired by XRPro Sciences Jul 2015 |
Icagen (2) |
Acquired by Ligand Apr 2020; Purchased Icagen assets from Pfizer |
ICBiotec |
Acquired by eGenesis, May 2020 |
Ichorion Therapeutics |
Acquired by Cerecor, Sep 2018, $26.6M |
Icon Bioscience |
Acquired by pSivida, rebranded as EyePoint Pharmaceuticals |
Iconix Biosciences |
Acquired by Entelos, Aug 2007 |
Icos |
Acquired by Eli Lilly, 2006, $2.2B |
ID Biomedical |
Acquired by GSK, Sep 2005, $1.7B |
ID Pharma |
Acquired by I'rom Group |
IDbyDNA |
Acquired by Illumina, Jun 2022 |
Idenix Pharmaceuticals |
Bought by Merck, Jun 2014 |
IDEV Technologies |
Bought by Abbott, Jul 2013, $310M |
IDM Pharma |
Acquired by Takeda |
Idun Pharmaceuticals |
Acquired by Pfizer Feb 2005, Acquired by Conatus Pharmaceuticals Aug 2010 |
IFM Therapeutics (1) |
Acquired by BMS after less than a year, $300M + $1B milestones. Spinning out some assets into new company with same name |
Igenica Biotherapeutics |
Assets acquired by Pierre Fabry, May 2017 |
iGenomX |
Acquired by Twist Biosciences, Jun 2021 |
Ignyta |
Acquired by Roche, Feb 2018; $1.2B |
Ikaria |
Acquired by Mallinckrodt, Apr 2015 |
iLab Solutions |
Assets acquired by Agilent, Aug 2016 |
ILEX Oncology |
Acquired by Genzyme, Dec 2004, $1B in stock |
Ilypsa |
Bought by Amgen $420M Jun 2007 |
Imaging Advantage |
Acquired by Envision Healthcare, Mar 2017 |
Imago Biosciences |
Acquired by Merck, Jan 2023, $1.35B |
Imara |
Acquired by Enliven Therapeutics, Oct 2022 |
imarc |
Acquired by Avania, Jun 2021 |
ImaRx |
Assets acquired by newly formed Cerevast Therapeutics in 2009 |
ImClone |
Bought by Lilly, Oct 2008, $6.5B |
Imgenex |
Acquired by Novus Biologicals Oct 2013 |
Immco Diagnostics |
Acquired by Trinity Biotech, Aug 2013, $33M |
Immucor |
Acquired by Werfen, Mar 2023, $2B |
ImmuMetrix |
Bought by CareDx Jun 2014 |
Immune Design |
Bought by Merck, Feb 2019, $300M |
Immunetics |
Acquired by Oxford Immunotec, Oct 2016 |
Immunex |
Bought by Amgen, Jul 2002, $16B |
Immunitrack |
Acquired by Eli Lilly, Oct 2023 |
ImmunoCellular Therapeutics |
Rebranded as EOM Pharmaceuticals, Nov 2022; Assets bought Aug 2019, $500k |
Immunomedics |
Acquired by Gilead, Oct 2020 |
Impac Medical Systems |
Acquired by Elekta, Jan 2005 |
Impact Biomedicines |
Bought by Celgene, Jan 2018, up to $7B |
Impilo Therapeutics (1) |
Acquired by CEND Therapeutics, Sep 2020 |
Impopharma |
Acquired by Rubicon Research, Jan 2020 |
ImThera Medical |
Acquired by LivaNova, Dec 2017 |
Imugen |
Acquired by Oxford Immunotec, Jul 2016, $22M |
In Vitro ADMET Laboratories |
Acquired by Discovery Life Sciences, Dec 2021 |
In2Bones |
Acquired by Conmed, Jun 2022, $145M |
Incisive Surgical |
Acquired by CooperSurgical, Jan 2019 |
Incline Therapeutics |
Acquired by The Medicines Company, Dec 2012 |
Indevus |
Acquired by Endo Pharmaceuticals 2009 |
InDex Pharmaceuticals |
Acquired by Investors, Jun 2024 |
Indicia Biotechnology |
Acquired by Platine Pharma Services, Jun 2013 |
IndiPharm |
Acquired by private equity to be relaunched as InClinica |
IndUS Pharmaceuticals |
Bought by Pivot Pharmaceuticals, Nov 2015 |
Inexia |
Acquired by Centessa |
InfaCare |
Acquired by Mallinckrodt, Sep 2017, $80M + $345M milestones |
Inflazome |
Acquired by Roche, Sep 2020, $450M |
InGen Biosciences |
Acquired by Exonhit 2012 |
Ingenuity Systems |
Bought by Qiagen, renamed Ingenuity, folded into Qiagen |
Inhibitex |
Acquired by BMS 2012, $2.5B |
Inivata |
Acquired by NeoGenomics, May 2021, $390M |
Injex Pharma |
Bought by Chinese Investor, Jan 2016 |
Innate Immunotherapeutics |
Acquired Amplia Therapeutics, took its name |
InnAVasc Medical |
Acquired by W.L. Gore, Aug 2022 |
InnFocus |
Acquired by Santen, Jul 2016 |
Innocutis |
Acquired by Cipher Pharmaceuticals, Apr 2015 |
Innogenetics |
Acquired by Fujirebio Europe, Sep 2010 |
InnoPharma |
Acquired by Pfizer, Sep 2014, $225M + $135M milestones |
Innovalve |
Acquired by Edwards, Jul 2024, $300M |
Innovative Therapies |
Acquired by Cardinal Health, Aug 2014 |
Innovus Pharmaceuticals |
Acquired by Aytu Bioscience, Feb 2020 |
Inositec |
Acquired by Vifor Pharma, Nov 2021, CHF20M |
Inova Diagnostics |
Acquired by Werfen, 2008 |
Inova Labs |
Bought by ResMed, Jan 2016 |
Inpharmatica |
Acquired by Galapagos, Jul 2019 |
Insight Genetics |
Acquired by Oncocyte, Feb 2020 |
Insight Medical Systems |
Acquired by Enovis, Jul 2022 |
Insight Pharmaceuticals |
Acquired by Prestige Brands, Apr 2014, $650M |
InSilico Solutions |
Acquired by Kiromic, Jul 2021 |
InSite Vision |
Acquired by Sun pharma Sep 2015 |
Inspire Pharmaceuticals |
Acquired by Merck 2011 |
Instratek |
Assets acquired by Stryker, Sep 2016 |
InstruNor |
Acquired by Fluidigm, Feb 2020 |
InSymbiosis |
Acquired by Camargo, Jun 2019 |
Intabio |
Acquired by SCIEX, Jan 2021 |
Intact Vascular |
Acquired by Philips, Aug 2020, $275M |
Intarcia Therapeutics |
Acquired by i2o Therapeutics, Aug 2023 |
Intec Pharma |
Acquired by Decoy Biosystems via Reverse Merger, Aug 2021 |
INTEGA Skin Sciences |
Acquired by Crescita Therapeutics, Sep 2016 |
IntegenX |
Acquired by Thermo Fisher, Mar 2018 |
Integrated Diagnostics |
Acquired by Biodesix, Jul 2018 |
Integrated Diagnostics (2) |
Acquired by Biodesix, Jul 2018 |
Integrated Laboratory Systems |
Acquired by Inotiv, Jan 2022, $56M |
Integrated Proteomics Applications |
Acquired by Bruker, Sep 2020 |
Integrity Bio LyoTip |
Acquired by Curia, Jul 2021 |
Integromics |
Bought by Perkin-Elmer 2017 |
InteKrin |
Owned by Coherus Biosciences |
Intellicyt |
Acquired by Sartorius, Jun 2016, $90M |
Intelligent Biosystems |
Acquired by Qiagen, Jun 2012 |
Intellikine |
Bought by Millennium 2011 |
IntelliSyn R&D |
Acquired by X-Chem, Jan 2021 |
Intendis |
Acquired by Bayer 2006, Renamed Bayer Health Care 2012 |
Interferon Source |
Bought by PBL Assay Science |
InterMune |
Bought by Roche, Aug 2014, 8.5B |
Interpares Biomedicine |
Acquired by Clarified Precision Medicine, Aug 2021 |
Intersect ENT |
Acquired by Medtronic, May 2022, $1.1B |
Intrafuse |
Tech acquired by Conventus Orthopedics, Dec 2019 |
Intrinsic Bioprobes |
Acquired by Thermo Fisher Sep 2011 |
Intronn |
Acquired by VIRxSYS, Sep 2007 |
Inviragen |
Bought by Takeda, May 2013 Announced |
Invitae |
Acquired by Labcorp, Apr 2024; Chapter 11 Bankruptcy, Feb 2024 |
Invitrogen |
Acquired by Thermo Fisher, Apr 2013, $13.6B |
Invuity |
Acquired by Stryker, Oct 2018, $190M |
Iogyn |
Acquired by Boston Scientific, May 2014 |
Iomai |
Bought by Intercell 2008 |
IOmet Pharma |
Acquired by Merck, Jan 2016, $400M |
IONTOX |
Acquired by LifeNet Health LifeSciences, Aug 2022 |
iperian |
Acquired by Bristol-Myers Squibb, Apr 2014, $175M |
IPM Biotech |
Acquired by BioAgilytix, Feb 2016 |
Iquum |
Acquired by Roche, Apr 2014 |
IRIS International |
Acquired by Danaher, Sep 2012 |
IRISYS |
Acquired by Recro, Aug 2021 |
IROC Inocross |
Assets acquired by Avedro, Sep 2014 |
Irvine Pharmaceutical Services |
Acquired by Nitto Denko Avecia, Oct 2016 |
Irvine Scientific |
Acquired by Fujifilm, Jun 2018 |
iScience Interventional |
Acquired by Ellex, Jan 2014 |
IsoPlexis |
Acquired by Berkeley Lights, Mar 2023, $57.8M |
Isotechnika |
Acquired and merged with Aurinia, Sep 2013 |
Ista Pharmaceuticals |
Bought by Bausch & Lomb - 2012 |
Italchimici |
Acquired by Recordati, May 2016 |
ITC |
Acquired Accumetrics, Rebranded as Accriva Diagnostics |
Ivantis |
Website down Feb 2023; Acquired by Alcon, Jan 2022, $475M |
IVAX Corporation |
Acquired by Teva 2006 |
Ivera Medical |
Bought by 3M, Feb 2015 |
IVERIC Bio |
Acquired by Astellas, Jul 2023, $5.9B; fka Ophthotech |
Jade Therapeutics |
Acquired by EyeGate Pharma, Mar 2016, stock |
Janpix |
Acquired by Centessa Pharmaceuticals |
Jantibody |
Acquired by H-Cyte, Sep 2022 |
Jecure Therapeutics |
Acquired by Genentech, Nov 2018 |
Jennerex |
Acquired by SillaJen, Nov 2013, up to $150M |
Jerini |
Acquired by Shire, 2008 |
JHP Pharma |
Bought by Par Pharmaceuticals |
Jounce Therapeutics |
Acquired by Concentra Biosciences, May 2023 |
Jouvenal |
Bought by Warner-Lambert, 1997 |
JSW Life Sciences |
Acquired by QPS, Jan 2012 |
Jungla |
Acquired by Invitae, Jul 2019, $65M |
Juniper Pharmaceuticals |
Acquired by Catalent, Aug 2018 |
Juno Therapeutics |
Acquired by Celgene, Jan 2018, $9B |
Just Biotherapeutics |
Acquired by Evotec, Jul 2019, up to $90M |
K2M |
Acquired by Stryker, Nov 2018 |
Kadmon |
Acquired by Sanofi, Sep 2021 |
KAI Pharmaceuticals |
Bought by Amgen 2012 |
KAI Research |
Acquired by Navitas Life Sciences |
Kairos Therapeutics |
Acquired by Zymeworks |
Kalila Medical |
Acquired by Abbott, Feb 2016 |
Kalon Biotherapeutics |
Acquired by Fujifilm Diosynth Dec 2014 |
KaNDy Therapeutics |
Acquired by Bayer, Sep 2020, $425M |
Kantar Health |
Acquired by Cerner, Apr 2021, rebranded as Cerner Enviza |
Kanyos Bio |
Acquired by Anokion, Sep 2019 |
Kapa Biosystems |
Bought by Roche, Aug 2015 |
Kapplex |
Acquired by Miroculus, Apr 2016 |
Karos Pharmaceuticals |
Sold to Roivant Sciences, 2017 |
Katena Products |
Acquired by Corza Medical, Dec 2021 |
Kedalion Therapeutics |
Acquired by Novartis, Jun 2022 |
Kemwell Biopharma |
Bought by Recipharm, Apr 2016, $205M |
Kendle |
Acquired by INC Research 2011 |
Kenta Biotech |
Assets acquired by Aridis Pharmaceuticals, May 2013 |
Khepri Pharmaceuticals |
Acquired by Arris Pharmaceuticals Nov 1995 |
Kiadis Pharma |
Acquired by Sanofi, Oct 2020, $357M |
Kinaxo |
Bought by Evotec |
Kinetic Discovery |
Acquired by Exscientia, Nov 2018 |
Kinetix Pharmaceuticals |
Bought by Amgen 2000 |
King Pharmaceuticals |
Bought by Pfizer, Oct 2010, $3.6B |
Kinnate Biopharma |
Acquired by Xoma, Apr 2024 |
Kiq |
Acquired by Unum Therapeutics, Jul 2020 |
Kleo Pharmaceuticals |
Acquired by Biohaven, Jan 2021 |
KMT Hepatech |
Acquired by PhoenixBio, Dec 2017 |
Knoll Pharmaceutical |
Taken over by BASF 1975, sold to Abbott 2002, $6.9B |
Knome |
Acquired by Tute Genomice, Nov 2015 |
Koligo Therapeutics |
Acquired by Orgenesis, Oct 2020 |
Kolltan Pharmaceuticals |
Bought by Celldex, Nov 2016, $62.5M + $172.5M milestones |
KorvaLabs |
Acquired by Curative, May 2020 |
Kos Pharmaceuticals |
Acquired by Abbott 2006 |
Kosan Biosciences |
Acquired by BMS 2008 |
KPL |
Acquired by SeraCare, Aug 2013, Stock |
Kreatech Diagnostics |
Acquired by Leica Biosystems, Jul 2013 |
KuDOS Pharmaceuticals |
Acquired by AstraZeneca, Dec 2005, £120M |
Kuur Therapeutics |
Acquired by Athenex, May 2021, $70M stock + $115M milestones; fka Cell Medica |
KWS BioTest |
Acquired by Charles River, Jan 2018, £15M |
Kyalin Biosciences |
Acquired by Retrophin, Dec 2013 |
Kymab |
Acquired by Sanofi, Apr 2021, $1.45B |
Kythera Biopharmaceuticals |
Bought by Allergan, Oct 2015, $2.1B |
La Jolla Pharmaceutical |
Acquired by Innoviva, Aug 2022, $149M |
Lab901 |
Bought by Agilent |
Labcyte |
Acquired by Beckman Coulter, Jan 2019 |
Labopharm |
Bought by Paladin 2011 |
Labor Dr. Merk |
Acquired by Boehringer Ingelheim, Dec 2020 |
Laboratories Delalande |
Acquired by Synthélabo, 1991 |
Labrys Biologics |
Bought by Teva, Jun 2014 |
Lacrimedics |
Acquired by Innovia Medical, Nov 202 |
Lake Region Medical |
Bought by Greatbatch, Oct 2015, $1.73B |
LakePharma |
Acquired by Curia, Jul 2021 |
Laminar |
Acquired by Johnson & Johnson, Nov 2023, $400M |
Lancaster Laboratories |
Bought by eurofins, Apr 2011, $200M |
Landos Biopharma |
Acquired by AbbVie, May 2024, $137.5M |
Langhua Pharmaceutical |
Acquired by Viva Biotech, Aug 2020, $367M |
Lanx inc |
Acquired by Biomet, Nov 2013, $150M |
Laragen |
Acquired by Transnetyx, Aug 2023 |
Lasergen |
Acquired by Agilent, Apr 2018, $105M |
LAT Pharma |
Acquired by NanoAntibiotics, Apr 2016 |
Laureate Pharma |
Acquired by Gallus |
Lazarus Effect |
Acquired by Medtronic, Sep 2015, $100M |
LDR Global |
Acquire by Zimmer Biomet, Jun 2016, $1B |
LDR Holdings |
Bought by Zimmer Biomet, $1B, Jun 2016 |
LEAD Therapeutics |
Acquired by BioMarin Pharmaceuticals, 2010 |
Lederle Labs |
Bought by Wyeth 1994 |
LemnaGene |
Acquired by Biolex 2005 |
Lenetix |
Acquired by Bio-Reference Labs 2010 |
Lentigen |
Acquired by Miltenyi Biotech, Apr 2014 |
Leonard-Meron Biosciences |
Acquired by Citius Pharmaceuticals, Mar 2016 |
LeukoSite |
Acquired by Millennium 1999 |
Lexent Bio |
Acquired by Foundation Medicine, Jun 2020 |
Libertas Pharma |
Acquired by Mayne Pharma, Jul 2013 |
Libra Medical |
Acquired by RQM+, May 2023 |
Librede |
Acquired by Lygos, Jan 2020 |
Lidco |
Acquired by Masimo, Feb 2021 |
Life Technologies |
Bought by Thermo-Fisher, Apr 2013, $13.6B |
Lifecell |
Acquired by KCI, 2008, $1.7B; Sold to Allergan Dec 2016, $2.9B |
Lifecode |
Acquired by MedGenome, Feb 2016 |
Lifecode Health |
Assets Acquired by MedGenome, Feb 2016 |
LIFNano Therapeutics |
Website hijacked May 2023 - Aug 2023 |
LigoCyte Pharmaceuticals |
Acquired by Takeda Oct 2012 |
Lineage Therapeutics |
Acquired by Impax, Mar 2015 |
Lineagen |
Acquired by Bionano Genomics, Aug 2020, $9.6M |
Link Technologies |
Acquired by LGC, Jul 2017 |
Linkage Biosciences |
Acquired by Thermo Fisher, Jul 2017 |
Lipomics Technologies |
Acquired by Metabolon, Aug 2012 |
Liponex |
Acquired by ImaSight in reverse merger, Jun 2008 |
LipoScience |
Bought by LabCorp, Nov 2014, $85.3M |
Liposonix |
Bought by Medicis |
Living Pharma |
Acquired by Lentigen, Jul 2017 |
Lobesity |
Assets acquired by 9 Meters Biopharma, Jul 2021, $5M + $45M milestones |
Locemia Solutions |
Sole product acquired by Eli Lilly, Oct 2015 |
Lodo Therapeutics |
Acquired by Zymergen, May 2021 |
LogicBio Therapeutics |
Acquired by AstraZeneca, Nov 2022, $68M |
Lohmann Animal Health International |
Acquired by Elanco, Feb 2014 |
Loop Genomics |
Acquired by Element Biosciences, Feb 2022 |
Lotus Tissue Repair |
Acquired by Shire, Jan 2013, $49.3M + $275M milestones |
Lowell Therapeutics |
Acquired by AcelRx Pharmaceuticals, Jan 2022 |
LS9 |
Bought by Renewable Energy Group, Jan 2014 |
Lucigen |
Acquired by LGC, Feb 2018 |
LuinaBio |
Renamed AcuraBio, Aug 2022 |
Lumara Health |
Bought by Amag, Sep 2014, $675M |
Lumena Pharmaceuticals |
Bought by Shire, May 2014, $260M + $90M for milestone possibilities |
Lumigen |
Bought by Beckman-Coulter, Oct 2006 |
Luminex |
Acquired by Diasorin, Apr 2021, $1.8B |
Lumora |
Bought by Erba Diagnostics Sep 2015, Rebranded Erba MDX |
Lusochimica |
Owned by Menarini |
Lutonix |
Acquired by C.R. Bard, Dec 2011 |
Luxcel Biosciences |
Acquired by Agilent, Jan 2018 |
Lynx Therapeutics |
Acquired by reverse merger with Solexa, 2005 |
Lyophilization Services of New England |
Acquired by PCI Pharma Services, Dec 2021 |
Lypro Biosciences |
Acquired by Cerenis Therapeutics, Nov 2017 |
Lysosomal Therapeutics |
Acquired by BIAL, Sep 2020, rebranded BIAL Biotech |
M8 Pharmaceuticals |
Acquired by Acino, Dec 2023 |
Mablink Bioscience |
Acquired by Eli Lilly, Dec 2023 |
Mabpharm (1) |
Acquired by Cipla, Jul 2014 |
Macroceutics |
Acquired by HotSpot Therapeutics, Aug 2019 |
Macrochem |
Acquired by Access Pharmaceuticals, Feb 2009 |
MacroCyclics |
Acquired by Areva, Oct 2011 |
Macusight |
Effectively acquired by Santen, 2008 |
Magellan Diagnostics |
Purchased by Meridian Biosciences, Mar 2016, $66M |
Magenta Therapeutics |
Acquired by Dianthus, Sep 2023 |
Magnum Therapeutics |
Acquired by Introgen Therapeutics, Oct 2004 |
Maine Biotechnology Services |
Acquired by BBI, Mar 2018 |
Maine Standards Company |
Acquired by LGC, renamed LGC Main Standards, Nov 2015 |
Makiz |
Acquired by Stada, Aug 2007, €125M |
Mako Surgical |
Acquired by Stryker, Sep 2013, $1.65B |
Manchester Pharmaceuticals |
Acquired by Retrophin, Mar 2014, $29.5M + $33M milestones |
MAP Pharmaceuticals |
Acquired by Allergan 2013 |
Marcadia Biotech |
Acquired by Roche Dec 2010 |
MarDx |
Acquired by Fitzgerald Industries, 2007 |
Maribo Medico |
Acquired by ResMed, Nov 2015 |
Marker Gene Technologies |
Acquired by Abcam, Mar 2020 |
Martek Biosciences |
Bought by DSM |
Martindale Pharma |
Acquired by Ethypharm, Mar 2017 |
Mast Therapeutics |
Bought by Savara for its public shell, Jan 2017 |
MaSTherCell |
Acquired by Catalent, Feb 2020; Bought by Orgenesis, Mar 2015, $24M in shares |
Masy BioServices |
Acquired by Alcami, Dec 2021; fka Masy Systems |
MateraCor |
Acquired by BioVentrix, Jan 2022 |
Matritech |
Assets bought by Matritech 2007 |
Maverick Therapeutics |
Acquired by Takeda, Oct 2021, $525M |
Mavupharma |
Acquired by AbbVie, Jul 2019 |
Maxer Endoscopy |
Acquired by Erbe Elektromedizin, Apr 2021 |
Mazor Robotics |
Acquired by Medtronic, Dec 2018, $1.7B |
MD Biosciences |
Acquired by MLM Medical Labs |
med fusion |
Acquired by Quest Diagnostics, Jul 2017 |
Meda Pharmaceuticals |
Acquired by Mylan, Aug 2016 |
MedAlliance |
Acquired by Cordis, Oct 2023, $235M |
Medarex |
Bought by BMS 2009 |
MedCision |
Assets bought by MedCision, May 2018 |
Medeor |
Acquired by Relmada Therapeutics, Dec 2013 |
Mederi Medical |
Acquired by Restech, Apr 2018 |
Medevoke |
Acquired by MEDiSTRAVA, Jan 2024 |
Medi-Tate |
Acquired by Olympus, May 2021 |
Medicago |
Acquired by Mitsubishi Tanabe, Sep 2013, $357M |
Medical Device Usability |
Acquired by UL, 2018 |
Medicis Pharmacal |
Bought by Valeant Pharmaceuticals Dec 2012 |
Medicrea |
Acquired by Medtronic, Nov 2020 |
Medimetrics |
Assets acquired by Progenity, Sep 2019 |
MedImmune |
Acquired by AstraZeneca, Apr 2007, $15.6B; folded into AstraZeneca, Feb 2019 |
Medion Diagnostics |
Bought by Grifols? |
Medistem |
Bought by Intrexon Dec 2013 |
Medivation |
Bought by Pfizer, Oct 2016, $14B |
Medivative Technologies |
Acquired by Kimball Electronics, Jul 2016 |
Medivators |
Acquired by Cantel Medical, Sep 2015 |
MedPharmics |
Acquired by Velocity Clinical, Sep 2022 |
MedPlast |
Bought Integer Business & Rebranded as Viant Medical, Jul 2018 |
Medpointe Pharmaceuticals |
Acquired by Meda Aug 2007, $767M |
MedShape |
Acquired by DJO, Apr 2021 |
MedSource |
Acquired by Ergomed, Dec 2020, $18M |
Medtech |
Acquired by Zimmer Biomet, Jul 2016 |
MEDTOX |
Bought by Labcorp Jul 2012 |
Medventure |
Acquired by Helix Medical, Oct 2012 |
Meilleur Technologies |
Acquired by Lantheus, Jul 2024 |
MeiRui Pharma |
Bought by GSK |
Melanovus Oncology |
Assets acquired by Cipher Pharmaceuticals, Jan 2015 |
Memory Pharmaceuticals |
Acquired by Roche, Nov 2008 |
Mera Pharmaceuticals |
Bought by a karate business, Aug 2012, presumably for ticker |
Meraqi Medical |
Acquired by Viant Medical, Sep 2019 |
Merial |
Acquired by Sanofi 2009, swapped to Boehringer Ingelheim Jun 2016 |
Meridian BioGroup |
Acquired by Pace Life Sciences, Aug 2022 |
Meridian Medical Technologies |
Merged into Kindeva, Dec 2022; Acquired by Altaris, Dec 2021 |
Meridien Research |
Acquired by Accel Clinical Research, Jun 2020 |
Meritage Pharma |
Bought by Shire, Feb 2015, $70M +$175 milestones |
Merus Labs |
Bought by Norgine, Jul 2017, $342M |
Mesa Biotech |
Acquired by Thermo Fisher, Mar 2021, $550M |
Metabasis |
Bought by Ligand |
Metaphore Pharmaceuticals |
Acquired by ActivBiotics, Jan 2006 |
MethylGene |
Bought by Mirati Therapeutics Jun 2013 |
Metrics Contract Services |
Acquired by Catalent, Aug 2022, $475M |
Metys Pharmaceuticals |
Acquired by Novaremed, Sep 2021 |
MGI Pharma |
Acquired by Eisai, Jan 2008, $3.9B |
MiaMed |
Bought by Amicus Therapeutics, Jul 2016, $6.5M cash/stock + $85M milestones |
Michrom |
Bought by Bruker, Feb 2011, |
Microbiology Research Associates |
Acquired by private equity, combined into Analytical Lab Group |
Microchips Biotech |
Acquired by Dare Bioscience Nov 2019; fka microCHIPS inc |
MicroConstants |
Acquired by BioAgilytix, Aug 2021 |
MicroDose Therapeutx |
Bought by Teva, Jun 2013, $40M + $125 milestones |
MicroMed |
Acquired by Natus, Jan 2023 |
MicroMed Laboratories |
Acquired by Infinity Laboratories, Jun 2020 |
Micromet |
Bought by Amgen Jan 2012, $1.2B |
Microsulis Medical |
Acquired by AngioDynamics, 2013 |
Microtest |
Acquired by Accuratus Lab Services, Jul 2014 |
Micrus Endovascular |
Bought by J&J, Sep 2010 |
Middle Peak Medical |
Acquired by Symetis, technology moved to Polares Medical |
MiddleBrook Pharmaceuticals |
Bought by Victory Pharmaceuticals 2011 |
MIDI Labs |
Acquired by Biolog, Jan 2023 |
Midlothian Labs |
Acquired by Hi-Tech Pharmacal, Dec 2007 |
MIGS |
Acquired by DNA2.0, Apr 2016, |
Miikana Therapeutics |
Acquired by Entremed, Jan 2006 |
Millennium Pharmaceuticals |
Acquired by Takeda, May 2008, $8B, eventually rebranded as Takeda Oncology |
Millipede Medical |
Bought by Boston Scientific, Feb 2019, $325M |
Mindset Pharma |
Acquired by Otsuka Pharmaceuticals, Oct 2023, $59M |
Mirati Therapeutics |
Acquired by BMS, Jan 2024, $4.8B |
MirImmune |
Acquired by Rxi Pharma, Jan 2017, stock |
MiroBio |
Acquired by Gilead, Sep 2022 |
Miroculus |
Acquired by Integra Biosciences, Mar 2023 |
Miromatrix Medical |
Acquired by United Healthcare, Dec 2023, $91M |
Misonix |
Acquired by Bioventus, Oct 2021, $518M |
Mitim |
Acquired by Recipharm, Feb 2016, $75.5M |
Mitobridge |
Acquired by Astellas, Nov 2017, $225M + $225M milestones; Formerly Mitokyne |
Mitokinin |
Acquired by AbbVie, Oct 2023, $110M + $545 milestones |
MitoKor |
Bought by Micrologix Biotech Apr 2004 |
Mitosciences |
Acquired by Abcam, May 2011, $6M |
MJ Geneworks |
Acquired by Bio-Rad, Aug 2004, $32M |
MMI Genomics |
Assets bought by Neogen |
Mo Bio Laboratories |
Acquired by Qiagen, Jan 2016 |
Moberg ICU Solutions |
Acquired by Natus, Dec 2022 |
Mobius Imaging |
Bought by Stryker, Oct 2019, $500M |
MockV Solutions |
Acquired by Maravai LifeSciences, Mar 2020 |
ModiQuest |
Acquired by ImmumoPrecise, Apr 2018 |
Modis Therapeutics |
Bought by Zogenix, Sep 2019, $250M + $150M milestones |
Molecular Infusions |
Acquired by Surterra Wellness |
Molecular Insight Pharmaceuticals |
Acquired by Progenics, Jan 2013 |
Molecular Medicine |
Acquired by AGC Biologics, Sep 2021; aka MolMed |
Molecular Medicine Bioservices |
Acquired by SAFC |
Molecular Profiles |
Acquired by Columbia Labs, Sep 2013 |
Molecular Response |
Acquired by Bioduro, Mar 2018 |
MolecularMD |
Acquired by ICON plc, Feb 2019 |
Mologic |
Acquired by Gates & Soros and turned into nonprofit |
MoMelan Technologies |
Acquired by Kinetic Concepts, Nov 2012 |
Momenta Pharmaceuticals |
Acquired by J&J, Oct 2020, $6.5B |
Monogram Biosciences |
Bought by LabCorp 2009 |
Montigen Pharmaceuticals |
Acquired by SuperGen, Apr 2006, $18M |
Montis Pharmaceuticals |
Bought by SuperGen, Apr 2006 |
Morphochem |
Acquired by Deinove, May 2018 |
Morphogen-IX |
Acquired by Centessa Pharmaceuticals |
Morphotek |
Acquired by Eisai, Apr 2007 |
Morton Grove Pharmaceuticals |
Acquired by Wockhardt, Oct 2007 |
Motus Therapeutics |
Bought by Allergan, Oct 2016, $200M |
Mpex Pharmaceuticals |
Acquired by Axcan 2011, $17.5M + $195M milestones |
MPI Research |
Acquired by Charles River Laboratories, Apr 2018, $800M |
MultiGEN Diagnostics |
Bought by PCLS Apr 2014 |
Multiplicom |
Acquired by Agilent, €68M, Dec 2016 |
MVI Health |
Acquired by Penumbra, Sep 2018 |
MVP Laboratories |
Acquired by Phibro Animal Health, Jan 2016 |
MWG Biotech |
Owned by Eurofins |
Myogen |
Acquired by Gilead, Oct 2006, $2.5B |
MyoKardia |
Acquired by Bristol-Myers Squibb, Oct 2020, $13.1B |
Myonexus Therapeutics |
Bought by Sarepta, May 2019, $165M |
MYR Pharmaceuticals |
Acquired by Gilead, Mar 2021, €1.1B + €300M milestones |
Myraqa |
Acquired by Illumina Jul 2014 |
Myst Therapeutics |
Acquired by Turnstone Biologics, Jan 2021 |
N-of-One |
Acquired by Qiagen, Jan 2019 |
Nalpropion Pharmaceuticals |
Bought by Currax, Sep 2019 |
Nanna Therapeutics |
Acquired by Astellas, Apr 2020 |
Nano Science |
Acquired by EAG, 2006 |
Nano3D Biosciences |
Assets sold to Greiner Bio-One, May 2018 |
Nanolabz |
Acquired by HIL Applied Medical, Jun 2016 |
nanoMR |
Bought by DNA electronics, Jan 2015, $24M |
Nanopareil |
Acquired by Gamma Biosciences, Sep 2020 |
Nanosphere |
Acquired by Luminex, Jun 2016 |
Nanostim |
Acquired by St. Jude Medical, Octo 2013 |
NanoView Biosciences |
Acquired by Unchained Labs, May 2022; Merged with Nexgen Arrays, Dec 2016 |
Narus Biotechnologies |
Acquired by Cofactor Genomics, Feb 2016 |
NAT Diagnostics |
Acquired by Becton-Dickinson, May 2020 |
Natrix Separations |
Acquired by Merck KGaA/MilliporeSigma, Aug 2017 |
Nature Technology |
Acquired by Aldevron, Jan 2022 |
Naurex |
Acquired by Allergan, Jul 2015, $560M + milestones |
Navigenics |
Acquired by Life Technologies 2012 |
NBE Therapeutics |
Acquired by Boehringer Ingelheim, Dec 2020, €1.18B |
nContact |
Bought by AtriCure $99M, Oct 2015 |
Negma Labs |
Bought by Wockhardt, May 2007, $265M |
Nemod Biotherapeutics |
Assets bought by Glycotope Biotechnology 2007 |
NeoGenesis Pharmaceuticals |
Assets acquired by Schering-Plough, Jan 2005 |
Neomend |
Acquired by Bard, Oct 2012, $140M |
Neon Mind Biosciences |
Shell acquired by an energy company, Jan 2023 |
Neon Therapeutics |
Acquired by BioNTech, May 2020, $67M |
Neotract |
Acquired by Teleflex, Sep 2017, $1.1B |
Neovasc |
Acquired by Shockwave Medical, Apr 2023, $100M |
Neox Clinical Research |
Acquired by Emmes, Dec 2020 |
Nerio Therapeutics |
Acquired by Boehringer Ingelheim, Jul 2024, $1.3B |
Neuavi |
Acquired by Codman Neuro, Apr 2017 |
Neugenesis |
Bought by Intrexon, 2011 |
NeuMoDx Molecular |
Shut down Jun 2024; Fully acquired by Qiagen, Sep 2020 |
Neuravi |
Acquired by J&J, Apr 2017 - Became part of Cerenovus |
Neuro Kinetics |
Acquired by Neurolign, Oct 2019 |
Neuro3d |
Acquired by Evotec, Mar 2007 |
NeuroCycle Therapeutics |
Acquired by Engrail Therapeutics, Feb 2021 |
Neurogen |
Acquired by Ligand Pharmaceuticals 2009 |
Neuronex |
Acquired by Acorda Therapeutics, Dec 2012, $6.8M |
NeuroNova |
Acquired by Newron, Jun 2012 |
NeuroTherm |
Bought by St Jude Medical Aug 2014, $200M |
Neurovance |
Acquired by Otsuka Pharmaceuticals, Mar 2017, $100M + $150M milestones; Euthymics spinout |
NeuWave Medical |
Bought by Ethicon, Mar 2016 |
New River Pharmaceuticals |
Acquired by Shire, Apr 2007, $2.6B |
NewLink Genetics |
Acquired by Lumos Pharma in Reverse Merger, Mar 2020 |
Nexa Orthopedics |
Acquired by Tornier, Feb 2007 |
Nexgen Pharma |
Acquired by LGM Pharma, Jul 2020 |
NextBio |
Acquired by Illumina, Oct 2013 |
NextCODE Health |
Acquired by WuXi PharmTech, Jan 2015, $65M; rebranded as WuXi NextCODE |
Nextwave Pharmaceuticals |
Bought by Pfizer Oct 2012; Sold to Tris Pharma Sep 2018 |
Nexus Biosystems |
Acquired by Brooks, Jul 2011 |
Nexus Therapeutics |
Acquired by Transport Pharmaceuticals, Aug 2006 |
Nexvet |
Acquired by Zoetis, Jul 2017, $85M |
Nightstar Therapeutics |
Acquired by Biogen, Jun 2019, $800M; aka NightstaRx |
Nigra |
Acquired by Vernalis |
Nimbic Systems |
Acquired by Mizuho OSI, Sep 2020 |
NimbleGen |
Bought by Roche, renamed Roche Nimblegen, some tech sold to Arrowhead |
Nine Continents Medical |
Acquired by Coloplast, Oct 2020, $145M |
NitroMed |
Bought by private equity company, Jan 2009, effectively dissolved; Sole drug sold on to Arbor Pharmaceuticals, 2012 |
Noden Pharma |
Acquired by LXO Group, 2022 |
Nogra Pharma |
Bought by Celgene, Apr 2014, $710M |
Noria Therapeutics |
Acquired by Bayer, Jun 2021 |
Norphan Pharmaceuticals |
Acquired by Marathon Pharmaceuticals, 2013 |
Northern Biologics |
All products acquired as of Nov 2020 |
NovaCardia |
Bought by Merck, Jul 2007, $350M |
Novacea |
Bought by Transcept |
Novadaq |
Bought by Stryker, Sep 2017 |
Novalon Pharmaceutical |
Acquired by Karo Bio Nov 2000 |
Novartis Animal Health |
Acquired by Lilly |
NovaScreen Biosciences |
Acquired by Caliper Life Sciences, Oct 2005, $22M |
NovaTarg Therapeutics |
Acquired by Pano Therapeutics, Apr 2022 |
Novatract Surgical |
Acquired by Caldera Medical, 2016 |
Novavita Thera |
Acquired by Castle Creek Biosciences, Jan 2022 |
Novella Clinical |
Acquired by Quintiles, Sep 2013 |
Novellus Therapeutics |
Acquired by Brooklyn ImmunoTherapeutics, Jul 2021 |
NOVEX |
Acquired by Thermo-Fisher, Aug 1999, stock |
Novex Clinical Research |
Acquired by BTC Network, Aug 2016 |
Novira Therapeutics |
Bought by J&J, Nov 2015 |
Novosis |
Acquired by Acino, 2006 |
Novosteo |
Acquired by Cortexyme, May 2022 |
NPS Pharmaceuticals |
Acquired by Shire, Jan 2015, $5.2B |
Nucleo Life Sciences |
Acquired by CoreRx, May 2021 |
Nucleus Therapeutics |
Acquired by Patrys, Aug 2016 |
Nucryst |
Bought by Smith & Nephew |
Nuevolution |
Bought by Amgen May 2019 |
NuGEN Technologies |
Acquired by Tecan, Aug 2018, $54.4M |
NuPak Medical |
Bought by Katena Products, Jul 2017 |
NuPathe |
Bought by Teva, Jan 2014, $144M |
Nura |
Acquired by Omeros |
NuVera Medical |
Acquired by Biosense Websiter, Sep 2021 |
nVision Medical |
Acquired by Boston Scientific, Apr 2018, $275M |
NxThera |
Acquired by Boston Scientific, Apr 2018, $306M + $100M milestones |
Nycomed |
Acquired by Takeda 2011 |
OBP Medical |
Acquired by CooperSurgical, May 2021, $60M |
Obsidio |
Acquired by Boston Scientific, Aug 2022 |
Ocata Therapeutics |
Acquired by Astellas, Jan 2016, $379M; fka Advanced Cell Technology |
Ocean Ridge Biosciences |
Acquired by Frontage, Apr 2021 |
Oceana Therapeutics |
Acquired by Salix Pharmaceuticals, Nov 2011, $300M |
OcellO |
Acquired by Crown Bioscience, May 2021 |
Ocera Therapeutics |
Acquired by Mallinckrodt, Dec 2017, $42M |
Ockham |
Acquired by Chiltern, Jul 2014 |
Oclassen Pharmaceuticals |
Acquired by Watson Pharmaceuticals, Feb 1997 |
Octagen |
Assets bought by Ipsen, 2008 |
Octoplus |
Acquired by Dr. Reddy's, 2013, $36M |
Oculeve |
Bought by Allergan, Jul 2015, $125M |
Oculex Pharmaceuticals |
Acquired by Allergan, Oct 2003 |
Oculos Clinical Research |
Acquired by iuvo BioScience, Jul 2018 |
Ogeda |
Bought by Astellas, May 2017, €500M |
Ohm Laboratories |
Owned by Ranbaxy, then Sun Pharma |
Ohr Pharmaceuticals |
Acquired by NeuBase Therapeutics via Reverse Merger, Jul 2019 |
Okairos |
Acquired by GSK, May 2013 |
Okapi Sciences |
Acquired by Aratana Therapeutics, Jan 2014 |
Ology Bioservices |
Acquired by Resilience, Apr 2021 |
OMBU Bio |
Assets acquired by Boca Biolistics, Feb 2015 |
Omega Pharma |
Acquired by Perrigo, Mar 2015 |
Omni-Tract Surgical |
Acquired by Integra LifeSciences, Jan 2009 |
OmniGene Bioproducts |
Acquired by BioEnergy |
OMNILife Sciences |
Acquired by Corin Group, Mar 2019 |
Omniome |
Acquired by Pacific Biosciences, Sep 2021, $800M |
Omniseq |
Acquired by LabCorp, 2021 |
Omrix Biopharmaceuticals |
Bought by Ethicon |
Omthera Pharmaceuticals |
Bought by AstraZeneca, May 2013, $323M |
On-X Life technologies |
Acquired by CryoLife, Jan 2016, $130M |
Oncoceutics |
Acquired by Chimerix, Jan 2021, $78M |
Oncodisc |
Acquired by Veris Health, Jun 2021 |
OncoEthix |
Acquired by Merck, Dec 2014, $375M |
Oncogen |
Acquired by BMS, 1986 |
Oncogene Science |
Acquired by Nuclea Biotechnologies |
OncoImmune |
Acquired by Merck, Nov 2020, $425M |
OncoPlexDx |
Bought by Nantomics, Oct 2016 |
Oncos Therapeutics |
Acquired by Oncos Therapeutics, Jun 2015 |
Oncoscope |
Assets acquired by SpectraScience, Feb 2016 |
OncoSynergy |
Acquired by Enochian BioSciences, Apr 2016 |
Oncotest |
Acquired by Charles River, Nov 2015, €34M |
One Lambda |
Acquired by Thermo Fisher, Sep 2012 |
Onset Dermatologics |
Acquired by Valeant Feb 2014 |
Onspira Therapeutics |
Acquired by Altavant Sciences, Jan 2020 |
Onux medical |
Acquired by Bard, Jul 2004 |
Onyvax |
Assets Apparently Acquired |
Onyx Pharmaceuticals |
Bought by Amgen, Aug 2013, $10.4B |
Open Biosystems |
Acquired by Thermo-Fisher 2008 |
Open Monoclonal Technology |
Acquired by Ligand, Jan 2016, $178M |
Opiant Pharmaceuticals |
Acquired by Indivior, Mar 2023, $145M |
Optima Neuroscience |
Acquired by Tucker-Davis Technologies, Sep 2011 |
Optime Therapeutics |
Acquired by Lippomix |
OptiMedica |
Acquired by Abbott Aug 2013, $400M |
Optimer Pharmaceuticals |
Acquired by Cubist Oct 2013 |
Optivia Biotechnology |
Acquired by BioIVT, Jul 2018 |
Optometrics |
Acquired by Dynasil, Mar 2005 |
Opus Medical |
Acquired By ArthroCare, Nov 2004, $130M |
OPX Biotechnologies |
Acquired by Cargill, Apr 2015 |
OraPharma |
Owned by Valeant |
Oraya Therapeutics |
Absorbed into Zeiss, Jun 2016 |
Orbis Biosciences |
Acquired by Adare Pharmaceuticals, May 2020 |
Orchid Cellmark |
Acquired by LabCorp Dec 2011 |
Orexia |
Acquired by Centessa |
Organon |
Bought by Schering-Plough Nov 2007, integrated into Merck post 2009 acquisition |
OriCiro Genomics |
Acquired by Moderna, Jan 2023, $85M |
Oriel Therapeutics |
Bought by Sandoz, Jun 2010 |
Origenix |
Acquired by Micrologix Biotech, Sep 2002, $320M |
Origimm Biotechnology |
Acquired by Sanofi, Dec 2021 |
Origin BioMed |
Assets sold to Knight Therapeutics, Jun 2015 |
Origo Biopharma |
Acquired by Agomab, Oct 2021 |
Orphan Europe |
Acquired by Recordati, Sep 2007 |
Orphan Technologies |
Acquired by Travere Therapeutics (Retrophin), Nov 2020, $90M + $427 Milestones |
Orphazyme |
Acquired by kemPharm, May 2022, $7.6M |
Ortho Clinical Diagnostics |
Acquired by Quidel, Dec 2021, $6B |
Orthocon |
Assets Acquired by Abryx, Apr 2013 |
OrthogenRx |
Acquired by Avanos Medical, Dec 2021, $160M |
Orthogonal Biologics |
Acquired by Cyrus Biotechnology, Dec 2021 |
Orthosensor |
Acquired by Stryker, Jan 2021 |
OrthoSpin |
Acquired by Depuy Synthes, Dec 2021 |
Oscine Therapeutics |
Acquired by Sana Biotechnology, Oct 2020 |
Oscor |
Acquired by Integer, Dec 2021 |
OSI Pharmaceuticals |
Bought by Astellas |
Osiris Therapeutics |
Acquired by Smith & Nephew, Apr 2019, $660M |
OSO Biopharmaceuticals |
Acquired by AMRI, Jul 2014 |
Osseon |
Dissolved, assets acquired by Merit medical, Sep 2014 |
Ossis |
3D-printed orthopedic implants |
Osteotech |
Acquired by Medtronic Aug 2010 |
Othera Pharmaceuticals |
Acquired by Colby Pharmaceuticals 2012 |
Ovation Pharmaceuticals |
Acquired by Lundbeck 2009 |
Oxitec |
Bought by Intrexon, Aug 2015, $160M |
Oxxon Therapeutics |
Acquired by Oxford Biomedica Mar 2007 |
Oyster Point Pharmaceuticals |
Acquired by Viatris, Jan 2023 |
PAA Laboratories |
Acquired by GE Healthcare, Aug 2011 |
Pacific Bio-Material Management |
Acquired by Brooks Life Sciences, Jul 2017 |
PacificGMP |
Bought by Abzena, Sep 2015, $8.4M |
Paddock Labs |
Bought by Perrigo Jan 2011 |
Padlock Therapeutics |
Acquired by BMS, Mar 2016, $225 + $375 milestone |
Paganini Biopharma |
Bought by OncoResponse, Nov 2017 |
Paidion Research |
Acquired by Premier Research, May 2021 |
PAIRimmune |
Acquired by Pacific Biomarkers, Jun 2019 |
Palamedrix |
Acquired by SomaLogic, Jul 2022, $35M |
Palette Life Sciences |
Acquired by Teleflex, Oct 2023, $600M |
Paloma Pharmaceuticals |
Acquired by Stratus Media, Renamed RestorGenex, Mar 2014 |
PAN Medical |
Bought by Zavation, Sep 2018 |
Pandion Therapeutics |
Acquired by Merck, Feb 2021, $1.85B |
Pangenetics |
Bought by Abbott |
Panoptes Pharma |
Acquired by EyeGate Pharmaceuticals, Jan 2021 |
Panther Biotechnology |
Acquired in Reverse Merger by media company, presumably for ticker symbol |
Par Pharmaceutical |
Acquired by Endo Pharmaceuticals, Sep 2015, $8.05B |
Paradigm Diagnostics |
Acquired by Exact Sciences, Mar 2020 |
Paradigm Spine |
Acquired by RTI Surgical, Mar 2019 |
Paragon Bioservices |
Acquired by Catalent, May 2019, $1.2B |
Parallax Medical |
Acquired by ArthroCare, Jan 2004, $35M; Sold to NeuroTherm, Jul 2011 |
Parcus Medical |
Acquired by Anika Therapeutics, Jan 2020, $35M + $60M milestones |
Pardes Biosciences |
Acquired by MediPacific, Aug 2023; Product failed Apr 2023, strategic alts |
Park Therapeutics |
Acquired by Tris Pharma, Apr 2021 |
Parsagen Diagnostics |
Acquired by Qiagen |
Patch Biosciences |
Acquired by Gingko Bioworks, Feb 2024 |
PathoGenesis |
Acquired by Chiron, 2000, $600M |
Pathway Medical |
Acquired by Bayer, Aug 2011, $125M |
Pathway Oncology |
Acquired by Virax, Mar 2014 |
Pattern Genomics |
Acquired by Intus Bio, Jun 2023 |
PaxVax |
Acquired by Emergent Biosolutions, Oct 2018, $270M |
PCT Cell Therapy |
Acquired by Hitachi, Mar 2017, $75M, rebranded as Hitachi Chemical Advanced Therapeutics Solutions |
Pearl Therapeutics |
Acquired by AstraZeneca Jul 2013, $560M+$450milestones |
PegaOne |
Centessa Company |
Pegasus Biologics |
Assets acquired by Synovis Life Technologies, Jul 2009 |
Pelican Therapeutics |
Bought by Heat Biologics, Mar 2017 |
Peloton Therapeutics |
Bought by Merck, May 2019, $1.05B + $1.2B Milestones |
Pelvalon |
Acquired by Laborie, Oct 2021 |
Peninsula Pharmaceuticals |
Acquired by Ortho-McNeil, Apr 2005 |
Penn Pharma |
Bought by PCI Pharma Services, Jul 2014, $215M |
Penwest |
Bought by Endo |
Peplin |
Acquired by Leo Pharma 2009 |
PeproTech |
Acquired by Thermo Fisher, Jan 2022, $1.85B |
PepSep |
Acquired by Bruker, Feb 2022 |
Perbio Science |
Acquired by Fisher Scientific, Jun 2003 |
PermeaDerm |
Acquired by Stedical Scientific, Aug 2019 |
Perosphere Pharmaceuticals |
Acquired by AMAG Pharmaceuticals, Jan 2019 |
Perseid Therapeutics |
Bought by Astellas May 2011 |
Perseon Medical |
Assets bought by Medlink, Aug 2016, $4M; fka BSD Medical |
PerSeptive Biosystems |
Acquired by Perkin-Elmer, 1998 |
Persys Medical |
Acquired by Safeguard Medical, Jun 2021 |
Pervasis |
Bought by Shire, Sep 2009 |
Pervasis Therapeutics |
Bought by Shire 2012 |
Pfenex |
Acquired by Ligand, Oct 2020, $437.5M + $78M milestone; Spun out of Dow Chemical 2009 |
PFS Genomics |
Acquired by Exact Sciences, May 2021, $30.6M |
Phadia |
Acquired by Thermo Fisher, May 2011, $3.5B |
PhagoMed |
Acquired by BioNTech, Nov 2021 |
PharmaCell |
Acquired by Lonza, May 2017 |
Pharmacopeia |
Acquired by Ligand Pharmaceuticals 2008 |
Pharmacore |
Acquired by Cambrex, Sep 2016, $25M |
Pharmacyclics |
Bought by AbbVie, $21B May 2015 |
PharmaFluidics |
Acquired by Thermo Fisher, Oct 2021 |
PharmaForm |
Bought by Biotech Investment Group, Relaunched as Formex Jul 2013 |
PharmaKinetics Laboratories |
Acquired by BASi, Jun 2002? |
PharmaSphere |
Acquired by Marijuna company, Nov 2011 |
Pharmasset |
Bought by Gilead, Nov 2011, $11B |
Pharmatech |
Acquired by Caris Life Sciences, May 2019 |
Pharmatek |
Acquired by Catalent, Sep 2016 |
Pharmaterials |
Acquired by Quotient Sciences, Nov 2017 |
Pharmavene |
Acquired by Shire, Mar 1997 |
Pharmion |
Acquired by Celgene 2007 |
Phase Forward |
Bought by oracle |
Phenix Research Products |
Acquired by Thomas Scientific |
PhenomeX |
Acquired by Bruker, Oct 2023, $108M; fka Berkeley Lights |
Pherin Pharmaceuticals |
Acquired by Vistagen, Feb 2023 |
Phitonex |
Acquired by Thermo Fisher, Jan 2021 |
PhosImmune |
Acquired by Agenus, Dec 2015, up to $45M |
Phosphagenics |
Renamed Avecho Biotechnology |
PHT Corporation |
Acquired by ERT, May 2015 |
PhyNexus |
Acquired by Biotage, Jan 2019 |
Physio-Control |
Bought by Stryker, Feb 2016, $1.28B - became Stryker Emergency Care |
Phytera |
Assets sold to Galileo, Apr 2002 |
Phytopharm |
Acquired by Ixico, Sept 2013 |
Phyxius Pharma |
Assets acquired by Oxygen Therapeutics, Nov 2013, effectively merged |
Pinewood |
Bought by Wockhardt, Feb 2013, €150M |
Pinnacle Biologics |
Bought by Concordia Healthcare Dec 2013 |
Pinnacle Pharmaceuticals |
Acquired by New River Pharmaceuticals, 2011 |
Pionyr Immunotherapeutics |
Acquired by Akena Oncology, Aug 2023; fka Precision Immune |
Piramed Pharma |
Acquired by Roche, Apr 2008, $160M + $15M milestones |
Pivot Medical |
Bought by Stryker, Mar 2014 |
Platine Pharma Services |
Bought by ABL inc, Jul 2014 |
Plato BioPharma |
Acquired by Inotiv, Oct 2021, $15M |
Plex Pharmaceuticals |
No news 2020-2023; Acquired by Collidion, 2017 |
Plexxikon |
Acquired by Daiichi Sankyo, Feb 2011 |
PML Microbiologicals |
Bought by Bimerieux Dec 2008 |
PneumRx |
Acquired by BTG plc, Dec 2014, $475M |
POINT Biopharma |
Acquired by Eli Lilly, Dec 2023, $1.4B |
Pola Pharma |
Acquired by Sun Pharma, Jan 2019 |
Polyganics |
Acquired by Collagen Matrix, Oct 2022 |
Polyplus Transfection |
Acquired by Sartorious, Sep 2023, €2.4B |
Porex Surgical |
Acquired by Stryker, Sep 2010 |
PortaScience |
Acquired by DCN Dx, Jun 2021 |
Portola Pharmaceuticals |
Acquired by Alexion Pharmaceuticals, Jul 2020, $1.4B |
Potenza Therapeutics |
Bought by Astellas, Dec 2018 |
PowderMed |
Acquired by Pfizer 2006 |
Powervision |
Acquired by Alcon, Mar 2019, $285M |
PQ Bypass |
Acquired by Thermo Fisher, Apr 2021, $17.4B |
PRA Health Sciences |
Acquired by ICON plc., Jul 2021, $12B |
PRAECIS Pharmaceuticals |
Acquired by GSK, Dec 2006, $54.8M |
Praha Vaccines |
Acquired by Novavax, Jun 2020 |
Praxis Life Sciences |
Acquired by Treximo, Mar 2019 |
preCARDIA |
Acquired by Abiomed, Jun 2021 |
Precision Healing |
Acquired by Sanara MedTech, Apr 2022 |
Precision Nanosystems |
Acquired by Cytiva, Apr 2024 |
PreClinOmics |
Acquired by Crown Bioscience, Mar 2016 |
Pregenen |
Bought by bluebird bio Jun 2014 |
PregLem |
Acquired by Richter, Oct 2010 |
Prescient Neuropharma |
Acquired and renamed, pivoted to mining |
Preventice Solutions |
Acquired by Boston Scientific, Jan 2021, $925M + $300M milestones |
Prexton Therapeutics |
Acquired by Lundbeck, Mar 2018, $123M |
Primatope Therapeutics |
Acquired by Kiniksa, May 2019 |
PrimeraDx |
Bought by Qiagen, Jun 2014 |
Primity Bio |
Acquired by Caprion Biosciences, Sep 2018 |
Primorigen Biosciences |
Acquired by Nucleus Biologics, Aug 2019 |
Principia Biopharma |
Acquired by Sanofi, Sep 2020 |
Prionics |
Acquired by Thermo Fisher, Mar 2014 |
Prism Pharmaceuticals |
Acquired by Baxter 2011 |
Prismic Pharmaceuticals |
Acquired by FSD Pharma, Jun 2019 |
Prochon Biotech |
Acquired by Histogenics |
ProCyte |
Acquired by PhotoMedex, Mar 2005 |
ProEthic Laboratories |
Acquired by Kowa, Sep 2008 |
ProFibrix |
Bought by The Medicines Company, Aug 2013, $90M + $140 milestones |
ProfoundBio |
Acquired by Genmab, May 2024, $1.8B |
Progen Pharmaceuticals |
Acquired by TBG Diagnostics, Jan 2016, Drug sold off to Zucero Therapeutics Aug 2016 |
Progenics Pharmaceuticals |
Acquired by Lantheus, Jun 2020 |
Progenika |
Bought by Grifols |
Prolifaron |
Acquired by Alexion, Sep 2000, $41M |
Prolor Biotech |
Acquired by OPKO, Aug 2013, renamed Opko Biologics |
ProMedDx |
Acquired by Precision for Medicine, Aug 2019 |
Promedior |
Acquired by Roche, Feb 2020 |
Prometheus Biosciences |
Acquired by Merck, Jun 2023, $11B; fka Precision IBD, took Prometheus Biosciences name after buying Prometheus Laboratories from Nestle, Jun 2019 |
Pronostics |
Assets acquired by Phadia, Jan 2009 |
Pronova BioPharma |
Acquired by BASF, Jan 2013 |
Pronovo Biopharma |
Bought by BASF, Nov 2012, $844M |
Proof Diagnostics |
Acquired by Ginkgo Bioworks, Feb 2024; fka Pine Trees Health |
Propeller Health |
Acquired by ResMed, Dec 2018, $225M |
Prosensa |
Acquired by BioMarin, Nov 2014, $680M+milestones |
Prosidion |
Bought by OSI pharmaceuticals, Apr 2005 |
Prosonix |
Bought by Circassia, Jun 2015, $158M |
Prostrakan |
Acquired by Kyowa Hakko Kirin; renamed Kyowa Kirin Apr 2016 |
Protagen Diagnostics |
Acquired by Oncimmune, Mar 2019 |
Protein Forest |
Bought by Cell Biosciences |
Protein Sciences |
Acquired by Sanofi, Aug 2017, $650M + $100M milestones |
ProteinSimple |
Bought by biotechne, Aug 2014, $300M |
Protenium Clinical Research |
Acquired by Eligo Health Research, Jan 2019 |
Proteolix |
Bought by Onyx Pharmaceuticals, Oct 2009, up to $851M |
Proteologix |
Acquired by J&J May 2024, $850M; No website, Feb 2023 - Nov 2023 |
Proteom |
Acquired by Amura Ltd |
Proteon Therapeutics |
Acquired by ArTara Therapeutics, Reverse Merger, Jan 2020 |
Proteona |
Acquired by Singleron, Mar 2022 |
Protez Pharma |
Bought by Novartis 2008, Closed 2010 |
Protherics |
Bought by BTG plc, Sep 2008, £218M |
Proven Process |
Acquired by NextPhase Medical Devices, May 2021 |
Provention Bio |
Acquired by Sanofi, Apr 2023, $2.9B |
Providence Clinical Research |
Acquired by Velocity Clinical Research |
Provista Diagnostics |
Acquired by Todos Medical Apr 2021; Acquired by Ascenda BioSciences, Jun 2019 |
Proximagen |
Acquired by Upsher-Smith, Aug 2012; Originally spun out of King's College London |
ProZyme |
Acquired by Agilent, Aug 2018 |
PSMA Therapeutics |
Acquired by Bayer, Jun 2021 |
Psyadon Pharmaceuticals |
Acquired by Emalex Biosciences, Aug 2018 |
PsyCheNomicS |
Acquired by Novasite Pharmaceuticals, Jun 2005 |
Pulsar Vascular |
Bought by J&J Jul 2017 - Became part of Cerenovus; Previously acquired by Codman Neuro, Dec 2016 |
Pulse Systems |
Acquired by Heraeus, 2020 |
Purigen Biosystems |
Acquired by Bionano Genomics, Nov 2022 |
Pursuit Vascular |
Acquired by ICU Medical, Nov 2019, $75M |
Putney |
Acquired by Dechra, Mar 2016 |
PvP Biologics |
Bought by Takeda, Feb 2020, up to $330M |
PX' Therapeutics |
Acquired by Promise Proteomics, Jul 2019 |
Qrumpharma |
Acquired by MannKind, Dec 2020 |
QS Pharma |
Acquired by Quotient Clinical, 2017 |
Quad Technologies |
Acquired by Bio-techne, Jun 2018 |
Quadrants Scientific |
Acquired by Infinity Laboratories |
Qualyst |
Acquired by BioIVT, Sep 2017 |
Quanam Medical |
Acquired by Boston Scientific, Apr 2001, $8M |
Quanta BioDesign |
Acquired by Vector Laboratories, Jul 2023 |
QuantaLife |
Acquired by Bio-Rad, Oct 2011, $162M |
Quanticel Pharmaceuticals |
Acquired by Celgene, $100M +$300M milestones, Apr 2015 |
Quantum Pharma |
Acquired by Clinigen, Nov 2017 |
Quartesian |
Acquired by Veranex, Jun 2021 |
QuatRx |
Acquired by Shionogi, 2017 |
Quellis Biosciences |
Acquired by Catabasis Pharmaceuticals, Jan 2021 |
Questcor Pharmaceuticals |
Acquired by Mallinckrodt, Aug 2014 $5.8B |
Quethera |
Bought by Astellas, Aug 2018, up to $109M |
Quotient Bioresearch |
Acquired by Pharmaron, Feb 2016 |
R-Tech Ueno |
Acquired by Sucampo, Aug 2015, $276B |
Ra Pharmaceuticals |
Bought by UCB, Apr 2020, $2.1B |
Radiant Genomics |
Acquired by Zymergen, Jan 2018 |
RadioTherapeutics |
Acquired by Boston Scientific, Nov 2001, $150M |
Raindance Technologies |
Acquired by Bio-Rad, Jan 2017 |
Raptor Pharmaceuticals |
Acquired by Horizon Pharma, Oct 2016, $800M |
Rare Thyroid Therapeutics |
Acquired by PledPharma, Oct 2020 |
RareGen |
Acquired by Liquidia, Jun 2020 |
Raven Biotechnologies |
Acquired by MacroGenics Jul 2008 |
RCP Diagnostics |
Acquired by Provista Life Sciences, Dec 2006 |
ReadCoor |
Acquired by 10X Genomics, Oct 2020 |
Realm Therapeutics |
Acquired by ESSA Pharma, Jul 2019; fka PuriCore, abandoned all clinical work Sep 2018, seems to be wound care/topical 510(k) products |
Reata Pharmaceuticals |
Acquired by Biogen, Sep 2023, $7.3B |
Rebound Therapeutics |
Bought by Integra LIfeSciences, Sep 2019 |
Receptos |
Bought by Celgene, Jul 2015, $7.2B |
RedoxTherapies |
Acquired by Juno, Jul 2016, $10M + milestones |
Redwood Bioscience |
Acquired by Catalent, Oct 2014 |
Reflectance Medical |
Acquired by Sotera, Feb 2015 |
Regulatory Professionals, Inc. |
Acquired by Premier Research, Jul 2018 |
Regulus Pharmaceutical Consulting |
Acquired by Clinipace |
Reinnervate |
Acquired by ReproCELL, combined with Biopta to become ReproCELL Europe, Jul 2016 |
Reliable Biopharmaceutical |
Bought by VWR Nov 2016 |
Relypsa |
Bought by Galenica, Jul 2016, $1.5B, became part of Vifor |
Rempex Pharmaceuticals |
Acquired by The Medicines Company Dec 2013, $140M |
ReNAgade Therapeutics |
Acquired by Orna Therapeutics, May 2024 |
RenaMed Biologics |
Assets sold to Nephrion, 2007 |
Renovacor |
Acquired by Rocket Pharmaceuticals, Dec 2022; Went public via SPAC Sep 2021 |
Replace Therapeutics |
Acquired by Tome Biosciences, Jan 2024, $185M |
Reproductive Health Science |
Acquired by Perkin-Elmer, Jul 2018 |
Reprogenetics |
Acquired by CooperSurgical, Jun 2016 |
Repros Therapeutics |
Acquired by Allergan, Dec 2017 |
Research Across America |
Acquired by Synexus, Mar 2016 |
Research Diagnostic, Inc. |
Acquired by Fitzgerald Industries, 2005 |
ReSearch Pharmaceutical Services |
Acquired by PRA, renamed RPS Strategic Solutions Division |
ReShape Medical |
Acquired by EnteroMedics, Oct 2017 |
Respicardia |
Acquired by Zoll, Apr 2021 |
Respironics |
Bought by Philips, Mar 2008, $5.1B |
RespiVert |
Acquired by Centocor Jun 2010 |
Response Genetics |
Acquired by Cancer Genetics, Aug 2015 |
Retrogenix |
Acquired by Charles River Labs, Mar 2021 |
RetroSense Therapeutics |
Bought by Allergan, Sep 2016, $60M |
Revascular Therapeutics |
Acquired by Boston Scientific, Feb 2011 |
Reverie Labs |
Acquired by Ginkgo Bioworks, Feb 2024 |
Reverse Medical Corp |
Bought by Covidien, 08/14 |
ReViral |
Acquired by Pfizer, Jun 2022, up to $525M |
Revivicor |
Acquired by United Therapeutics, 2011, $7.6M |
Revolutionary Medical Devices |
Acquired by Vyaire, Oct 2017 |
RF Surgical Systems |
Bought by Medtronic, Jul 2015, $235M |
RHEINCELL Therapeutics |
Acquired by Catalent, Jun 2021 |
RhoVac |
Reverse Merged with Chosa, Jan 2023 |
Rhythm Xience |
Acquired by Acutus Medical, May 2019 |
Ribonomics |
Sold to MBL International |
Richcore Lifesciences |
Acquired by Laurus Labs, Jan 2021 |
Riemser Pharma |
Acquired by Esteve, Jan 2020 |
Rigenerand |
Acquired by Evotec, Jul 2022, €23M |
Rigontec |
Bought by Merck, Sep 2017, $150M + $453 Milestones |
Rinat |
Bought by Pfizer 2006 |
Rio Grande Neurosciences |
Assets sold to Endonovo Therapeutics, Dec 2017, $4.5M |
RITA Medical Systems |
Bought by AngioDynamics 2007 |
River Vision Development Corp |
Acquired by Horizon Pharma, May 2017, $145M |
rMark Bio |
Acquired by Within3, Apr 2021 |
RMC Pharmaceutical Solutions |
Acquired by Syner-G BioPharma Group, Jan 2023 |
RND Group |
Acquired by Gener8, Dec 2021 |
Rodeo Therapeutics |
Acquired by Amgen, Apr 2021, $55M + $666 milestones |
Rodin Therapeutics |
Acquired by Alkermes, Nov 2019, up to $950M |
Rosetta Inpharmatics |
Bought by Merck 2001 |
Rotation Medical |
Bought by Smith & Nephew, Oct 2017 |
Roush Life Sciences |
Assets purchased by Foxx Life Sciences, 2011 |
Roxane Labs |
Acquired from Boehringer-Ingleheim by Hikma, Feb 2016, merged into West-Ward Laboratories |
Roxro Pharma |
Acquired by Luitpold 2010 |
Roxwood Medical |
Acquired by BTG plc, Oct 2017 |
RPS Diagnostics |
Assets acquired by Quidel, May 2017, $14M, shell merged into Lumos Diagnostics, May 2019 |
RQX Pharmaceuticals |
Acquired by Amgen, Feb 2013, $111M |
RTS Life Science |
Bought by Brooks Automation Apr 2011 |
Rubicon Genomics |
Acquired by Takara, Jan 2017 |
Rules-Based Medicine |
Acquired by Myriad Genetics, Apr 2011, $80M; rebranded Myriad-RBM |
Safis Solutions |
Acquired by Pharmalex, Apr 2017 |
SAGE Labs |
Acquired by Horizon Discovery, $48M, Sep 2014 |
Sairiyo Therapeutics |
Acquired by PharmaDrug, Feb 2021 |
Salgomed |
Shut down Apr 2022 |
SalvaRx |
Bought by Portage Biotech, Aug 2018 |
Salzman Group |
Acquired by Kalytera, Feb 2021; Residential address May 2021 |
SAMDI Tech |
Acquired by Charles River, Jan 2023, $40M |
Sanarus |
Acquired by Hologic, 2020 |
Sandstone Diagnostics |
Assets acquired by Labcorp |
Sanifit |
Acquired by Vifor Pharma, Nov 2021, €205M + €170M milestones |
Sanomune |
Acquired by Diamedica, Dec 2009 |
Santaris Pharma |
Bought by Roche, Aug 2014 |
Santarus |
Acquired by Salix Pharmaceuticals, Jan 2014 |
Sapphire Biotech |
Acquired by AXIM Biotechnologies, Jan 2020 |
Sapphire Therapeutics |
Acquired by Helsinn 2009 |
SARcode |
Bought by Shire Mar 2013 |
Satiogen Pharmaceuticals |
Acquired by Mirum Pharmaceuticals, May 2022 |
Satoris |
Bought by Rules-Based Medicine |
Savage Laboratories |
Was part of Fougera which was acquired by Sandoz, Jul 2012 |
ScalmiBio |
Acquired by ALX Oncology, Oct 2021 |
Scandipharm |
Bought by Axcan Pharma, $100M |
Scendia Biologics |
Acquired by Sanara MedTech |
Schein Pharmaceutical |
Acquired by Watson Pharmaceuticals, Aug 2000, $674M |
Schering-Plough |
Acquired by Merck, Nov 2009 |
Schwartz Pharma |
Acquired by UCB, 2006, €4.4B |
Schwarz Pharma Manufacturing |
Acquired by UCB 2006 |
Scidera Genomics |
Bought by Neogen, Jan 2013 |
Sciele Pharma |
Bought by Shionogi |
Sciformix |
Acquired by LabCorp, Jun 2018 |
SciGen |
Bough by Yifan Pharmaceutical, Aug 2018 |
Scil Technology |
Acquired by Nanohale, Sep 2012, creating subsidiary Formycon |
Scioderm |
Bought by Amicus Aug 2015, $229M+$618M milestones |
Scios |
Bought by JnJ, Feb 2003 |
SciSafe |
Acquired by Biolife Solutions, Sep 2020 |
SCM Pharma |
Taken over by Shire, Aug 2014 |
Sea Lane Biotechnologies |
Assets acquired by i2 Pharmaceuticals, May 2017 |
SeaGen |
Acquired by Pfizer, Dec 2023, $43B |
Seahorse Bioscience |
Acquired by Agilent, Nov 2015 |
SeaView Research |
Acquired by Quotient Clinical, Feb 2017 |
Securus Medical |
Bought by Boston Scientific, Apr 2018, $40M |
Segetis |
Assets bought by GFBiochemicals, Feb 2016 |
SegWay Orthopedics |
Acquired by Trice Medical, Feb 2019 |
Select ImmunoGenomics |
Acquired by GeneCentric Therapeutics, Aug 2019 |
Selexis |
Merged with KBI Bio by parent, May 2023; Purchased by JSR Life Sciences, Jul 2017 |
Selexys |
Bought by Novartis, Nov 2016, $665M |
Semba Biosciences |
Acquired by Tosoh Biosciences, Oct 2021 |
Semma Therapeutics |
Acquired by Vertex, Sep 2019, $950M |
Semprus Biosciences |
Acquired by Teleflex Jun 2012 |
Senorx |
Acquired by Bard, May 2010, $200M |
Sense Biodetection |
Acquired by Sherlock Biosciences, Feb 2023 |
Sense Proteomics |
Acquired by Oxford Gene Technology, Mar 2009 |
Sensile Medical |
Acquired by Gerresheimer, Jul 2019, up to €350M |
SentreHEART |
Bought by AtriCure, Aug 2019, $300M |
Sentrx |
Bought by Telerx, Apr 2013 |
SeqRight |
Acquired by GE Apr 2012 |
Sequana Therapeutics |
Bought by Arris Pharmaceuticals 1998 |
Sequenom |
Bought by LabCorp, Sep 2016, $371M |
Sequenta |
Acquired by Adaptive Biotechnologies, Jan 2015 |
Seragon Pharmaceuticals |
Acquired by Genentech, Aug 2014 $725M + $1B Milestones; Acquired by JNJ Aug 2013 $650M + $350 Milestones |
Serametrix |
Acquired by Caprion Biosciences, Apr 2019 |
Serendex Pharmaceuticals |
Bought by Savara Pharmaceuticals, Jun 2016 |
Serendipity Bio |
Acquired by Arbor Biotechnologies |
Serenity Pharmaceuticals |
Acquired by Acerus, Mar 2022 |
SERF SAS |
Acquired by Stryker, Mar 2024 |
Serica Technologies |
Bought by Allergan |
Serono Laboratories |
Acquired by Merck KGaA, 2006 |
Sestina Bio |
Acquired by Inscripta, Jan 2023 |
Sexton Biotechnologies |
Acquired by BioLife Solutions, Sep 2021 |
SeylanMED |
Acquired by DermBiont, Oct 2020 |
SFL Regulatory Affairs & Scientific Communication |
Acquired by Veristat, Mar 2022 |
SGM Biotech |
Acquired by Mesa Biotech, Apr 2010 |
SGX Pharma |
Acquired by Eli Lilly Jul 2008 |
Shantha Biotech |
Acquired by Sanofi, Jul 2009, $784M |
Shenandoah Biotechnology |
Acquired by Fujifilm Irvine Scientific, Mar 2022 |
Sherpa Clinical |
Acquired by PCI Pharma Services, Oct 2018 |
Shire |
Bought by Takeda, Jan 2019, $62B |
Shutt Medical Technologies |
Acquired by CONMED, 1983 |
Sicor Biotech |
Bought by Teva 2004 |
Sierra Oncology |
Acquired by GSK, Jul 2022, $1.9B |
SIG Medical |
Acquired by Zimmer, Sep 2019 |
Sigilon Therapeutics |
Acquired by Eli Lilly, Aug 2023, $35M + $273.4M milestones |
Sigma-Aldrich |
Bought by Merck KgAA, Sep 2014, $17B, now part of MilliporeSigma |
SignalChem Lifesciences |
Acquired by Sino Biological, Oct 2023 |
Silarx Pharmaceuticals |
Acquired by Lannett, Jun 2015 |
Silene Biotech |
Acquired by NanoSurface Biomedical, Sep 2019 |
Silicon Therapeutics |
Acquired by Roivant, Feb 2021, $450M |
Siloam Biosciences |
Acquired by MiCo BioMed, May 2018 |
Silvergate Pharmaceuticals |
Acquired by cutisPharma, Jun 2019 |
SimplicityBio |
Acquired by Precision for Medicine, Mar 2019 |
Simplify Medical |
Acquired by NuVasive, Feb 2021, $150M |
Sinensis Life Sciences |
Acquired by eurofins, Jan 2016 |
Singular Bio |
Acquired by Invitae, Jun 2019 |
Sirion Biotechnology |
Acquired by PerkinElmer, Jun 2021 |
Sirius Analytical |
Acquired by pion, May 2017 |
Sirna Therapeutics |
Bought by Merck 2006, Sold to Alnylam Jan 2012 |
Sirtris Pharmaceuticals |
Acquired by GSK Apr 2008, Subsumed Mar 2013 |
Sitari Pharmaceuticals |
Acquired by GSK, Sep 2019 |
Siva Therapeutics |
Acquired by Sona Nanotech, Mar 2023, $2M + $6.65M milestones |
Skeletech |
Acquired by MDS, Aug 2005 |
SkinMedica |
Acquired by Allergan Dec 2012 ($350 million) |
Skyland Analytics |
Acquired by IDBS, Nov 2021 |
Slate Pharmaceuticals |
Bought by Actient Pharmaceuticals Dec 2011 |
Slayback Pharma |
Acquired by Azurity Pharmaceuticals, Sep 2023 |
Sloning Biotechnology |
Bought by MorphoSys, Oct 2010, $26.5M |
Small Pharma |
Acquired by Cybin, Aug 2023 |
SmartCells |
Bought by Merck Dec 2010 |
Smith Therapeutics |
Acquired by AZTherapies, Oct 2019 |
Smiths Medical |
Acquired by ICU Medical, Jan 2022, $2.35B |
Snapdragon Chemistry |
Acquired by Cambrex, Nov 2022 |
SNBL |
Acquired by Altasciences |
SNBL CPC |
Acquired by Pharmaron, Feb 2017 |
SOFAR surgical |
Acquired by TransEnterix, Sep 2015, $100M |
Soin Therapeutics |
Acquired by JanOne, Sep 2022 |
Solana Biosciences |
Acquired by Inscripta, Sep 2018 |
Solentim |
Acquired by Advanced Instruments, Aug 2021 |
Solid Form Solutions |
Acquired by Avista Pharma, Jan 2018 |
SoloHill Engineering |
Acquired by Pall, Mar 2014 |
Solstice Neurosciences |
Acquired by US World Meds 2010 |
Solsys Medical |
Acquired by Misonix, Sep 2019, $97M stock; fka Soluble Systems |
Solta Medical |
Acquired by Valeant, $236M Dec 2014 |
Soluble Therapeutics |
Bought by CytoBioscience, Dec 2016 |
Solvay |
Bought by Abbott 2010 |
Somahlution |
Acquired by Marizyme, Sep 2020 |
Somaxon Pharmaceuticals |
Bought by Pernix Mar 2013, Renamed Pernix Sleep |
Somerset Pharmaceuticals |
Acquired by Mylan, Jul 2008 |
Somna Therapeutics |
Acquired by Restech, Jun 2020 |
SoniTrack Systems |
Acquired by Zimmer Biomet, Jun 2016 |
Sonoma Orthopedics |
Acquired by Arthrex, Jul 2017 |
Sourcia |
Acquired by Alira Health, Apr 2022 |
Spatial Transcriptomics |
Acquired by 10x Genomics, Dec 2018 |
SpecialTeam |
Assets Acquired by Desco, Dec 2013 |
Specifar Pharmaceuticals |
Acquired by Watson Pharmaceuticals, May 2011, $562M |
Specific Diagnostics |
Acquire by bioMérieux, May 2022 |
Spectranetics |
Acquired by Philips, Aug 2017, $1.9B |
Spectrum Laboratories |
Bought by Repligen, Aug 2017, $359M |
Spectrum Pharmaceuticals |
Acquired by Assertio, Apr 2023, $248M |
Speedel Pharma |
Bought by Novartis, Jul 2008, $880M |
Sphinx Pharmaceuticals |
Acquired by Eli Lilly Mar 1994 |
Spinal Dynamics |
Acquired by Medtronic, Jun 2002, $270M |
Spinal Kinetics |
Acquired by Orthofix, Mar 2018, $105M |
Spindle Biotech |
Acquired by Applied DNA Sciences, Jul 2023, $1.6M |
Spinifex Pharmaceuticals |
Bought by Novartis, $200M + milestones, Jul 2015 |
Spinnovation Biologics |
Acquired by Sinensis Life Sciences, Oct 2014 |
Spiral Genetics |
Acquired by Omicia, Jan 2017 |
Spiration |
Acquired by Olympus, Jun 2010 |
Spirogen |
Bought by AstraZeneca, Oct 2013 |
Spirosure |
Acquired by Caire, Jun 2020; fka Spirometrix |
Spirox |
Bought by Stryker, Jul 2017 |
Springborn Laboratories |
Acquired by Charles River Labs, Oct 2002 |
SQN Clinical |
Acquired by Veristat, Feb 2021 |
SSCI |
Bought from Aptuit by AMRI, Jan 2015 |
SSS International Clinical Research |
Acquired by Optimapharma Group, Dec 2021 |
St. Jude Medical |
Acquired by Abbott, Jan 2017, $25B |
Stage Cell Therapeutics |
Bought by Juno Therapeutics, May 2015, €52.5 million |
SteadyMed |
Acquired by United Therapeutics, Aug 2018, $75M + $150M milestones |
Stealth Biologics |
Acquired by Occulo, Apr 2018 |
Stelios Therapeutics |
Acquired by LEXEO Therapeutics, Jul 2021 |
StelKast |
Acquired by Globus Medical, Sep 2019, $24.1M + $4.3M milestones |
Stellar Biotechnologies |
Acquired/Merged with Edesa Biotech, Jun 2019 |
Stemcentrx |
Bought by AbbVie, Apr 2016, $5.8B +$4B milestones |
Stemgent |
Acquired by ReproCELL, Sep 2014 |
Stiefel |
Acquired by GSK |
Stimgenics |
Acquired by Medtronic, Jan 2020 |
Strand Diagnostics |
Acquired by P4 Diagnostix, Feb 2020 |
Stratagene |
Acquired by Agilent, Apr 2007, $246M |
StrataGent Life Sciences |
Acquired by Corium, 2007 |
Stratatech |
Bought by Mallinckrodt, Aug 2017, $76M + $121M milestones |
Strategic Diagnostic Antibodies |
Acquired by Fitzgerald Industries, 2004 |
Strativa Pharmaceuticals |
Bought by Par Pharmaceutical, Sep 2007 |
Stratos Genomics |
Acquired by Roche, May 2020 |
Stromedix |
Bought by Biogen Idec 2012 |
Strongbridge Biopharma |
Acquired by Xeris, Oct 2021, $267M; fka Cortendo |
Stuart Pharmaceuticals |
Acquired by Atlas Chemical Industries |
Sucampo Pharmaceuticals |
Acquired by Mallinckrodt, Feb 2018 |
Sugen |
Acquired by Pharmacia & Upjohn, 1999, $650M stock; Shut down 2003 |
Summit Biosciences |
Acquired by Kindeva Drug Delivery, Jan 2024 |
Sun Pharm Corp |
Acquired by Geltex Pharmaceuticals |
Sunesis Pharmaceuticals |
Acquired by Viracta Therapeutics, Feb 2021 |
Sunstone BioSciences |
Acquired by Intelligent Material Solutions, 2010 |
superDimension |
Acquired by Covidien May 2012 |
Suppremol |
Acquired by Baxter, Mar 2015, €225M, part of Baxalta now |
Surface Logix |
Bought by Nano Terra |
Surface Oncology |
Acquired by Coherus, Sep 2023, $65M |
Surgical Specialties |
Renamed Corza Medical after acquisition/merger |
SurgiQuest |
Acquired by ConMed, Jan 2016, $265M |
SurgRx |
Acquired by Ethicon, Aug 2008 |
Suros Surgical Systems |
Bought by Hologic, Jul 2006, $240M |
Swift Biosciences |
Acquired by Integrated DNA Technologies, Mar 2021 |
SwiftScale Biologics |
Acquired by Resilience, Dec 2021 |
Swissfillon |
Acquired by ten23, Oct 2021 |
Sylics |
Acquired by Innoser, Jan 2023 |
Symbient Product Development |
Acquired by Gener8, Feb 2020 |
Symbiomix Therapeutics |
Acquired by Lupin, Oct 2017, $150M |
Symetis |
Acquired by Boston Scientific, May 2017, $435M |
Symmetry medical |
Acquired by Tecomet, Dec 2014 |
Symmetry Surgical |
Acquired by Aspen Surgical, Oct 2022 |
Symphogen |
Acquired by Servier, Jun 2020 |
Synageva BioPharma |
Acquired by Alexion, Jun 2015, $8.4B |
Synaptic Pharmaceuticals |
Acquired by Lundbeck, Nov 2002 |
Synbiotics |
Acquired by Pfizer Dec 2010. Included in Zoetis spinout |
SynCo Bio Partners |
Acquired by Wacker, May 2018 |
Syndesi Therapeutics |
Acquired by AbbVie, Mar 2022, $130M + $870M milestones |
Synergen |
Bought by Amgen 1994 |
Synergetics USA |
Acquired by Valeant, Sep 2015, $190M; Neurosurgical portfolio sold to Stryker, Feb 2016 |
Synergx |
Owned by Morphogenesis |
Synergy Health |
Acquired by Steris, Nov 2015 |
Synergy Pharmaceuticals |
Acquired by Bausch Mar 2019; Bankrupt, Dec 2018, want to accept Bausch bid $200M for assets, auction forthcoming |
Synosia Therapeutics |
Acquired by Biotie |
Synovel Sciences |
Bought by Fountain Pharma, Jan 2017 |
Synpromics |
Acquired by AskBio, Aug 2019 |
Syntagon |
Acquired by Ardena, May 2018 |
Syntax for Science |
Acquired by Optimapharm, Nov 2020 |
Synthes |
Acquired by Johnson & Johnson, Jun 2012, $19.7B |
Synthorx |
Acquired by Sanofi, Jan 2020, $2.5B |
Syntimmune |
Acquired by Alexion, Nov 2018, $400M + $800M milestones |
Syntonix Pharmaceuticals |
Acquired by Biogen, Jan 2007 |
Syrinx Bioanalytics |
Acquired by Senexa Life Science, May 2022 |
Syrrx |
Acquired by Takeda, Feb 2005, $270M |
Systagenix |
Acquired by KCI, Oct 2013, $485M |
SyStemix |
Acquired by Novartis, Jan 1997 |
Systems Medicine |
Acquired by CTI Jul 2007 |
T-cell Factory |
Bought by Kite Pharma Mar 2015 €20M |
Tacere Therapeutics |
Bought by Benitec Biopharma Oct 2012 |
Talaria Therapeutics |
Acquired by Esperion Therapeutics, Oct 2000, $7.3M shares |
Talent Biotechs |
Bought by Kalytera Therapeutics, Mar 2017, $10M + $20M milestones |
Taligen Therapeutics |
Acquired by Alexion |
Talon Therapeutics |
Bought by Spectrum Pharmaceuticals Jul 2013 |
Tamir Biotechnology |
Acquired by Orgenesis, Apr 2020 |
Tandem Laboratories |
Bought by LabCorp, 2008 |
Tandem Life |
Acquired by LivaNova, Feb 2018 |
TangenX |
Acquired by Novasep 2006, sold to Repligen, Dec 2016, $39M |
Tangshian Yian Biological Engineering |
Acquired by Sinovac |
Tanox |
Acquired by Genentech, Aug 2007, $919M |
Tantti |
Acquired by Repligen, Jul 2024 |
TAP Pharmaceuticals |
Acquired by Takeda |
Tapemark |
Acquired by LTS, Aug 2022 |
Tara Biosystems |
Acquired by Valo Health, Apr 2022 |
Tarbis Farma |
Acquired by Hetero Labs, Jan 2019 |
Targanta |
Bought by The Medicines Company |
TargeGen |
Bought by Sanofi 2010 |
Target Therapeutics |
Bought by Boston Scientific, Jan 1997 |
Taris Biomedical |
Acquired by J&J, Dec 2019 |
Tarsa Therapeutics |
Product rights acquired |
Tarus Therapeutics |
Acquired by Portage Biotech, Jul 2022 |
Taueret Laboratories |
Acquired by Predictive Technology Group, Mar 2019 |
Taurus Biosciences |
Acquired by Ligand Pharmaceuticals, Sep 2020, $5M |
Taxon Biosciences |
Acquired by DuPont, Apr 2015 |
TearScience |
Acquired by J&J, Nov 2017 |
TEI Biosciences |
Bought by Integra Life Sciences, Jun 2015 |
Telavant |
Acquired by Roche from Roivant, Dec 2023 |
Telesta Therapeutics |
Bought by ProMetic, Aug 2016, $34M |
Tenaxis Medical |
Bought by The Medicines Company, Sep 2013 |
Tendyne Holdings |
Acquired by Abbott, Sep 2015, $225M |
TeneoBio |
Acquired by Amgen, Oct 2021, $900M; fka OMT Therapeutics |
TeneoTwo |
Acquired by AstraZeneca, Aug 2022 |
Tenet Medicines |
Acquired by Eliem Therapeutics, Jun 2024 |
Tensha Therapeutics |
Acquired by Roche, Jan 2016, $115M + $420 Milestones |
Tepha Medical Devices |
Acquired by BD, Jul 2021 |
TeraImmune |
Acquired by Baudax Bio, Jun 2023 |
Tercica |
Bought by Ipsen, Oct 2008 |
TerraGen Discovery |
Acquired by Cubist Aug 2000, $31M stock |
Tesaro |
Acquired by GSK, Jan 2019, $5.1B |
TetraGenetics |
Acquired by AbCellera, Sep 2021 |
Tetraphase Pharmaceuticals |
Acquired by La Jolla Pharmaceuticals, Jul 2020, $43M |
Tetris Pharma |
Acquired by Arecor Therapeutics, Aug 2022 |
TGA Sciences |
Acquired by Absorption Systems, Dec 2017 |
Thallion Pharmaceuticals |
Bought by Taro Mar 2017; Bought by Bellus Health, Aug 2013 |
Thar Pharmaceuticals |
Acquired by Grünenthal, Nov 2016 |
The Binding Site |
Acquired by Thermo Fisher, Jan 2023, $2.6B |
The Medicines Company |
Acquired by Novartis, Jan 2020, $9.7B |
The Tech Group |
Acquired by West Pharma, May 2016 |
The Weinberg Group |
Acquired by ProPharma Group, Jan 2019 |
Themis Bioscience |
Acquired by Merck KgAA/MSD Jun 2020 |
Theorem Clinical Research |
Bought by Chiltern, Sep 2015 |
Therabron Therapeutics |
Bought by Brace Pharma Capital Jan 2015 |
TheraCell |
Acquired by Isto Biologics, Apr 2022 |
Therachon |
Bought by Pfizer, Jul 2019, $340M + $470M milestones |
Theragnostics |
Acquired by Ariceum Therapeutics, Jun 2023 |
Therapeia |
Program Acquired by Telix, Jan 2017 |
Therapeutic Human Polyclonals |
Acquired by Roche, Apr 2007, $56.5M |
Therapure Biopharma |
Acquired by Resilience, Apr 2021 |
TheraSense |
Acquired by Abbott, Jan 2004, $1.2B |
Theravant |
Assets acquired by STRATA Skin Sciences |
Therics |
Acquired by Integra |
TherOx |
Acquired by Zoll, Jun 2019 |
Therox Pharmaceuticals |
Acquired by OXIS International, Jul 1995 |
Theseus Pharmaceuticals |
Acquired by Concentra Pharmaceuticals, Feb 2024 |
Thievon-Wright Consulting Group |
Acquired by ERG Clinical, Apr 2018 |
Third Wave Technologies |
Acquired by Hologic Jun 2008 |
Thoratec |
Bought by St. Jude Medical, Oct 2015, $3.4B |
Thrive Earlier Detection |
Acquired by Exact Sciences, Oct 2020, $2.15B |
Tiancheng Pharmaceutical |
Acquired by Grifols, Mar 2022, $1.27B |
Tibotec Therapeutics |
Bought by JnJ, now Janssen Therapeutics |
Tidal Therapeutics |
Acquired by Sanofi, Apr 2021, $160M + $310M milestones |
TiGenix |
Acquired by Takeda, Jul 2018, $630M |
Tilos Therapeutics |
Acquired by Merck, Jun 2019, up to $773M |
Timber Pharmaceuticals |
Acquired by LEO Pharma, Nov 2023 |
TISSUE SOLUTIONS |
Acquired by BioIVT, Jul 2021 |
Titan Spine |
Bought by Medtronic, Jun 2019 |
Tmunity Therapeutics |
Acquired by Kite Therapeutics, Feb 2023 |
TNI Medical |
Acquired by Masimo, Mar 2020 |
Tobira Therapeutics |
Bought by Allergan, Nov 2016, $600M + milestones |
Tocris Bioscience |
Acquired by Bio-Techne, 2011 |
Tolero Pharmaceuticals |
Rolled in Sumitomo Dainippon Pharma Oncology, Jun 2020; Acquired by Sumitomo Dainippon Pharma, Jan 2017 |
TomegaVax |
Acquired by Vir Biotechnology, Jan 2017 |
TomoTherapy |
Bought by Accuray, Mar 2011, $277M |
Tonbo Biosciences |
Acquired by Cytek Biosciences, Nov 2021 |
Tongjitang Chinese Medicines Company |
Bought by Winteam Pharmaceutical |
Topaz Pharma |
Bought by Sanofi Pasteur 2012 |
Topera Medical |
Acquired by Abbott, 2014, renamed Abbott Electrophysiology |
Topokine Therapeutics |
Acquired by Allergan, Apr 2016, $85M + milestones |
TopoTarget USA |
Sold to Apricus Bio, Dec 2011 |
Topstone Research |
Acquired by Veristat, Oct 2018 |
TORAX Medical |
Acquired by Ethicon, Mar 2017 |
toSense |
Acquired by Baxter, Jun 2020 |
Totient |
Acquired by Absci, Jul 2021 |
Toxikon |
Acquired by Labcorp, Dec 2021 |
Tramontane Therapeutics |
Acquired by Kriya Therapeutics, Sep 2023 |
Transcend Medical |
Acquired by Alcon, Feb 2016, up to $740M |
Transferra Nanosciences |
Acquired by Evonik Jun 2016; fka Northern lipids |
Transform Pharmaceuticals |
Bought by JnJ 2005 |
Transition Therapeutics |
Bought by Opko, $60M stock, Jul 2016 |
Transkaryotic Therapies |
Acquired by Shire, 2005 |
Translate Bio |
Acquired by Sanofi, Sep 2021, $3.2B; fka RaNa Therapeutics |
TransMolecular |
Assets Sold to Eisai 2011 |
Transmotion Medical |
Assets acquired by Winco, Jun 2015 |
TransPharma Medical |
Assets acquired by Syneron, Mar 2012 |
Transport Pharmaceuticals |
Purchased by NitricBio, Oct 2009 |
Travanti Pharma |
Acquired by Teikoku Pharma, May 2009 |
Trevigen |
Acquired by Bio-Techne, Sep 2017 |
Triad Isotopes |
Acquired by Jubilant, Jun 2019 |
Triad Therapeutics |
Acquired by Monogram Energy Oct 2009 |
Triangle Pharmaceuticals |
Acquired by Gilead, 2003, $464M |
Triangle Research Labs |
Acquired by Lonza, Jun 2016 |
Trianni |
Acquired by AbCellera, Nov 2020, $90M |
Triax Pharmaceuticals |
Acquired by Onset Dermatology |
TrichoScience Innovations |
Owned by RepliCel Life Sciences |
Trigenesis Therapeutics |
Acquired by Dr. Reddy's Laboratories |
TRIGR Therapeutics |
Acquired by Compass Therapeutics, Jun 2021, $50M |
Trilliant Surgical |
Acquired by DJO, Jan 2021 |
Trillium Therapeutics |
Acquired by Pfizer, Nov 2021, $2.3B |
Trimb Healthcare |
Acquired by Karo Pharma, Sep 2019 |
Trinity Pharmaceuticals |
Acquired by Chiesi Farmaceutici, 1999 |
Tripos |
Bought by Certara |
Trius Therapeutics |
Acquired by Cubist Sep 2013 |
Trophos |
Acquired by Roche, Jan 2015, €120M + €350 milestones |
Trubion Pharmaceuticals |
Acquired by Emergent BioSolutions Aug 2010, $97M |
True North Therapeutics |
Acquired by Bioverativ, Jun 2017, $400M + $425M milestones; Spinout from iPerian, 2013 |
Truvic Medical |
Acquired by Imperative Care, Jul 2021 |
TRx Pharmaceuticals |
Acquired by Cerecor, Nov 2017 |
Tryp Therapeutics |
Acquired by Exopharm, May 2024 |
tte laboratories |
Acquired by Transcat |
Tularik |
Bought by Amgen, Mar 2004, $1.3B |
Turning Point Therapeutics |
Acquired by BMS, Aug 2022, $4.1B; fka TP Therapeutics |
Tusk Therapeutics |
Acquired by Roche, Sep 2018, $81M + $679M milestones; Team spinning out into new company Black Belt Therapeutics |
Tusker Medical |
Acquired by Smith & Nephew, Jan 2020 |
Tute Genomics |
Acquired by PierianDx, Oct 2016 |
Twelve |
Bought by Medtronic, Aug 2015, $458M |
Twelve Bio |
Acquired by Ensoma, Feb 2023 |
TX3 Services |
Acquired by Tricentis, Mar 2022 |
TxCell |
Bought by Sangamo, Oct 2018, $84M |
TyrNovo |
Bought by Kitov Therapeutics, Jan 2017, $2M + $1.8M stock |
TYRX |
Acquired by Medtronic, Jan 2014, $160M |
U3 pharma |
Bought by Daiichi Sankyo, May 2008, $235M; closed 2015 |
UDL Laboratories |
Acquired by Mylan 1996 |
Ultransonix |
Acquired by Analogic, Mar 2013, $83M |
UmanDiagnostics |
Acquired by Quanterix, Jun 2019, $16M cash+$6.5M stock |
Unimed Pharmaceuticals Inc |
Acquired by Solvay Jun 1999 |
URL Pharma |
Bought by Takeda Apr 2012, Bought by Sun Pharma Dec 2012 |
Urogenix |
Acquired by Astellas |
Urovant Sciences |
Acquired by Sumitomo Dainippon Pharma with four other Roivant companies, Dec 2019, $3B; |
US Diagnostics |
Bought by Alere, Jul 2015, $60M |
US Endoscopy |
Acquired by Steris, Jul 2012 |
US Labs |
Bought by Labcorp |
Valence Health |
Acquired by Evolent Health, Oct 2016 |
ValenzaBio |
Acquired by Acelyrin, Jan 2023 |
Valeritas |
Acquired by Zealand Pharma, Feb 2020, $23M |
Valinor |
Acquired by Grunenthal, Jul 2024, $250M |
Valitacell |
Acquired by Beckman Coulter, Sep 2022 |
Valocor Therapeutics |
Acquired by Dermira, Oct 2011 |
Valtech Cardio |
Acquired by Edwards Lifesciences, Jan 2017, $340M |
ValueGene |
Acquired by Integrated DNA Technologies, Jun 2016 |
Vanadis Diagnostics |
Bought by PerkinElmer, Jan 2016 |
Vandalia Research |
Assets acquired by Applied DNA Sciences, $1.5M, Sep 2015 |
Vanrx Pharmasystems |
Acquired by Cytiva, Feb 2021 |
VARIAGENICS |
Acquired by Hyseg Pharmaceuticals, Nov 2002, $55.9M |
Varian Bio |
Acquired by Biodexa, May 2023 |
Vascular Insights |
Assets acquired by Merit Medical, Jan 2019 |
Vascular Solutions |
Acquired by Teleflex, Dec 2016 |
VasoGen |
Assets acquired in complex transaction by Intellipharmaceutics, Oct 2009 |
VasoNova |
Acquired by Teleflex Medical |
VaxDesign |
Acquired by Sanofi Pasteur, Sep 2010, $55M |
VaxGen |
Acquired by diaDexus, Jul 2010 |
VCN Biosciences |
Acquired by Synthetic Biologics, Mar 2022 |
VectivBio |
Acquired by Ironwood Pharmaceuticals, May 2023, $1B |
Vedere Bio |
Renamed Vedere Bio II ayfter most assets acquired by Novartis, Oct 2020, $150M + $130M Milestones |
Velano Vascular |
Acquired by BD, Jul 2021 |
Velesco Pharmaceutical Services |
Acquired by Pace Analytical, Oct 2021 |
Velocity Medical Solutions |
Acquired by Varian Medical, Apr 2014 |
Velos |
Acquired by WCG, Mar 2018 |
VelosBio |
Acquired by Merck, Oct 2020, $2.75B |
Velquest |
Bought by Accelrys Jan 2012 |
Veniti |
Acquired by Boston Scientific, Aug 2018, $108M + milestones (already owned 25%) |
Ventana |
Acquired by Roche, Jan 2008 $3.4B |
VentiRx Pharmaceuticals |
Apparently acquired by Celgene |
Veran Medical Technologies |
Acquired by Olympus, Dec 2020, $340M |
VeraSci |
Acquired by WCG, Jul 2021; fka Neurocog Trials |
Verb Surgical |
Acquired by J&J Dec 2019 |
Verenium |
Bought by BASF, Dec 2013 |
Veridex |
Bought by J&J, now Part of Janssen Diagnostics |
Verinata Health |
Acquired by Illumina, Jan 2013, $350M+ |
Verisante Technology |
Acquired via Reverse Merger and seems to have left life sciences, Apr 2018 |
Verlyx Pharma |
Acquired by Odan Laboratories, Dec 2018; fka Oncozyme Pharma, McGill spinout |
Verogen |
Acquired by Qiagen, Jan 2023, $150M |
VeroPharm |
Acquired by Abbott, Dec 2014, $495M |
Verrow Pharmaceuticals |
Acquired by Ligand Pharmaceuticals, Jan 2018, $2M |
Versantis |
Acquired by genfit, Sep 2022, CHF40M + CHF65M milestones |
Vertera Spine |
Bought by NuVasive, Sep 2017 |
Vertical Bio |
Acquired by Pierre Fabre, Sep 2023 |
Vertiflex |
Acquired by Boston Scientific, Jun 2019, $465M |
Vessix Vascular |
Acquired by Boston Scientific, Nov 2012, $425M |
Vetex Medical |
Acquired by Surmodics, Jul 2021, $40M + $10.5M milestones |
Vexim |
Acquired by Stryker, Feb 2018, $216M |
Via Biomedical |
Acquired by Heraeus Medical, Sep 2019 |
ViaCyte |
Acquired by Vertex, Nov 2022, $320M |
Viagene |
Acquired by Chiron, Apr 1995, $95M |
Viamet Pharmaceuticals |
Acquired by NovaQuest Capital Management, assets put into new company Selenity Therapeutics, Jan 2018 |
Viasys Healthcare |
Acquired by Cardinal Health, May 2007, $1.5B |
Viatris (1) |
Acquired by Meda, Aug 2005, €750M |
Vibalogics |
Acquired by Recipharm, Feb 2022 |
Vibalogics |
Acquired by Recipharm, Feb 2022 |
Vicept Therapeutics |
Acquired by Allergan, 2011 |
Victory Pharma |
Assets Acquired by Shionogi |
Vicuron Pharmaceuticals |
Acquired by Pfizer (2005) then sold to Durata (2010) |
Vidara Therapeutics |
Acquired by Horizon Pharma, Sep 2014 |
Viela Bio |
Acquired by Horizon Therapeutics, Mar 2021, $3B; MedImmune spinout |
Vifor Pharma |
Acquired by CSL, Aug 2022, $11.7B |
Vigene Biosciences |
Acquired by Charles River, Jun 2021, $292M + $57M milestones |
Vintage Pharmaceuticals |
Acquired by Apax Partners, Sep 2007, now part of Endo |
Viracor-IBT |
Renamed Viracor Eurofins; Bought by Eurofins, May 2014 |
Viralytics |
Bought by Merck KGaA, Jun 2018, $394M |
Virapur |
Acquired by Microbiologics, 2017 |
ViraTherapeutics |
Bought by Boehringer Ingelheim, Sep 2018, $244M |
Virco |
Bought by J&J |
Virdante Pharmaceuticals |
Assets acquired by Momenta |
Viridian Pharma |
Acquired by Martindale Pharma, Jul 2016 |
Viridus Animal Health |
Bought by Huvepharma, Mar 2014 |
ViroCyt |
Acquired by Sartorius, Jul 2016, $16M; Spun out of InDevR |
ViroMed Laboratories |
Acquired by LabCorp, Jun 2001 |
ViroPharma |
Bought by Shire Jan 2014 |
Viroxis |
Acquired by an oil company, folded into Santalis, Jun 2015 |
Virttu Biologics |
Acquired by TNK Therapeutics, Apr 2017 |
VisEn Medical |
Acquired by PerkinElmer, 2010 |
Visterra |
Acquired by Otsuka, Sep 2018, $430M |
|